<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/doi/10.1126/sciimmunol.aao3669');</script>

        <script> var body_html = '<body > <div > <div > <div > <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div ><a >Anywhere</a><a >Science</a><a >Science Advances</a><a >Science Immunology</a><a >Science Robotics</a><a >Science Signaling</a><a >Science Translational Medicine</a></div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > <a >covid-19</a> </li> <li > <a >climate</a> </li> <li > <a >science policy</a> </li> <li > <a >genome editing</a> </li> <li > <a >batteries</a> </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > <a >Current Issue</a> </li> <li > <a >First release papers</a> </li> <li > <a >Archive</a> </li> <li > <div > <a >About</a> <div > <a >About Science Immunology</a> <a >Mission Scope</a> <a >Editors Advisory Boards</a> <a >FOCIS Highlights</a> <a >Editorial Policies</a> <a >Information for Authors</a> <a >Information for Reviewers</a> <a >Journal Metrics</a> <a >Contact Us</a> <a >Free Sample Articles</a> </div> </div> </li> </ul> </div> <div > <ul > <li > <a >Submit manuscript</a> </li> <li > <div > <a >More</a> </div> </li> </ul> </div> </div> <a >GET OUR E-ALERTS</a> </div></div></div> <main > <div ><div ><div ><div ><div > <div ><a >Home</a><a >Science Immunology</a><a >Vol. 6, No. 66</a>IL-17–dependent fibroblastic reticular cell training boosts tissue protective mucosal immunity through IL-10–producing B cells</div><div >Back To Vol. 6, No. 66</div> </div> <article ><section ><header><div ><div ><div ><div >FREE ACCESS</div><div >Research Article</div><div >MUCOSAL IMMUNOLOGY</div></div><div ><div > <div >Share on</div> </div></div></div><h1 >IL-17–dependent fibroblastic reticular cell training boosts tissue protective mucosal immunity through IL-10–producing B cells</h1><div >Dongwen Wu https://orcid.org/0000-0001-7909-5708, Catherine H. Poholek https://orcid.org/0000-0002-9381-9618, Saikat Majumder https://orcid.org/0000-0002-6591-9515, Qixing Liu https://orcid.org/0000-0002-9076-6274, Shankar K. Revu, Kanishka Mohib https://orcid.org/0000-0002-7332-5530, David M. Rothstein https://orcid.org/0000-0002-9455-7971, and Mandy J. McGeachy https://orcid.org/0000-0001-5029-1668 [email protected]</div><div >Science Immunology • 17 Dec 2021 • Vol 6, Issue 66 • DOI: 10.1126/sciimmunol.aao3669</div><div ><div > <div > <a ><div ><div ><h6>PREVIOUS ARTICLE</h6><div>Move over NAIP, DDX17 diversifies the NLRC4 inflammasome</div></div></div>Previous</a><a ><div ><div ><h6>NEXT ARTICLE</h6><div>In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4<sup>+</sup> T<sub>H</sub>1 cell response</div></div></div>Next</a> </div> </div></div></div></header><div ><div ><section ><h2 >Stromal cells in training immunity</h2><div >Immune responses to pathogens are heightened in individuals previously exposed to pathogen-associated stimuli, a phenomenon known as innate immune training. Innate immune training is accomplished through metabolic reprogramming and epigenetic changes, but the underlying mechanisms are not fully understood. In this study, Wu <i>et al.</i> investigate the functional requirement of IL-17 receptor signaling in fibroblastic reticular cells (FRCs) in the development of protective antibody responses against gut infection and studied how innate immune training affects these responses. Mild gut inflammatory training before <i>C. rodentium</i> infection enhanced gut-protective antibody production and reduced colon inflammation. Inflammatory training required IL-17 signaling in FRCs and IL-10 production by B cells. These findings reveal a mechanism of innate immune training in FRCs for protection against gut infection.</div></section><section ><h2 >Abstract</h2><div >Prior experience of pathogen-associated stimuli reduces morbidity and mortality to newly encountered infections through innate immune training, which can be enhanced by childhood vaccination. Fibroblastic reticular cells (FRCs) are stromal cells in lymphoid organs that support lymphocyte localization and survival and modulate adaptive immune responses. IL-17 signaling is important for FRC metabolism and proliferation during inflammatory responses. Here, we show that FRC-intrinsic IL-17 signaling was required for protective antibody-mediated immunity to the gut bacterial pathogen <i>Citrobacter rodentium.</i> We asked whether prior activation of FRC through nonspecific inflammatory “training” of the gut would alter subsequent immune response to <i>C. rodentium</i>. Inflammatory training increased the number of activated FRC in mesenteric LN (MLN) and enhanced the antibody response to <i>C. rodentium</i> in an IL-17–dependent manner. FRC demonstrated cardinal features of innate immune training, including increased epigenetic markers of activation and increased metabolic response to infection. Enhanced responses were still evident 6 weeks after training. The kinetics of bacterial infection were not changed by inflammatory training, but colon inflammation was paradoxically reduced. Mechanistically, IL-10 production by activated B cells was required for colon protective effects of inflammatory training. Enhancing tissue protective B cell responses thus led to increased production of antibody and IL-10, allowing clearance of infection with reduced tissue inflammation. These data identify a new mode of immune training through FRC to modulate future adaptive responses and better preserve host health.</div></section></div></div></section><section ><div ><section ><h2>INTRODUCTION</h2><div >Vaccination programs have greatly reduced childhood mortality, even beyond the prevalence of the specific diseases targeted. One of the mechanisms underlying this broad protective effect is innate immunological training, whereby exposure to pathogen-associated molecules activates a form of nonspecific innate memory that more effectively resists future “new” infections (<a ><i>1</i></a>). This heightened responsiveness is accomplished through metabolic reprogramming and epigenetic modifications that persists for months after the initial challenge. Trained immunity likely contributes to the increasing resistance to infectious disease, both previously encountered and new, which occurs over time in children as they are exposed to a range of microbes, and hence, vaccination hastens this process.</div><div >Diarrheagenic pathogens are the second leading cause of infection-related deaths in children under the age of 5 years according to the World Health Organization (<a ><i>2</i></a>, <a ><i>3</i></a>). <i>Escherichia coli</i> is a major contributor to diarrheal-related deaths (<a ><i>4</i></a>, <a ><i>5</i></a>), with more than 300 million illnesses and 200,000 deaths globally each year (<a ><i>6</i></a>). <i>Citrobacter rodentium</i> is widely studied as the murine equivalent to enteropathogenic <i>E. coli</i> and enterohemorrhagic <i>E. coli</i>, two pathotypes of diarrheagenic <i>E. coli</i>, because they share a similar colonization strategy known as attaching and effacing lesion formation (<a ><i>7</i></a>, <a ><i>8</i></a>). Interleukin-17 (IL-17), interferon-γ, and IL-22 produced by T helper 17 (T<sub>H</sub>17) and innate lymphoid cells induce the production of antimicrobial peptides by intestinal epithelium and activate myeloid cells (<a ><i>9</i></a>–<a ><i>11</i></a>). Although effective in controlling the infection, the by-product of this proinflammatory response is transient colitis that lasts 2 to 4 weeks after infection. In contrast, antibody specific to <i>C. rodentium</i> protects against reinfection without causing inflammation (<a ><i>12</i></a>, <a ><i>13</i></a>). This is the goal of vaccination programs, to bypass the early inflammation driven by innate and T cell immunity and invoke an antibody response that can provide protective immunity without affecting host health.</div><div >Secondary lymphoid organs provide critical support for both T and B cell activation and optimal antibody production through germinal center (GC) formation (<a ><i>14</i></a>, <a ><i>15</i></a>). Fibroblastic reticular cells (FRCs) are lymph node (LN) stromal cells that produce cytokines and chemokines to support survival and function of lymphocytes and organization of LN architecture (<a ><i>16</i></a>, <a ><i>17</i></a>). FRCs have been found to both promote and regulate adaptive immune responses and thus are considered active players in immune responses (<a ><i>18</i></a>). We recently showed that IL-17 signaling is critical for metabolic reprogramming of activated FRC during experimental autoimmune encephalomyelitis (EAE) and linked IL-17–dependent activation of FRC to enhanced autoantibody production (<a ><i>19</i></a>).</div><div >In this study, we queried the functional requirement for IL-17 receptor signaling in FRCs during development of protective antibody responses to gut infection. Because metabolic reprogramming is a hallmark of immunological training in myeloid cells (<a ><i>1</i></a>, <a ><i>20</i></a>), we further hypothesized that prior FRC activation through nonspecific gut inflammation could alter a subsequent immune response to gut infection with <i>C. rodentium</i> by enhancing <i>C. rodentium</i>–specific antibody. Here, we demonstrate that IL-17–dependent FRC activation promotes protective antibody responses both in adaptive memory and in nonspecific inflammatory training models. Furthermore, inflammatory training not only enhances antibody production but also reduces colon inflammation independent of <i>C. rodentium</i> infection burden. Last, we show that inflammatory training relies on FRC-intrinsic IL-17 signaling and IL-10 production by B cells, revealing a previously unappreciated mechanism of FRC training that modulates adaptive immunity with increased host health during infection.</div></section><section ><h2>RESULTS</h2><section ><h3>Loss of FRC-intrinsic IL-17 signaling delays <i>C. rodentium</i> clearance</h3><div >To determine whether IL-17 signaling in LN stromal cells plays a role in protection during infection of the gut, mice lacking the IL-17 receptor subunit IL-17RA specifically in FRCs were generated by crossing <i>Ccl19</i><sup>cre</sup> mice with <i>Il17ra</i><sup>fl/fl</sup> mice, hereafter termed FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice. There is no difference in basal numbers of FRC in this mouse strain (<a ><i>19</i></a>). Control mice were <i>Ccl19</i>cre<sup>−</sup><i>Il17ra</i><sup>fl/fl</sup> wild-type (WT) littermates (FRC<sup>Ctrl</sup>). Upon infection with <i>C. rodentium,</i> FRC numbers were reduced in the mesenteric LNs (MLNs) draining the gut of infected FRC<sup>∆</sup><i><sup>Il17ra</sup></i> compared with FRC<sup>Ctrl</sup> mice (<a >Fig. 1A</a> and fig. S1A). This was expected from our prior studies on FRC numbers in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice in EAE and dextran sulfate sodium (DSS) colitis (<a ><i>19</i></a>). Fecal burden of <i>C. rodentium</i> was similar between FRC<sup>∆</sup><i><sup>Il17ra</sup></i> and FRC<sup>Ctrl</sup> mice during the first week of infection, indicating that there was no difference in the ability of the innate response to control infection in the colon during this initial phase. However, during the second week of infection, corresponding to the adaptive immune response, FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice showed an impaired ability to clear bacteria (<a >Fig. 1B</a>).</div><div >Although <i>C. rodentium</i> infection and associated transient colitis do not typically induce severe weight loss in WT mice, infected FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice had a slight but significant reduction in body mass compared to controls (<a >Fig. 1C</a>). FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice also had significantly shorter colons, indicating increased colitis (<a >Fig. 1D</a>). Gene expression analysis of the FRC<sup>∆</sup><i><sup>Il17ra</sup></i> colon further supported an enhanced local inflammatory response compared with controls, with increased expression of <i>Il17a</i> and <i>Ifng</i> (<a >Fig. 1E</a>). Unexpectedly, the T<sub>H</sub>17-associated proinflammatory gene <i>Csf2</i>, encoding granulocyte-macrophage colony-stimulating factor (GM-CSF), was reduced in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mouse colon, suggesting a possible defect in myeloid cell activation. However, a major product of protective myeloid cell function in <i>C. rodentium</i>, <i>Il1b</i>, was increased in the absence of FRC signaling (<a >Fig. 1E</a>) (<a ><i>21</i></a>, <a ><i>22</i></a>). IL-22 plays important roles in <i>C. rodentium</i> clearance through induction of antimicrobial peptides including REGIIIγ and increased IL-18 expression in infected epithelial cells (<a ><i>23</i></a>–<a ><i>26</i></a>). IL-22 expression was also notably reduced, but <i>Il18</i> was unchanged, and <i>RegIIIg</i> was increased (<a >Fig. 1E</a>), suggesting possible compensation for example through enhanced IL-17 signaling.</div><div >Overall, these data suggest that delayed clearance is associated with altered tissue cytokine responses and increased inflammation, but key effector molecules (such as antimicrobial peptides) continue to be induced and are perhaps increased. We therefore turned to investigate another key mediator of protective immunity in <i>C. rodentium</i> infection, namely, B cell activation and antibody production. There was a significant decrease in the frequency of GC B cells when FRCs could not respond to IL-17 (<a >Fig. 1F</a> and fig. S1B). Although immunoglobulin A (IgA) antibody responses are most strongly associated with mucosal immunity, <i>C. rodentium</i>–specific IgG is essential for its clearance (<a ><i>27</i></a>, <a ><i>28</i></a>). Correspondingly, total IgG and <i>C. rodentium</i>–specific IgG were significantly reduced in serum of FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice on day 14 after infection (<a >Fig. 1, G and H</a>). Fecal <i>C. rodentium</i>–specific IgA was similarly reduced at multiple time points after infection (<a >Fig. 1I</a>). Hence, delayed clearance of <i>C. rodentium</i> in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice corresponds to impaired antibody responses accompanied by perturbation of the colon cytokine response and increased inflammation.</div></section><section ><h3>Loss of protective immunity against <i>C rodentium</i> without FRC-intrinsic IL-17 signaling</h3><div >Because antibodies are the basis of protective immunity to <i>C. rodentium</i>, we tested the susceptibility of FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice to reinfection. Sixty days after primary infection, <i>C. rodentium</i> DNA could not be detected in stool for either FRC<sup>Ctrl</sup> or FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice (<a >Fig. 2A</a>). This indicated that the increased cytokine-driven antimicrobial response in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice had sufficiently compensated for reduced antibody to clear the infection. Upon rechallenge with <i>C. rodentium,</i> the bacteria were not detectable in most of the control mice and only in low amounts in those that developed infection, demonstrating the potency of immune memory (<a >Fig. 2, A and B</a>). However, all of the FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice developed detectable <i>C. rodentium</i> infection by 10 days after reinfection (<a >Fig. 2, A and B</a>). Reinfected FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice experienced significant weight loss and colitis (colon shortening) compared with FRC<sup>Ctrl</sup> mice (<a >Fig. 2, C and D</a>). Because memory T cell responses are expected to peak earlier upon reinfection, we analyzed the colon on day 10 for expression of inflammatory genes. These were mostly unchanged with a trend toward increased IL-17 and IL-1β in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice compared with FRC<sup>Ctrl</sup> mice (<a >Fig. 2E</a>). <i>Csf2</i>, encoding GM-CSF, was the only marker to show decreased expression in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice on day 10 after reinfection (<a >Fig. 2E</a>). However, both the percentage and absolute number of GC B cells in gut-draining LNs were reduced in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice (<a >Fig. 2, F and G</a>). Correspondingly, the production of <i>C. rodentium</i>–specific IgG was decreased in both FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice serum and feces (<a >Fig. 2, H and I</a>).</div></section><section ><h3>Mild gut inflammation enhances FRC and antibody response to subsequent infection</h3><div >DSS induces transient gut injury and inflammation and is a commonly used mouse model of colitis (<a ><i>29</i></a>). DSS colitis increases FRC numbers in MLNs (<a ><i>19</i></a>), lasting several weeks after DSS removal (fig. S2A). We therefore administered a low dose (1%) of DSS to induce mild gut injury as a nonspecific inflammatory immune training for a period of 7 days, followed by 1 week of rest to allow resolution of colon inflammation. Mice were then infected with <i>C. rodentium</i>, and the outcome was compared 14 days after infection. Mild DSS training did not cause significant weight loss in most mice (fig. S2B). However, after <i>C. rodentium</i> infection, MLN from trained mice had increased FRC numbers compared with MLNs from untrained mice (<a >Fig. 3A</a>). Similarly, total numbers of MLN cells were increased in infected mice with prior inflammatory training (<a >Fig. 3B</a>). The proportion of MLN CD4<sup>+</sup> T cells were not changed under any condition (fig. S2C). In contrast, the percentage and number of total B cells and GC B cells were significantly increased in mice that were infected by <i>C. rodentium</i> after inflammatory training (<a >Fig. 3, C and D</a>, and fig. S2, D and E). Corresponding to increased GC B cells, T follicular helper (T<sub>FH</sub>) cells were increased in MLN from trained mice after infection (<a >Fig. 3, E and F</a>, and fig. S2F). DSS treatment alone did not induce any appreciable increase in total IgG or <i>C. rodentium</i>–specific IgG (<a >Fig. 3, G and H</a>). However, prior experience of gut inflammatory training significantly enhanced the IgG response to <i>C. rodentium</i> (<a >Fig. 3, G and H</a>). Despite the enhanced antibody response, there was no consistent change in kinetics of <i>C. rodentium</i> infection or clearance in mice that had experienced mild DSS colitis before infection (<a >Fig. 3I</a>).</div><div ><i>C. rodentium</i> induces transient colitis, and given that prior inflammatory training led to an increased adaptive immune response, we initially predicted that inflammatory gut training followed by infection would enhance colon inflammation and immunopathology. Instead, mice that had experienced mild DSS colitis were unexpectedly protected from <i>C. rodentium</i>–induced colitis as measured by colon shortening (<a >Fig. 3J</a>). This was further supported by reduced <i>Il17a</i> expression in colon tissues on day 14 after infection, whereas other inflammatory cytokines and antimicrobial peptides were unchanged by training (<a >Fig. 3, K to Q</a>). In accordance with the similar early infection load in trained and untrained mice, prior DSS treatment did not cause appreciable changes in inflammatory or antimicrobial immune responses in the distal colon on day 5 after infection (<a >Fig. 3, K to Q</a>). Together, these data demonstrate that prior inflammation leads to an altered adaptive immune response to subsequent de novo infection, resulting in enhanced B cell immunity but reduced tissue inflammation.</div></section><section ><h3>Evidence for trained immunity in MLN FRC after mild colitis</h3><div >The enhanced protective response to a new infection after mild colitis was reminiscent of the protection provided by innate immune training. There are several hallmark features of trained immunity, particularly (i) enhanced response to de novo stimuli, (ii) longevity of the innate “memory,” (iii) epigenetic alterations that create memory, and (iv) enhanced metabolic status of trained cells. Our data, so far, support enhanced adaptive response to infection. To test for longevity, we administered DSS and rested mice for 6 weeks before infection with <i>C. rodentium</i>. Mice that were trained 6 weeks before infection again showed significantly increased numbers of FRC (<a >Fig. 4A</a>), accompanied by increased GC B cells in MLN (<a >Fig. 4, B and C</a>), and enhanced antibody responses to <i>C. rodentium</i> (<a >Fig. 4, D and E</a>). As before, training resulted in protection of colon tissue as measured by colon length and expression of inflammatory cytokines (<a >Fig. 4, F to M</a>). The reduction in inflammation was more clearly demarcated when mice were rested for 6 weeks, suggesting that residual inflammation from the mild DSS treatment was still present when rested for only 1 week. Hence, these data support the longevity of the trained response leading to enhanced humoral immunity and reduced inflammation.</div><div >We next tested for epigenetic changes in the expanded FRC population after DSS training (<a >Fig. 4N</a>). FRC from trained mice showed enhanced trimethylation at the fourth lysine residue of the DNA packaging protein histone H3 (H3K4me3), an epigenetic modification suggesting increased promoter activity (<a >Fig. 4O</a> and fig. S3A).</div><div >We have previously shown that inflammatory activation leads to enhanced glucose uptake by FRC in an IL-17–dependent manner, corresponding to enhanced function in metabolic assays (<a ><i>19</i></a>). On the basis of this, we asked whether prior activation of FRC by DSS colitis resulted in altered glucose uptake as a measure of metabolic capacity in response to subsequent infection. Glucose uptake by FRC at 5 days after infection was significantly enhanced in infected mice that had received DSS training compared with untrained infected controls (<a >Fig. 4, P and Q</a>, and fig. S3B). Hence, FRC bear hallmark features of trained immunity after mild gut inflammation that corresponds to a sustained capacity to boost the immune response to a new infection.</div></section><section ><h3>FRC-intrinsic IL-17 signaling is required for immune training during gut inflammation</h3><div >The data so far suggest that FRC activation by prior gut inflammatory training results in increased antibody responses and reduced colon inflammation when a new pathogen (<i>C. rodentium</i>) is encountered. However, other cell types in the colon or MLNs could also undergo immune training to contribute to the effect. We previously showed that FRC-intrinsic IL-17 signaling is required for metabolic reprogramming and proliferation of FRC (<a ><i>19</i></a>). We therefore tested the gut inflammation-trained response in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice. Inflammatory training did not prevent the weight loss experienced by FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice upon infection (fig. S4). As predicted, FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice had significantly fewer MLN FRC compared with trained FRC<sup>Ctrl</sup> mice after inflammatory training and infection (<a >Fig. 5A</a>). Similar defects were seen in numbers of GC B cells and antibody response to <i>C. rodentium</i> (<a >Fig. 5, B to D</a>).</div><div >FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice have defects in <i>C. rodentium</i> clearance and antibody response (<a >Fig. 1</a>); therefore, we compared responses in untrained FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice with trained FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice. Inflammatory training was unable to boost the FRC or B cell response compared with untrained FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice after infection (<a >Fig. 5, A to D</a>). Similarly, FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice retained a poor capacity to clear <i>C. rodentium</i> infection after training (<a >Fig. 5E</a>). Trained FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice had no protection from gut inflammation as measured by colon length (<a >Fig. 5F</a>). Inflammatory training of FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice resulted in increased expression of inflammatory markers in colon tissue compared with untrained FRC<sup>∆</sup><i><sup>Il17ra</sup></i> colon (<a >Fig. 5G</a>). Hence, these data further implicate FRC in the trained gut immunity by showing that deletion of IL-17 receptor in FRC prevented the beneficial protective outcome of mild inflammatory training and instead promoted inflammation.</div><div >Because FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice have inherent defects in <i>C. rodentium</i> antibody response, we took an additional approach to test the role of IL-17–dependent FRC expansion in this model of inflammatory training. IL-17A was transiently blocked during the training period by administering neutralizing antibody at the start of DSS challenge. IL-17A blockade during DSS treatment resulted in increased weight loss (fig. S5A), as expected from prior reports that IL-17 promotes epithelial repair after injury (<a ><i>30</i></a>, <a ><i>31</i></a>). To allow resolution of colon inflammation and for clearance of the administered anti–IL-17 antibody, we rested mice for 2 weeks after DSS before infecting with <i>C. rodentium</i>. After infection, there were no significant changes in body weight between mice that received inflammatory training in the presence or absence of anti–IL-17, and weights were not altered compared with untrained controls (fig. S5A). Colon lengths were also similar at 2 weeks after DSS, confirming resolution of overt inflammation by this time point (fig. S5B). IL-17A blockade during training prevented the increased numbers of FRC (<a >Fig. 6A</a>) and the enhanced B cell response to <i>C. rodentium</i> infection in trained mice (<a >Fig. 6, B to D</a>). IL-17A blockade also abrogated the tissue protective effect of training on colitis, as determined by increased colon shortening (<a >Fig. 6E</a>) and increased expression of inflammatory cytokines compared with mice treated with isotype control during DSS training (<a >Fig. 6F</a>). It was apparent that IL-17A neutralization did not completely abrogate the training effect, in contrast to IL-17RA deletion in FRCs (comparing <a >Figs. 5</a> and <a >6</a>). Because IL-17RA is a shared receptor with IL-17F, this suggests that there may be some additional IL-17F signaling that contributes to training of FRC, although the statistical significance of reductions observed suggest that this would be a minor contribution compared with IL-17A. Overall, these data demonstrate a critical role for IL-17 signaling, particularly in FRC, in promoting the enhanced B cell response to infection after DSS training.</div></section><section ><h3>Colon protection from inflammatory training is mediated through B cell IL-10</h3><div >The data so far indicate that inflammatory activation of FRC results in a trained response that enhances adaptive immunity through increased T<sub>FH</sub> and B cell activation but paradoxically decreased colon inflammation during <i>C. rodentium</i> infection. IL-10 is a key regulatory cytokine for mucosal inflammation (<a ><i>32</i></a>). Training either 1 or 6 weeks before infection resulted in increased colon IL-10 expression on day 14 after infection (<a >Fig. 7, A and B</a>), corresponding with the reduced inflammation. Colon IL-10 was reduced in trained mice when IL-17 was neutralized during training or FRC lacked IL-17RA (<a >Fig. 7, C and D</a>). During primary infection without training, there was no difference in colon IL-10 expression between FRC<sup>∆</sup><i><sup>Il17ra</sup></i> and FRC<sup>Ctrl</sup> mice (fig. S6A), suggesting that tissue IL-10 production is not inherently impaired in FRC<sup>∆</sup><i><sup>Il17ra</sup></i> mice. However, there was reduced expression of IL-10 in the reinfected FRC<sup>Δ</sup><i><sup>Il17ra</sup></i> mice (<a >Fig. 7E</a>), again implicating an enhanced IL-10 response after an initial inflammatory event in an FRC-dependent manner. These findings thus support a role for training of FRC in an IL-17–dependent manner, leading to the increased expression of IL-10 and tissue protection in the colon.</div><div >Although regulatory T cells are a common source of IL-10 in the gut, we saw no correlation between IL-10 and forkhead box P3 (Foxp3) expression in these experiments (fig. S6, B to E). B cells can also provide an important source of regulatory IL-10 (<a ><i>33</i></a>–<a ><i>36</i></a>). We therefore queried whether the increased activation of B cells contributes to tissue protection after training via IL-10 production. There was an increase of class-switched IgG<sup>+</sup> B cells in the colon lamina propria of trained mice after infection with <i>C. rodentium</i> (<a >Fig. 7F</a>), and IgG<sup>+</sup> B cells showed the greatest expression of IL-10 among colonic lamina propria B cells (<a >Fig. 7G</a> and fig. S6F). We next tested the contribution of IL-10 produced by B cells by using <i>Cd19</i><sup>Cre</sup> × <i>Il10</i><sup>fl/fl</sup> mice, which have a B cell–intrinsic deletion of IL-10 (B cell<sup>ΔIL10</sup>). Control mice were <i>Cd19</i><sup>cre</sup><i>Il10</i><sup>+/+</sup> (B cell<sup>Ctrl</sup>). After <i>C. rodentium</i> infection, IgG production was similar between B cell<sup>ΔIL10</sup> and B cell<sup>Ctrl</sup> mice, and both B cell frequency and IgG were enhanced by training to an equal degree (<a >Fig. 7H</a> and fig. S6G), demonstrating that B cell IL-10 is not required for the antibody response. However, deletion of B cell–derived IL-10 abrogated the colon protective outcome of training on infectious colitis (<a >Fig. 7I</a>). Furthermore, after infection, trained B cell<sup>ΔIL10</sup> mice had reduced colon IL-10 expression compared with trained controls and similar colon IL-10 expression to untrained mice (<a >Fig. 7J</a>), confirming B cells as the critical source of colon IL-10 after training. The altered expression of inflammatory cytokines was similarly reversed in trained infected B cell<sup>ΔIL10</sup> mice (<a >Fig. 7, K to M</a>, and fig. S6, H to K). These data pinpoint the enhanced B cell IL-10 response as a major regulator of the tissue protective effects after inflammatory training in the gut.</div></section></section><section ><h2>DISCUSSION</h2><div >Within a given population, the same infection can have vastly different outcomes for individuals, ranging from asymptomatic infection to severe inflammation and tissue injury. Some factors that contribute to determining these outcomes are known, including prior microbial experience through infection or vaccination leading to innate immune training. Our data have revealed a previously unknown pathway modulating adaptive immune responses through IL-17–dependent inflammatory FRC training. By enhancing B cell activation to a newly encountered infection, this form of inflammatory training through FRC boosts the protective antibody response along with B cell IL-10 production in the intestinal tissue. The result is improved host protection by clearing the infection with reduced inflammatory side effects.</div><div >IL-17 is required for B cell activation during autoimmune disease (<a ><i>37</i></a>, <a ><i>38</i></a>). Although early studies suggested a possible direct role for IL-17 acting on B cells, the consensus is that the mechanism is more likely to be indirect. We previously showed that IL-17 signaling in FRC was required for optimal autoimmune antibody in a model of multiple sclerosis (<a ><i>19</i></a>). Here, we confirmed a similar defect in antibody response to <i>C. rodentium</i> when FRC could not respond to IL-17. On the other hand, increased expansion and activation of FRC by a mild inflammatory stimulus before infection increased both the numbers of T<sub>FH</sub> cells and GC B cells to enhance the antibody response. This finding is reminiscent of a study showing that T<sub>FH</sub> cells have reduced entry to GC light zones in the absence of IL-17 (<a ><i>39</i></a>) and further implicates an indirect role for IL-17 in promoting antibody responses through T<sub>FH</sub> cell activation via FRC. The molecular mechanisms by which FRC promote T<sub>FH</sub> have yet to be determined: One possibility is that IL-17–dependent proliferation of FRC is required to maintain the migratory routes of FRC to the GC because FRC are the “road” along which T cells move within lymphoid structures (<a ><i>40</i></a>). Another non-exclusive possibility is that IL-17–stimulated FRC provide cytokine cues, such as IL-6, to promote T<sub>FH</sub> cell activation and metabolic fitness, as has been shown for CD8 T cells (<a ><i>41</i></a>). Last, FRC are key providers of the B cell growth and survival factor B cell activating factor (BAFF), so increasing their numbers in an IL-17–dependent manner would also increase the availability of BAFF to support B cell activation, as suggested by the increased B cell frequency in trained MLN.</div><div >We had predicted that prior inflammation might exacerbate the transient colitis normally induced by <i>C. rodentium</i> infection in the gut, so it was a surprise to instead find reduced inflammation in infected colons after inflammatory training. However, this finding corresponds well to the clinical conundrum presented by the presence of IL-17–producing cells in both health and disease states in the gut. Despite the clear association between increased IL-17 and inflammatory bowel disease (IBD), clinical trials targeting IL-17 in IBD failed because of lack of efficacy and exacerbated disease in some individuals (<a ><i>42</i></a>). It has been posited that IL-17 promotes restoration of the epithelial barrier after gut injury, in addition to regulating microbiota populations that are more numerous in the gut compared to skin (<a ><i>43</i></a>–<a ><i>45</i></a>). Our data further suggest that IL-17 signaling in gut-draining LN helps to tune the adaptive immune response, particularly B cells, with a net protective outcome to inflammatory microbes through increased production of IL-10. In this regard, IL-10<sup>+</sup> regulatory B cells exhibit potent anti-inflammatory effects in a number of autoimmune models including colitis and EAE (<a ><i>35</i></a>, <a ><i>46</i></a>, <a ><i>47</i></a>). Specifically, IL-10<sup>+</sup> B cells were shown to increase in the chronically inflamed colon to limit colitis progression in α T cell receptor knockout mice lacking regulatory T cells (<a ><i>36</i></a>). Accordingly, we find that inflammation in the gut favors an enhanced regulatory B cell response to infection and implicate IL-17–dependent FRC activation in tuning gut immunoregulation.</div><div >Although we have not formally eliminated involvement of myeloid cells or innate lymphoid cells (ILC3) in our study, several lines of evidence lead us to think that these innate cells are not the primary driver of IL-17–dependent FRC effects on <i>C. rodentium</i> clearance in primary infection or after training. In contrast to many innate immune training models, training through DSS did not significantly alter the infection load of <i>C. rodentium</i>; this argues against a role for myeloid cells or innate lymphoid cells, which would be expected to more rapidly eliminate the infection. We did observe a reduction in <i>Csf2</i>, encoding GM-CSF, not only in the colon of FRC<sup>ΔIL17RA</sup> mice during primary infection but also in WT mice after training. ILC3 are a major producer of GM-CSF during colitis, along with IL-17 and IL-22, and GM-CSF recruits and activates inflammatory macrophages for which IL-1β is a hallmark (<a ><i>21</i></a>, <a ><i>22</i></a>, <a ><i>48</i></a>). However, mice with defective IL-17 signaling in FRC experienced enhanced expression of inflammatory cytokines that are associated with myeloid or innate lymphoid cell activation and GM-CSF signaling during <i>C. rodentium</i> control, including IL-1β, REGIIIγ, and IL-17 (<a ><i>21</i></a>, <a ><i>22</i></a>, <a ><i>48</i></a>); yet, these mice had delayed clearance during primary infection. Training further enhanced expression of IL-22 and IL-17 in the absence of FRC IL-17 signaling yet was still unable to improve <i>C. rodentium</i> clearance. Furthermore, FRC<sup>ΔIL17RA</sup> mice showed no benefit from training either in rate of infection clearance or colon inflammation, corresponding to reduced IL-10 and reduced B cell activation, supporting the importance of interactions between FRC and the adaptive immune system in this protective model.</div><div >Innate immunological training of myeloid lineage cells is typically mediated through IL-1β or lipopolysaccharide (LPS) signaling leading to metabolic and epigenetic changes that outlast the acute inflammatory response (<a ><i>49</i></a>). It is worth noting some interesting commonalities between LPS, IL-1β, and IL-17 signaling. All three stimuli drive nuclear factor κB (NF-κB) activation as a major signaling pathway and induce feed-forward transcriptional regulators including the NF-κB coactivator NF-kappa-B inhibitor zeta (Iκbζ) and transcription factor CCAAT enhancer binding protein beta (C/EBPβ), which was recently shown to be critical for trained immunity in hematopoietic stem cells that generate myeloid cells (<a ><i>50</i></a>). LPS and IL-1β are strong drivers of metabolic reprogramming in innate immune cells (<a ><i>51</i></a>); we recently showed that IL-17 is critical for metabolic reprogramming in FRC and identified Iκbζ as one of the regulators of IL-17–induced metabolic change (<a ><i>19</i></a>). Metabolic reprogramming and epigenetic modifications are intricately intertwined, and metabolites such as acetyl coenzyme A, succinate, and mevalonate influence chromatin accessibility. Rewiring of metabolic circuits thus poises innate immune cells to respond more rapidly after immune training (<a ><i>20</i></a>, <a ><i>52</i></a>). IL-17 typically targets nonhematopoietic cells including fibroblast-type stromal cells and epithelia, whereas LPS and IL-1β primarily activate immune cells. Nevertheless, these shared signaling outputs may provide the common outcomes of trained immunity through metabolic and epigenetic rewiring of target cells.</div><div >There is very limited understanding of contributions of immune or inflammatory training in non-immune cells to date. However, Naik <i>et al.</i> (<a ><i>53</i></a>) demonstrated that skin inflammation could speed up subsequent wound healing through “inflammatory memory” epigenetically programmed into epithelial stem cells. This form of inflammatory training required both IL-1β production and presence of RAR-related orphan receptor gamma (RORγt<sup>+</sup>) and IL-17–producing T cells (<a ><i>53</i></a>), again suggesting interplay between immune and non-immune systems for the enhanced outcome. Here, we showed that inflammatory training through DSS-induced IL-17 results in metabolic and epigenetic changes in FRC to promote enhanced function.</div><div >In summary, this study shows that IL-17 helps to simultaneously maintain intestinal defense and promote immunoregulation by enhancing the capacity of gut-draining LNs to support antibody and IL-10 production through improved B cell activation. We therefore propose that IL-17 induced by microbiota or infections during early life could tune the balance of antibody-mediated versus proinflammatory cytokine-mediated immune responses to reduce severity of infectious disease in mucosal tissues. The ability to induce IL-17 for FRC training should thus be considered as a factor that could enhance the efficacy of vaccines or the ability of individuals to respond to a known pathogenic threat for which there is not yet a vaccine, without boosting side effects of inflammation and tissue damage.</div></section><section ><h2>MATERIALS AND METHODS</h2><section ><h3>Study design</h3><div >The overall objective of this study was to determine the role of IL-17 signaling in FRC either before or during responses to infection with <i>C. rodentium</i> and to elucidate mechanisms that result in tissue protection after inflammatory training. This was achieved by using global IL-17– and IL-17RA–deficient mice, FRC-intrinsic deletion of IL-17RA, and antibody-mediated neutralization of IL-17 in DSS-mediated colitis and <i>C. rodentium</i> infection models of gut inflammation. Outcomes were changes in specific cell population numbers, phenotype, and function [measured by flow cytometry, enzyme-linked immunosorbent assay (ELISA), gene expression, and body weight]. All data points generated were included in the analysis. Group sizes were based on power analysis of previous publications and pilot studies for the included experiments. Groups for antibody neutralization and DSS treatment were randomly assigned. Groups with transgenic mice were assigned controls on the basis of existing age-matched littermates. The study was unblinded. All experiments were repeated more than once, and numbers of experimental repeats are indicated in figure legends.</div></section><section ><h3>Mice</h3><div >C57BL/6 was obtained from the Jackson Laboratory. FRC<sup>Δ</sup><i><sup>Il17ra</sup></i> mice generated by crossing <i>Il17ra</i><sup>fl/fl</sup> [a gift from J. Kolls (<a ><i>45</i></a>)] with Ccl19<sup>Cre</sup> [obtained from B. Ludewig via Eur0pean Mouse Mutant Archive (EMMA) repository, Infrafrontier (<a ><i>54</i></a>)]. B cell<sup>Δ</sup><i><sup>Il10</sup></i> mice were generated by crossing IL-10<sup>fl/fl</sup> [provided by D. Rothstein with permission of W. Muller (<a ><i>55</i></a>)] with CD19<sup>cre</sup> (the Jackson Laboratory). All experiments included age- and sex-matched littermate controls that were cohoused before experiments, and both males and females aged between 7 and 10 weeks were used. Mice were housed under specific pathogen–free conditions in an American Association of Laboratory Animal Care (AAALAC)-approved facility at the University of Pittsburgh. Protocols were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and adhered to guidelines in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.</div></section><section ><h3><i>C. rodentium</i> infection and fecal bacteria detection</h3><div >Mice were orally gavaged with fresh cultured 10<sup>9</sup> colony-forming units (CFUs) of <i>C. rodentium</i> strain DBS100 (American Type Culture Collection 51459). For reinfection experiments, two doses of <i>C. rodentium</i> were given 60 days apart. Body weight was monitored every 3 days. For fecal culture, fresh feces were collected, weighed, and homogenized in 300 μl of phosphate-buffered saline (PBS). Serial dilutions of feces homogenates were plated onto MacConkey agar (Oxoid) and incubated for 18 hours at 37°C. <i>C. rodentium</i> colonies were identified by their characteristic pink center surrounded by a white rim. For fecal <i>C. rodentium</i> polymerase chain reaction (PCR), DNA in feces was isolated with the QIAamp Fast DNA Stool Mini Kit (QIAGEN), <i>Espb</i> gene expression was quantified by quantitative PCR (qPCR) (SYBR Green; espB-F: 5′-ATGCCGCAGATGAGACAGTTG-3′, espB-R: 5′-CGTCAGCAGCCTTTTCAGCTA-3′) and normalized relative to total bacterial 16<i>S rRNA</i> (5′-ATTACCGCGGCTGCTGGC-3′, 5′-ACTCCTACGGGAGGCAGCAGT-3′).</div></section><section ><h3>DSS-induced colitis</h3><div >Mice received 1% DSS (36,000 to 50,000 molecular weight; MP Biomedicals) in their drinking water for 7 days, followed by 7 or 14 days of distilled water without DSS. Control animals received distilled water for the entire period. Mice were monitored every 3 days for body weight and infected with <i>C. rodentium</i> after rest. For in vivo neutralization of IL-17, 100 μg of anti–IL-17 monoclonal antibody (clone 17F3; Bio X Cell) and an equal amount of isotype control IgG (IgG1, clone MOPC-21; Bio X Cell) were administered intraperitoneally on day 0 starting DSS.</div></section><section ><h3>Quantitative PCR</h3><div >RNA was isolated with the RNeasy Mini Kit (QIAGEN), and cDNA was generated with Superscript III First Strand kits (Invitrogen), followed by real-time PCR (RT-PCR) using SYBR Green Master mix with ROX (Invitrogen) and the following RT2 qPCR primers from QIAGEN: <i>Foxp3</i> (<i>catalog number</i> PPM05497F), <i>Il1b</i> (PPM03109F), <i>Il10</i> (PPM03017C), <i>Il17a</i> (PPM03023A), <i>Il18</i> (PPM03112B), <i>Il22</i> (PPM05481A), <i>Ifng</i> (PPM03121A), <i>Csf2</i> (PPM02990F), and <i>Reg3g</i> (PPM35204A) on a 7300 Real-Time instrument (Applied Biosystems). Gene expression was normalized to <i>Gapdh</i> (PPM02946E).</div></section><section ><h3>FRC preparation for flow cytometry</h3><div >MLNs were incubated at 37°C in digestion medium (RPMI), deoxyribonuclease I (DNase I; 0.1 mg/ml; Invitrogen), and Liberase (0.1 mg/ml; Roche). Collected single-cell suspensions were filtered. For flow cytometry, cells were stained with Ghostdye510 viability dye (Tonbo Biosciences) in PBS, followed by labeling with CD45 (clone 30-F11, Invitrogen), CD45.2 (104, BD Biosciences), podoplanin (PDPN) (8.1.1, BioLegend), CD31 (MEC 13.3, BD Biosciences), H3K4me3 (C42D8, Cell Signaling Technology), and CountBright Absolute Counting Beads (Molecular Probes). For glucose uptake assays, 500 nM 2-(<i>N</i>-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2NBDG; Cayman Chemicals) was injected via tail vein 30 min before sacrifice.</div></section><section ><h3>CD4 and B cell analysis in MLN by flow cytometry</h3><div >Single-cell suspensions were obtained from LNs by mechanical isolation and filtered before staining with Ghostdye510 (Tonbo Biosciences) viability dye in PBS and then surface staining in fluorescence-activated cell sorting (FACS) buffer. For T<sub>FH</sub> staining, cells were fixed, permeabilized with eBioscience Foxp3/Transcription Factor Staining Buffer Set, and incubated with antibodies to CXCR5 in Permeabilization Buffer with 3.3% normal rat serum overnight at 4°C. FACS antibodies and staining reagents were purchased from the following companies: CD4 (no. GK1.5, Invitrogen), B220 (no. RA3-6B2, BD Biosciences), CD19 (6D5, BioLegend), GL-7 (no. GL-7, BD Pharmingen), CD44 (IM7, eBioscience), PD1 (RMP1-30, BioLegend), CXCR5 (2G8, BD Biosciences), IL-10 (JES5-16E3, BioLegend), and IgG (Poly4053, BioLegend). Flow cytometry data were acquired on a FACS LSRFortessa (BD Biosciences) and analyzed with FlowJo software.</div></section><section ><h3>Lamina propria preparation and B cell IL-10 analysis</h3><div >Colons were excised, splayed open, and rinsed with cold RPMI 1640 containing 3% fetal calf serum (FCS), penicillin-streptomycin (100 μg/ml), 25 mM Hepes, and 50 mM β-mercaptoethanol (β-ME). Tissue was minced and digested with RPMI 1640 containing 3% FCS, penicillin-streptomycin (100 μg/ml), 25 mM Hepes, 50 mM β-ME, 5 mM EDTA, and 1,4-dithiothreitol (145 μg/ml) for 20 min with continuous stirring in an incubator at 37°C/5% CO<sub>2</sub>. Tissue was strained and further digested by briefly agitating tissue with RPMI 1640 containing penicillin-streptomycin (100 μg/ml), 25 mM Hepes, 50 mM β-ME, and 2 mM EDTA. Tissue was strained, minced, and further digested with serum-free RPMI 1640 containing penicillin-streptomycin (100 μg/ml), 25 mM Hepes, 50 mM β-ME, 2 mM l-glutamine, 1 mM sodium pyruvate, 1× minimum essential medium (MEM) non-essential amino acids, DNase I (500 μg/ml; Sigma-Aldrich), and Liberase TL (100 μg/ml; Roche) for 25 min with continuous stirring in an incubator at 37°C/5% CO<sub>2</sub>. Cell suspensions were serially filtered through 70- and 40-μm cell strainers, spun down, and resuspended in complete RPMI 1640 medium containing 10% fetal bovine serum, penicillin-streptomycin (100 μg/ml), 25 mM Hepes, 50 mM β-ME, 2 mM l-glutamine, 1 mM sodium pyruvate, and 1× MEM nonessential amino acids before use. For IL-10 analysis, colon lamina propria lymphocytes were stimulated with LPS from <i>E. coli</i> O111:B4 (Sigma-Aldrich; 10 μg/ml), phorbol 12-myristate 13-acetate (50 ng/ml), and ionomycin (1 μg/ml) for 5 hours at 37°C; GolgiStop (BD) and GolgiPlug (BD) were added to cultures after 1 hour. Cells were incubated with viability dye in PBS, washed, incubated with Fc block, and then stained for surface markers as previously described. Intracellular staining for IL-10 was performed using BD Cytofix/Cytoperm reagents as per the manufacturer’s protocol, using antibody clones listed above.</div></section><section ><h3>Antibody ELISA</h3><div >Total IgG concentrations in serum were detected using a mouse IgG ELISA kit (Invitrogen). For detection of <i>C. rodentium</i>–specific antibody in serum, 96-well plates were coated overnight with <i>C. rodentium</i> (10<sup>8</sup> CFU per well) at 37°C incubator, blocked for 2 hours, and then incubated with sera (serial dilutions starting at 1:100) for 3 hours. After washing, antibodies bound to <i>C. rodentium</i> were detected by horseradish peroxidase–labeled anti-IgG (RD Systems). Optical density (OD) value for 1:1000 dilution was used for each experiment because standards for anti–<i>C. rodentium</i> IgG are not commercially available. For fecal antibody, fecal pellets were collected from the indicated groups at specific time points. Fecal supernatant was prepared [10% (w/v)] with PBS, and fecal IgG was detected by the same protocol as <i>C. rodentium</i>–specific antibody in serum. Horseradish peroxidase–labeled anti-IgA (Thermo Fisher Scientific) was used for detecting <i>C. rodentium–</i>specific IgA in feces with a similar protocol.</div></section><section ><h3>Statistics</h3><div >Experimental results were analyzed for significance using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test (for multiple groups) or unpaired Student’s <i>t</i> test. Statistical analyses were performed using GraphPad Prism. <i>P</i> values are shown as *<i>P</i> &lt; 0.05, **<i>P</i> &lt; 0.01, ***<i>P</i> &lt; 0.001, and ****<i>P</i> &lt; 0.0001 where statistical significance was found, and all data are represented as means ± SEM. Individual points in graphs represent biological replicates (i.e., individual mice) pooled from multiple experiments.</div></section></section><section ><h2>Acknowledgments</h2><div >We thank P. Biswas, S. Gaffen, R. Elsner, and T. Hand for thoughtful discussion and reading of manuscript; staff of the Division of Laboratory Animal Research for animal husbandry; and the Unified Flow Core for flow cytometry services.</div><div ><b>Funding:</b> Funding for the project was from NIH AI148356 to M.J.M. D.W. was sponsored by the Third Xiangya Hospital, Central South University and acknowledges the encouragement of F. Wang. S.M. was a recipient of the AAI 2019-2020 trainee fellowship, CLP funded by T32 trainee award AI089443, and D.R. acknowledges funding from NIH AI114587.</div><div ><b>Author contributions:</b> D.W. designed and performed experiments and data analysis. C.H.P., S.K.R., Q.L., and S.M. performed experiments and data analysis. R.E., S.M., K.M., and D.M.R. provided technical expertise. D.M.R. also provided mice. M.J.M. designed and directed the study, obtained funding, and wrote the manuscript with assistance from D.W., C.H.P., and D.M.R.</div><div ><b>Competing interests</b>: The authors declare that they have no competing interests.</div><div ><b>Data and materials availability</b>: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials.</div></section> </div></section><section ><div ><section ><h2>Supplementary Materials</h2><section ><h3>This PDF file includes:</h3><div ><div ><div>Figs. S1 to S6</div></div><div >Download (1.50 MB)</div></div></section><section ><h3>Other Supplementary Material for this manuscript includes the following:</h3><div ><div ><div>Table S1</div></div><div ><a >Download (137.45 KB)</a></div></div></section></section><div ><a >View/request a protocol for this paper from <i>Bio-protocol</i>.</a></div><section ><h2>REFERENCES AND NOTES</h2><div ><div >1</div><div ><div ><div >M. G. Netea, J. Domínguez-Andrés, L. B. Barreiro, T. Chavakis, M. Divangahi, E. Fuchs, L. A. B. Joosten, J. W. M. van der Meer, M. M. Mhlanga, W. J. M. Mulder, N. P. Riksen, A. Schlitzer, J. L. Schultze, C. Stabell Benn, J. C. Sun, R. J. Xavier, E. Latz, Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. <b>20</b>, 375–388 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >2</div><div ><div ><div >L. Liu, H. L. Johnson, S. Cousens, J. Perin, S. Scott, J. E. Lawn, I. Rudan, H. Campbell, R. Cibulskis, M. Li, C. Mathers, R. E. Black; Child Health Epidemiology Reference Group of WHO and UNICEF, Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet <b>379</b>, 2151–2161 (2012).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >3</div><div ><div ><div >K. L. Kotloff, J. P. Nataro, W. C. Blackwelder, D. Nasrin, T. H. Farag, S. Panchalingam, Y. Wu, S. O. Sow, D. Sur, R. F. Breiman, A. S. Faruque, A. K. Zaidi, D. Saha, P. L. Alonso, B. Tamboura, D. Sanogo, U. Onwuchekwa, B. Manna, T. Ramamurthy, S. Kanungo, J. B. Ochieng, R. Omore, J. O. Oundo, A. Hossain, S. K. Das, S. Ahmed, S. Qureshi, F. Quadri, R. A. Adegbola, M. Antonio, M. J. Hossain, A. Akinsola, I. Mandomando, T. Nhampossa, S. Acácio, K. Biswas, C. E. O’Reilly, E. D. Mintz, L. Y. Berkeley, K. Muhsen, H. Sommerfelt, R. M. Robins-Browne, M. M. Levine, Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet <b>382</b>, 209–222 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >4</div><div ><div ><div >M. A. Croxen, R. J. Law, R. Scholz, K. M. Keeney, M. Wlodarska, B. B. Finlay, Recent advances in understanding enteric pathogenic <i>Escherichia coli</i>. Clin. Microbiol. Rev. <b>26</b>, 822–880 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >5</div><div ><div ><div >J. P. Nataro, J. B. Kaper, Diarrheagenic <i>Escherichia coli</i>. Clin. Microbiol. Rev. <b>11</b>, 142–201 (1998).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >6</div><div ><div ><div >A. H. Havelaar, M. D. Kirk, P. R. Torgerson, H. J. Gibb, T. Hald, R. J. Lake, N. Praet, D. C. Bellinger, N. R. de Silva, N. Gargouri, N. Speybroeck, A. Cawthorne, C. Mathers, C. Stein, F. J. Angulo, B. Devleesschauwer; World Health Organization Foodborne Disease Burden Epidemiology Reference Group, World health organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. <b>12</b>, e1001923 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >7</div><div ><div ><div >S. W. Barthold, G. L. Coleman, P. N. Bhatt, G. W. Osbaldiston, A. M. Jonas, The etiology of transmissible murine colonic hyperplasia. Lab. Anim. Sci. <b>26</b>, 889–894 (1976).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >8</div><div ><div ><div >C. Mullineaux-Sanders, J. Suez, E. Elinav, G. Frankel, Sieving through gut models of colonization resistance. Nat. Microbiol. <b>3</b>, 132–140 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >9</div><div ><div ><div >J. M. Chan, G. Bhinder, H. P. Sham, N. Ryz, T. Huang, K. S. Bergstrom, B. A. Vallance, CD4<sup>+</sup> T cells drive goblet cell depletion during <i>Citrobacter rodentium</i> infection. Infect. Immun. <b>81</b>, 4649–4658 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >10</div><div ><div ><div >H. Ahlfors, P. J. Morrison, J. H. Duarte, Y. Li, J. Biro, M. Tolaini, P. Di Meglio, A. J. Potocnik, B. Stockinger, IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. <b>193</b>, 4602–4613 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >11</div><div ><div ><div >K. Atarashi, T. Tanoue, M. Ando, N. Kamada, Y. Nagano, S. Narushima, W. Suda, A. Imaoka, H. Setoyama, T. Nagamori, E. Ishikawa, T. Shima, T. Hara, S. Kado, T. Jinnohara, H. Ohno, T. Kondo, K. Toyooka, E. Watanabe, S.-I. Yokoyama, S. Tokoro, H. Mori, Y. Noguchi, H. Morita, I. I. Ivanov, T. Sugiyama, G. Nuñez, J. G. Camp, M. Hattori, Y. Umesaki, K. Honda, Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell <b>163</b>, 367–380 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >12</div><div ><div ><div >N. Kamada, K. Sakamoto, S.-U. Seo, M. Y. Zeng, Y.-G. Kim, M. Cascalho, B. A. Vallance, J. L. Puente, G. Núñez, Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe <b>17</b>, 617–627 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >13</div><div ><div ><div >X. Bai, X. Chi, Q. Qiao, S. Xie, S. Wan, L. Ni, P. Wang, W. Jin, C. Dong, T. Follicular, T follicular helper cells regulate humoral response for host protection against intestinal <i>Citrobacter rodentium</i> infection. J. Immunol. <b>204</b>, 2754–2761 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >14</div><div ><div ><div >N. H. Ruddle, E. M. Akirav, Secondary lymphoid organs: Responding to genetic and environmental cues in ontogeny and the immune response. J. Immunol. <b>183</b>, 2205–2212 (2009).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >15</div><div ><div ><div >S. Fagarasan, S. Kawamoto, O. Kanagawa, K. Suzuki, Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. <b>28</b>, 243–273 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >16</div><div ><div ><div >A. Link, T. K. Vogt, S. Favre, M. R. Britschgi, H. Acha-Orbea, B. Hinz, J. G. Cyster, S. A. Luther, Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. <b>8</b>, 1255–1265 (2007).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >17</div><div ><div ><div >F. D. Brown, S. J. Turley, Fibroblastic reticular cells: Organization and regulation of the T lymphocyte life cycle. J. Immunol. <b>194</b>, 1389–1394 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >18</div><div ><div ><div >A. T. Krishnamurty, S. J. Turley, Lymph node stromal cells: Cartographers of the immune system. Nat. Immunol. <b>21</b>, 369–380 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >19</div><div ><div ><div >S. Majumder, N. Amatya, S. Revu, C. V. Jawale, D. Wu, N. Rittenhouse, A. Menk, S. Kupul, F. Du, I. Raphael, A. Bhattacharjee, U. Siebenlist, T. W. Hand, G. M. Delgoffe, A. C. Poholek, S. L. Gaffen, P. S. Biswas, M. J. McGeachy, IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nat. Immunol. <b>20</b>, 534–545 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >20</div><div ><div ><div >S.-C. Cheng, J. Quintin, R. A. Cramer, K. M. Shepardson, S. Saeed, V. Kumar, E. J. Giamarellos-Bourboulis, J. H. A. Martens, N. A. Rao, A. Aghajanirefah, G. R. Manjeri, Y. Li, D. C. Ifrim, R. J. W. Arts, B. M. J. W. van der Veer, P. M. T. Deen, C. Logie, L. A. O’Neill, P. Willems, F. L. van de Veerdonk, J. W. M. van der Meer, A. Ng, L. A. B. Joosten, C. Wijmenga, H. G. Stunnenberg, R. J. Xavier, M. G. Netea, mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science <b>345</b>, 1250684 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >21</div><div ><div ><div >S.-U. Seo, P. Kuffa, S. Kitamoto, H. Nagao-Kitamoto, J. Rousseau, Y.-G. Kim, G. Núñez, N. Kamada, Intestinal macrophages arising from CCR2<sup>+</sup> monocytes control pathogen infection by activating innate lymphoid cells. Nat. Commun. <b>6</b>, 8010 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >22</div><div ><div ><div >R. S. Longman, G. E. Diehl, D. A. Victorio, J. R. Huh, C. Galan, E. R. Miraldi, A. Swaminath, R. Bonneau, E. J. Scherl, D. R. Littman, CX<sub>3</sub>CR1<sup>+</sup> mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. <b>211</b>, 1571–1583 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >23</div><div ><div ><div >S. C. Liang, X.-Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, L. A. Fouser, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. <b>203</b>, 2271–2279 (2006).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >24</div><div ><div ><div >M. Muñoz, C. Eidenschenk, N. Ota, K. Wong, U. Lohmann, A. A. Kühl, X. Wang, P. Manzanillo, Y. Li, S. Rutz, Y. Zheng, L. Diehl, N. Kayagaki, M. van Lookeren-Campagne, O. Liesenfeld, M. Heimesaat, W. Ouyang, Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity <b>42</b>, 321–331 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >25</div><div ><div ><div >I. Backert, S. B. Koralov, S. Wirtz, V. Kitowski, U. Billmeier, E. Martini, K. Hofmann, K. Hildner, N. Wittkopf, K. Brecht, M. Waldner, K. Rajewsky, M. F. Neurath, C. Becker, C. Neufert, STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis. J. Immunol. <b>193</b>, 3779–3791 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >26</div><div ><div ><div >C. Manta, E. Heupel, K. Radulovic, V. Rossini, N. Garbi, C. U. Riedel, J. H. Niess, CX<sub>3</sub>CR1<sup>+</sup> macrophages support IL-22 production by innate lymphoid cells during infection with <i>Citrobacter rodentium</i>. Mucosal Immunol. <b>6</b>, 177–188 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >27</div><div ><div ><div >G. Caballero-Flores, K. Sakamoto, M. Y. Zeng, Y. Wang, J. Hakim, V. Matus-Acuña, N. Inohara, G. Núñez, Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk. Cell Host Microbe <b>25</b>, 313–323.e4 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >28</div><div ><div ><div >J. R. Singer, E. G. Blosser, C. L. Zindl, D. J. Silberger, S. Conlan, V. A. Laufer, D. DiToro, C. Deming, R. Kumar, C. D. Morrow, J. A. Segre, M. J. Gray, D. A. Randolph, C. T. Weaver, Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis. Nat. Med. <b>25</b>, 1772–1782 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >29</div><div ><div ><div >S. Wirtz, C. Neufert, B. Weigmann, M. F. Neurath, Chemically induced mouse models of intestinal inflammation. Nat. Protoc. <b>2</b>, 541–546 (2007).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >30</div><div ><div ><div >M. Veldhoen, Interleukin 17 is a chief orchestrator of immunity. Nat. Immunol. <b>18</b>, 612–621 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >31</div><div ><div ><div >J. A. Zepp, J. Zhao, C. Liu, K. Bulek, L. Wu, X. Chen, Y. Hao, Z. Wang, X. Wang, W. Ouyang, M. F. Kalady, J. Carman, W.-P. Yang, J. Zhu, C. Blackburn, Y. H. Huang, T. A. Hamilton, B. Su, X. Li, IL-17A-induced PLET1 expression contributes to tissue repair and colon tumorigenesis. J. Immunol. <b>199</b>, 3849–3857 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >32</div><div ><div ><div >O. Annacker, C. Asseman, S. Read, F. Powrie, Interleukin-10 in the regulation of T cell-induced colitis. J. Autoimmun. <b>20</b>, 277–279 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >33</div><div ><div ><div >E. C. Rosser, C. Mauri, Regulatory B cells: Origin, phenotype, and function. Immunity <b>42</b>, 607–612 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >34</div><div ><div ><div >S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray, S. M. Anderton, B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. <b>3</b>, 944–950 (2002).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >35</div><div ><div ><div >O. L. Rojas, A.-K. Pröbstel, E. A. Porfilio, A. A. Wang, M. Charabati, T. Sun, D. S. W. Lee, G. Galicia, V. Ramaglia, L. A. Ward, L. Y. T. Leung, G. Najafi, K. Khaleghi, B. Garcillán, A. Li, R. Besla, I. Naouar, E. Y. Cao, P. Chiaranunt, K. Burrows, H. G. Robinson, J. R. Allanach, J. Yam, H. Luck, D. J. Campbell, D. Allman, D. G. Brooks, M. Tomura, R. Baumann, S. S. Zamvil, A. Bar-Or, M. S. Horwitz, D. A. Winer, A. Mortha, F. Mackay, A. Prat, L. C. Osborne, C. Robbins, S. E. Baranzini, J. L. Gommerman, Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell <b>176</b>, 610–624.e18 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >36</div><div ><div ><div >A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, A. K. Bhan, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity <b>16</b>, 219–230 (2002).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >37</div><div ><div ><div >M. Mitsdoerffer, Y. Lee, A. Jäger, H.-J. Kim, T. Korn, J. K. Kolls, H. Cantor, E. Bettelli, V. K. Kuchroo, Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. U.S.A. <b>107</b>, 14292–14297 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >38</div><div ><div ><div >H.-C. Hsu, P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, T. L. Le, R. G. Lorenz, H. Xu, J. K. Kolls, R. H. Carter, D. D. Chaplin, R. W. Williams, J. D. Mountz, Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. <b>9</b>, 166–175 (2008).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >39</div><div ><div ><div >Y. Ding, J. Li, Q. Wu, P. Yang, B. Luo, S. Xie, K. M. Druey, A. J. Zajac, H.-C. Hsu, J. D. Mountz, IL-17RA is essential for optimal localization of follicular Th cells in the germinal center light zone to promote autoantibody-producing B cells. J. Immunol. <b>191</b>, 1614–1624 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >40</div><div ><div ><div >M. Bajénoff, J. G. Egen, L. Y. Koo, J. P. Laugier, F. Brau, N. Glaichenhaus, R. N. Germain, Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity <b>25</b>, 989–1001 (2006).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >41</div><div ><div ><div >F. D. Brown, D. R. Sen, M. W. LaFleur, J. Godec, V. Lukacs-Kornek, F. A. Schildberg, H.-J. Kim, K. B. Yates, S. J. H. Ricoult, K. Bi, J. D. Trombley, V. N. Kapoor, I. A. Stanley, V. Cremasco, N. N. Danial, B. D. Manning, A. H. Sharpe, W. N. Haining, S. J. Turley, Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nat. Immunol. <b>20</b>, 1668–1680 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >42</div><div ><div ><div >A. Yamada, J. Wang, Y. Komaki, F. Komaki, D. Micic, A. Sakuraba, Systematic review with meta-analysis: Risk of new onset IBD with the use of anti-interleukin-17 agents. Aliment. Pharmacol. Ther. <b>50</b>, 373–385 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >43</div><div ><div ><div >J. S. Lee, C. M. Tato, B. Joyce-Shaikh, M. F. Gulen, C. Cayatte, Y. Chen, W. M. Blumenschein, M. Judo, G. Ayanoglu, T. K. McClanahan, X. Li, D. J. Cua, Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity <b>43</b>, 727–738 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >44</div><div ><div ><div >Y. Belkaid, T. W. Hand, Role of the microbiota in immunity and inflammation. Cell <b>157</b>, 121–141 (2014).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >45</div><div ><div ><div >P. Kumar, L. Monin, P. Castillo, W. Elsegeiny, W. Horne, T. Eddens, A. Vikram, M. Good, A. A. Schoenborn, K. Bibby, R. C. Montelaro, D. W. Metzger, A. S. Gulati, J. K. Kolls, Intestinal interleukin-17 receptor signaling mediates reciprocal control of the Gut microbiota and autoimmune inflammation. Immunity <b>44</b>, 659–671 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >46</div><div ><div ><div >A. Cherukuri, K. Mohib, D. M. Rothstein, Regulatory B cells: TIM-1, transplant tolerance, and rejection. Immunol. Rev. <b>299</b>, 31–44 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >47</div><div ><div ><div >A. C. Lino, T. Dörner, A. Bar-Or, S. Fillatreau, Cytokine-producing B cells: A translational view on their roles in human and mouse autoimmune diseases. Immunol. Rev. <b>269</b>, 130–144 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >48</div><div ><div ><div >T. Castro-Dopico, A. Fleming, T. W. Dennison, J. R. Ferdinand, K. Harcourt, B. J. Stewart, Z. Cader, Z. K. Tuong, C. Jing, L. S. C. Lok, R. J. Mathews, A. Portet, A. Kaser, S. Clare, M. R. Clatworthy, GM-CSF calibrates macrophage defense and wound healing programs during intestinal infection and inflammation. Cell Rep. <b>32</b>, 107857 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >49</div><div ><div ><div >S. J. C. F. M. Moorlag, R. J. Röring, L. A. B. Joosten, M. G. Netea, The role of the interleukin-1 family in trained immunity. Immunol. Rev. <b>281</b>, 28–39 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >50</div><div ><div ><div >B. de Laval, J. Maurizio, P. K. Kandalla, G. Brisou, L. Simonnet, C. Huber, G. Gimenez, O. Matcovitch-Natan, S. Reinhardt, E. David, A. Mildner, A. Leutz, B. Nadel, C. Bordi, I. Amit, S. Sarrazin, M. H. Sieweke, C/EBPβ-dependent epigenetic memory induces trained immunity in hematopoietic stem cells. Cell Stem Cell <b>26</b>, 657–674.e8 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >51</div><div ><div ><div >B. Kelly, L. A. J. O’Neill, Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. <b>25</b>, 771–784 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >52</div><div ><div ><div >S. Bekkering, R. J. W. Arts, B. Novakovic, I. Kourtzelis, C. D. C. C. van der Heijden, Y. Li, C. D. Popa, R. Ter Horst, J. van Tuijl, R. T. Netea-Maier, F. L. van de Veerdonk, T. Chavakis, L. A. B. Joosten, J. W. M. van der Meer, H. Stunnenberg, N. P. Riksen, M. G. Netea, Metabolic induction of trained immunity through the mevalonate pathway. Cell <b>172</b>, 135–146.e9 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >53</div><div ><div ><div >S. Naik, S. B. Larsen, N. C. Gomez, K. Alaverdyan, A. Sendoel, S. Yuan, L. Polak, A. Kulukian, S. Chai, E. Fuchs, Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature <b>550</b>, 475–480 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >54</div><div ><div ><div >Q. Chai, L. Onder, E. Scandella, C. Gil-Cruz, C. Perez-Shibayama, J. Cupovic, R. Danuser, T. Sparwasser, S. A. Luther, V. Thiel, T. Rülicke, J. V. Stein, T. Hehlgans, B. Ludewig, Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity <b>38</b>, 1013–1024 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >55</div><div ><div ><div >A. Roers, L. Siewe, E. Strittmatter, M. Deckert, D. Schlüter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, W. Müller, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. <b>200</b>, 1289–1297 (2004).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div></section></div></section><div ><div ><header><h2>Information Authors</h2></header><section ><h3>Information</h3><section ><h4>Published In</h4><div > <div ><div >Science Immunology</div><div >Volume 6 | Issue 66December 2021</div></div></div></section><section ><h4>Copyright</h4><div >Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div >https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div >This is an article distributed under the terms of the Science Journals Default License.</div></section><section ><h4>Submission history</h4><div><b >Received</b>: 28 August 2020</div><div><b >Accepted</b>: 12 November 2021</div></section><section ><h4>Permissions</h4><div>Request permissions for this article.</div><div><a >Request Permissions</a></div></section><section ><h4>Acknowledgments</h4><div >We thank P. Biswas, S. Gaffen, R. Elsner, and T. Hand for thoughtful discussion and reading of manuscript; staff of the Division of Laboratory Animal Research for animal husbandry; and the Unified Flow Core for flow cytometry services.</div><div ><b>Funding:</b> Funding for the project was from NIH AI148356 to M.J.M. D.W. was sponsored by the Third Xiangya Hospital, Central South University and acknowledges the encouragement of F. Wang. S.M. was a recipient of the AAI 2019-2020 trainee fellowship, CLP funded by T32 trainee award AI089443, and D.R. acknowledges funding from NIH AI114587.</div><div ><b>Author contributions:</b> D.W. designed and performed experiments and data analysis. C.H.P., S.K.R., Q.L., and S.M. performed experiments and data analysis. R.E., S.M., K.M., and D.M.R. provided technical expertise. D.M.R. also provided mice. M.J.M. designed and directed the study, obtained funding, and wrote the manuscript with assistance from D.W., C.H.P., and D.M.R.</div><div ><b>Competing interests</b>: The authors declare that they have no competing interests.</div><div ><b>Data and materials availability</b>: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials.</div></section></section><section ><h3>Authors</h3><section ><h4>Affiliations</h4><div ><div >Dongwen Wu https://orcid.org/0000-0001-7909-5708</div><div ><div ><div >Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</div><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Catherine H. Poholek https://orcid.org/0000-0002-9381-9618</div><div ><div ><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div><div >Division of Pediatric Rheumatology, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Saikat Majumder https://orcid.org/0000-0002-6591-9515</div><div ><div ><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Qixing Liu https://orcid.org/0000-0002-9076-6274</div><div ><div ><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div><div >School of Medicine, Tsinghua University Beijing, China.</div></div><div >View all articles by this author</div></div></div><div ><div >Shankar K. Revu</div><div ><div ><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Kanishka Mohib https://orcid.org/0000-0002-7332-5530</div><div ><div ><div >Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >David M. Rothstein https://orcid.org/0000-0002-9455-7971</div><div ><div ><div >Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Mandy J. McGeachy<sup >*</sup> https://orcid.org/0000-0001-5029-1668 [email protected]</div><div ><div ><div >Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div >View all articles by this author</div></div></div></section><section ><h4>Funding Information</h4><div >American Association of Immunologists: AAI 2019-2020</div><div >NIH: AI148356</div><div >NIH: AI089443</div><div >NIH: AI114587</div></section><section ><h4>Notes</h4><div >*Corresponding author. Email: <a >[email protected]</a></div></section></section></div><div ><header><h2>Metrics Citations</h2></header><section ><h3>Metrics</h3><section > <h5 > Article Usage </h5> </section><section > <h5 > Altmetrics </h5> </section></section><section ><h3>Citations</h3><section > <div > <h5 >Export citation</h5> <p>Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div ><header><h2>View Options</h2></header><div ><h3>View options</h3><section ><h4>PDF format</h4><p>Download this article as a PDF file</p><a >Download PDF</a></section></div><div ><h3>Get Access</h3><section > <div ><h5>Log in to view the full text</h5> <p><a >AAAS Log in</a></p> <p>AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul > <li >Become a AAAS Member</li> <li ><a >Activate your Account</a></li> <li ><a >Purchase Access to Other Journals in the Science Family</a></li> <li><a >Account Help</a></li> </ul> <div > <div >Log in via OpenAthens. <div ><a >via OpenAthens</a></div> </div> <div >Log in via Shibboleth. <div ><a >via Shibboleth</a></div> </div> </div> </div> <div ><h4>More options</h4><p><a >Purchase digital access to this article</a></p><p >Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div></div><div ><header><h2>Media</h2></header><section ><h3>Figures</h3></section><section ><h3>Multimedia</h3></section></div><div ><header><h2>Tables</h2></header></div><div ><header><h2>Share</h2></header><h3>Share</h3><div ><section ><h4>Share article link</h4><div ><a >Copy Link</a><div ><p >Copied!</p><p >Copying failed.</p></div></div></section><section ><h4>Share on social media</h4><div ><a >facebook</a><a >twitter</a><a >linkedin</a><a >email</a></div></section></div></div></div></article><section ><div ><div ><div ><div ><h3 >Submit a Response to This Article</h3></div></div></div></div> <div > <div > <h2 >(0)eLetters</h2> </div> <p >eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p >No eLetters have been published for this article yet.</p> </div> </section> <div ><a >View Full Text</a><a >Download PDF</a></div> </div></div></div></div><div ><div ><div ><div ><section><div ><h4 > Current Issue </h4><div ><div > <div ><div><article ><div ><div ><h3 ><a >Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation</a></h3><ul ><li >By<ul > <li >Nathalie Niyonzima</li> <li >Jubayer Rahman</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >Tuft cell–produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation</h3><ul ><li >By<ul > <li >Saltanat Ualiyeva</li> <li >Evan Lemire</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >BNT162b2 vaccination induces durable SARS-CoV-2–specific T cells with a stem cell memory phenotype</h3><ul ><li >By<ul > <li >Gisella Guerrera</li> <li >Mario Picozza</li> <li >et al.</li> </ul> </li></ul></div></div></article></div><div >Table of Contents</div></div> </div></div></div></section><section > <h4 >LATEST NEWS</h4> <div > <div ><div > <article > <div > <div > News<time >30 Dec 2021</time> </div> <div > Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article > <div > <div > ScienceInsider<time >29 Dec 2021</time> </div> <div > <a > Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > The natural world loses two of its biggest advocates </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > <a > What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >25 Dec 2021</time> </div> <div > NASA’s Webb telescope takes flight—a Christmas gift to astronomers everywhere </div> </div> </article> <article > <div > <div > News<time >23 Dec 2021</time> </div> <div > <a > More than a virus: Science’s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57"><a title="valid: False, node: 58, tag: a, level: 16" node_number="58">Anywhere</a><a title="valid: False, node: 59, tag: a, level: 16" node_number="59">Science</a><a title="valid: False, node: 60, tag: a, level: 16" node_number="60">Science Advances</a><a title="valid: False, node: 61, tag: a, level: 16" node_number="61">Science Immunology</a><a title="valid: False, node: 62, tag: a, level: 16" node_number="62">Science Robotics</a><a title="valid: False, node: 63, tag: a, level: 16" node_number="63">Science Signaling</a><a title="valid: False, node: 64, tag: a, level: 16" node_number="64">Science Translational Medicine</a></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 65, tag: div, level: 12" node_number="65"> <a class="valid" valid="valid" title="valid: True, node: 66, tag: a, level: 13" node_number="66"><u class="valid" valid="valid" title="valid: True, node: 67, tag: u, level: 14" node_number="67">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 7" node_number="68"> <div class="valid" valid="valid" title="valid: True, node: 69, tag: div, level: 8" node_number="69"> <div class="valid" valid="valid" title="valid: True, node: 70, tag: div, level: 9" node_number="70"> <h6 class="valid" valid="valid" title="valid: True, node: 71, tag: h6, level: 10" node_number="71">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 72, tag: ul, level: 10" node_number="72"> <li class="valid" valid="valid" title="valid: True, node: 73, tag: li, level: 11" node_number="73"> <a class="valid" valid="valid" title="valid: True, node: 74, tag: a, level: 12" node_number="74">covid-19</a> </li> <li class="valid" valid="valid" title="valid: True, node: 75, tag: li, level: 11" node_number="75"> <a class="valid" valid="valid" title="valid: True, node: 76, tag: a, level: 12" node_number="76">climate</a> </li> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> <a class="valid" valid="valid" title="valid: True, node: 78, tag: a, level: 12" node_number="78">science policy</a> </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> <a class="valid" valid="valid" title="valid: True, node: 80, tag: a, level: 12" node_number="80">genome editing</a> </li> <li class="valid" valid="valid" title="valid: True, node: 81, tag: li, level: 11" node_number="81"> <a class="valid" valid="valid" title="valid: True, node: 82, tag: a, level: 12" node_number="82">batteries</a> </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 5" node_number="83"><div class="valid" valid="valid" title="valid: True, node: 84, tag: div, level: 6" node_number="84"><div class="valid" valid="valid" title="valid: True, node: 85, tag: div, level: 7" node_number="85"> <div class="valid" valid="valid" title="valid: True, node: 86, tag: div, level: 8" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 9" node_number="87"> <ul class="valid" valid="valid" title="valid: True, node: 88, tag: ul, level: 10" node_number="88"> <li class="valid" valid="valid" title="valid: True, node: 89, tag: li, level: 11" node_number="89"> <a class="valid" valid="valid" title="valid: True, node: 90, tag: a, level: 12" node_number="90">Current Issue</a> </li> <li class="valid" valid="valid" title="valid: True, node: 91, tag: li, level: 11" node_number="91"> <a class="valid" valid="valid" title="valid: True, node: 92, tag: a, level: 12" node_number="92">First release papers</a> </li> <li class="valid" valid="valid" title="valid: True, node: 93, tag: li, level: 11" node_number="93"> <a class="valid" valid="valid" title="valid: True, node: 94, tag: a, level: 12" node_number="94">Archive</a> </li> <li class="valid" valid="valid" title="valid: True, node: 95, tag: li, level: 11" node_number="95"> <div class="valid" valid="valid" title="valid: True, node: 96, tag: div, level: 12" node_number="96"> <a class="valid" valid="valid" title="valid: True, node: 97, tag: a, level: 13" node_number="97">About</a> <div class="valid" valid="valid" title="valid: True, node: 98, tag: div, level: 13" node_number="98"> <a class="valid" valid="valid" title="valid: True, node: 99, tag: a, level: 14" node_number="99">About Science Immunology</a> <a class="valid" valid="valid" title="valid: True, node: 100, tag: a, level: 14" node_number="100">Mission Scope</a> <a class="valid" valid="valid" title="valid: True, node: 101, tag: a, level: 14" node_number="101">Editors Advisory Boards</a> <a class="valid" valid="valid" title="valid: True, node: 102, tag: a, level: 14" node_number="102">FOCIS Highlights</a> <a class="valid" valid="valid" title="valid: True, node: 103, tag: a, level: 14" node_number="103">Editorial Policies</a> <a class="valid" valid="valid" title="valid: True, node: 104, tag: a, level: 14" node_number="104">Information for Authors</a> <a class="valid" valid="valid" title="valid: True, node: 105, tag: a, level: 14" node_number="105">Information for Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 106, tag: a, level: 14" node_number="106">Journal Metrics</a> <a class="valid" valid="valid" title="valid: True, node: 107, tag: a, level: 14" node_number="107">Contact Us</a> <a class="valid" valid="valid" title="valid: True, node: 108, tag: a, level: 14" node_number="108">Free Sample Articles</a> </div> </div> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 109, tag: div, level: 9" node_number="109"> <ul class="valid" valid="valid" title="valid: True, node: 110, tag: ul, level: 10" node_number="110"> <li class="valid" valid="valid" title="valid: True, node: 111, tag: li, level: 11" node_number="111"> <a class="valid" valid="valid" title="valid: True, node: 112, tag: a, level: 12" node_number="112">Submit manuscript</a> </li> <li class="valid" valid="valid" title="valid: True, node: 113, tag: li, level: 11" node_number="113"> <div class="valid" valid="valid" title="valid: True, node: 114, tag: div, level: 12" node_number="114"> <a class="valid" valid="valid" title="valid: True, node: 115, tag: a, level: 13" node_number="115">More</a> </div> </li> </ul> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 116, tag: a, level: 8" node_number="116">GET OUR E-ALERTS</a> </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 117, tag: main, level: 5" node_number="117"> <div class="valid" valid="valid" title="valid: True, node: 118, tag: div, level: 6" node_number="118"><div class="valid" valid="valid" title="valid: True, node: 119, tag: div, level: 7" node_number="119"><div class="valid" valid="valid" title="valid: True, node: 120, tag: div, level: 8" node_number="120"><div class="valid" valid="valid" title="valid: True, node: 121, tag: div, level: 9" node_number="121"><div class="valid" valid="valid" title="valid: True, node: 122, tag: div, level: 10" node_number="122"> <div class="valid" valid="valid" title="valid: True, node: 123, tag: div, level: 11" node_number="123"><a class="valid" valid="valid" title="valid: True, node: 124, tag: a, level: 12" node_number="124">Home</a><a class="valid" valid="valid" title="valid: True, node: 125, tag: a, level: 12" node_number="125">Science Immunology</a><a class="valid" valid="valid" title="valid: True, node: 126, tag: a, level: 12" node_number="126">Vol. 6, No. 66</a>IL-17&#8211;dependent fibroblastic reticular cell training boosts tissue protective mucosal immunity through IL-10&#8211;producing B cells</div><div class="valid" valid="valid" title="valid: True, node: 127, tag: div, level: 11" node_number="127">Back To Vol. 6, No. 66</div> </div> <article class="valid" valid="valid" title="valid: True, node: 128, tag: article, level: 10" node_number="128"><section class="valid" valid="valid" title="valid: True, node: 129, tag: section, level: 11" node_number="129"><header class="valid" valid="valid" title="valid: True, node: 130, tag: header, level: 12" node_number="130"><div class="valid" valid="valid" title="valid: True, node: 131, tag: div, level: 13" node_number="131"><div class="valid" valid="valid" title="valid: True, node: 132, tag: div, level: 14" node_number="132"><div title="valid: False, node: 133, tag: div, level: 15" node_number="133"><div title="valid: False, node: 134, tag: div, level: 16" node_number="134">FREE ACCESS</div><div title="valid: False, node: 135, tag: div, level: 16" node_number="135">Research Article</div><div title="valid: False, node: 136, tag: div, level: 16" node_number="136">MUCOSAL IMMUNOLOGY</div></div><div title="valid: False, node: 137, tag: div, level: 15" node_number="137"><div title="valid: False, node: 138, tag: div, level: 16" node_number="138"> <div title="valid: False, node: 139, tag: div, level: 17" node_number="139">Share on</div> </div></div></div><h1 class="valid" valid="valid" title="valid: True, node: 140, tag: h1, level: 14" node_number="140">IL-17&#8211;dependent fibroblastic reticular cell training boosts tissue protective mucosal immunity through IL-10&#8211;producing B cells</h1><div class="valid" valid="valid" title="valid: True, node: 141, tag: div, level: 14" node_number="141">Dongwen Wu https://orcid.org/0000-0001-7909-5708, Catherine H. Poholek https://orcid.org/0000-0002-9381-9618, Saikat Majumder https://orcid.org/0000-0002-6591-9515, Qixing Liu https://orcid.org/0000-0002-9076-6274, Shankar K. Revu, Kanishka Mohib https://orcid.org/0000-0002-7332-5530, David M. Rothstein https://orcid.org/0000-0002-9455-7971, and Mandy J. McGeachy https://orcid.org/0000-0001-5029-1668 [email&#160;protected]</div><div class="valid" valid="valid" title="valid: True, node: 142, tag: div, level: 14" node_number="142">Science Immunology &#8226; 17 Dec 2021 &#8226; Vol 6, Issue 66 &#8226; DOI: 10.1126/sciimmunol.aao3669</div><div class="valid" valid="valid" title="valid: True, node: 143, tag: div, level: 14" node_number="143"><div title="valid: False, node: 144, tag: div, level: 15" node_number="144"> <div title="valid: False, node: 145, tag: div, level: 16" node_number="145"> <a title="valid: False, node: 146, tag: a, level: 17" node_number="146"><div title="valid: False, node: 147, tag: div, level: 18" node_number="147"><div title="valid: False, node: 148, tag: div, level: 19" node_number="148"><h6 title="valid: False, node: 149, tag: h6, level: 20" node_number="149">PREVIOUS ARTICLE</h6><div title="valid: False, node: 150, tag: div, level: 20" node_number="150">Move over NAIP, DDX17 diversifies the NLRC4 inflammasome</div></div></div>Previous</a><a title="valid: False, node: 151, tag: a, level: 17" node_number="151"><div title="valid: False, node: 152, tag: div, level: 18" node_number="152"><div title="valid: False, node: 153, tag: div, level: 19" node_number="153"><h6 title="valid: False, node: 154, tag: h6, level: 20" node_number="154">NEXT ARTICLE</h6><div title="valid: False, node: 155, tag: div, level: 20" node_number="155">In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4<sup title="valid: False, node: 156, tag: sup, level: 21" node_number="156">+</sup> T<sub title="valid: False, node: 157, tag: sub, level: 21" node_number="157">H</sub>1 cell response</div></div></div>Next</a> </div> </div></div></div></header><div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 12" node_number="158"><div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 13" node_number="159"><section class="valid" valid="valid" title="valid: True, node: 160, tag: section, level: 14" node_number="160"><h2 title="valid: False, node: 161, tag: h2, level: 15" node_number="161">Stromal cells in training immunity</h2><div title="valid: False, node: 162, tag: div, level: 15" node_number="162">Immune responses to pathogens are heightened in individuals previously exposed to pathogen-associated stimuli, a phenomenon known as innate immune training. Innate immune training is accomplished through metabolic reprogramming and epigenetic changes, but the underlying mechanisms are not fully understood. In this study, Wu <i title="valid: False, node: 163, tag: i, level: 16" node_number="163">et al.</i> investigate the functional requirement of IL-17 receptor signaling in fibroblastic reticular cells (FRCs) in the development of protective antibody responses against gut infection and studied how innate immune training affects these responses. Mild gut inflammatory training before <i title="valid: False, node: 164, tag: i, level: 16" node_number="164">C. rodentium</i> infection enhanced gut-protective antibody production and reduced colon inflammation. Inflammatory training required IL-17 signaling in FRCs and IL-10 production by B cells. These findings reveal a mechanism of innate immune training in FRCs for protection against gut infection.</div></section><section class="valid" valid="valid" title="valid: True, node: 165, tag: section, level: 14" node_number="165"><h2 title="valid: False, node: 166, tag: h2, level: 15" node_number="166">Abstract</h2><div title="valid: False, node: 167, tag: div, level: 15" node_number="167">Prior experience of pathogen-associated stimuli reduces morbidity and mortality to newly encountered infections through innate immune training, which can be enhanced by childhood vaccination. Fibroblastic reticular cells (FRCs) are stromal cells in lymphoid organs that support lymphocyte localization and survival and modulate adaptive immune responses. IL-17 signaling is important for FRC metabolism and proliferation during inflammatory responses. Here, we show that FRC-intrinsic IL-17 signaling was required for protective antibody-mediated immunity to the gut bacterial pathogen <i title="valid: False, node: 168, tag: i, level: 16" node_number="168">Citrobacter rodentium.</i> We asked whether prior activation of FRC through nonspecific inflammatory &#8220;training&#8221; of the gut would alter subsequent immune response to <i title="valid: False, node: 169, tag: i, level: 16" node_number="169">C. rodentium</i>. Inflammatory training increased the number of activated FRC in mesenteric LN (MLN) and enhanced the antibody response to <i title="valid: False, node: 170, tag: i, level: 16" node_number="170">C. rodentium</i> in an IL-17&#8211;dependent manner. FRC demonstrated cardinal features of innate immune training, including increased epigenetic markers of activation and increased metabolic response to infection. Enhanced responses were still evident 6 weeks after training. The kinetics of bacterial infection were not changed by inflammatory training, but colon inflammation was paradoxically reduced. Mechanistically, IL-10 production by activated B cells was required for colon protective effects of inflammatory training. Enhancing tissue protective B cell responses thus led to increased production of antibody and IL-10, allowing clearance of infection with reduced tissue inflammation. These data identify a new mode of immune training through FRC to modulate future adaptive responses and better preserve host health.</div></section></div></div></section><section class="valid" valid="valid" title="valid: True, node: 171, tag: section, level: 11" node_number="171"><div class="valid" valid="valid" title="valid: True, node: 172, tag: div, level: 12" node_number="172"><section class="valid" valid="valid" title="valid: True, node: 173, tag: section, level: 13" node_number="173"><h2 class="valid" valid="valid" title="valid: True, node: 174, tag: h2, level: 14" node_number="174">INTRODUCTION</h2><div class="valid" valid="valid" title="valid: True, node: 175, tag: div, level: 14" node_number="175">Vaccination programs have greatly reduced childhood mortality, even beyond the prevalence of the specific diseases targeted. One of the mechanisms underlying this broad protective effect is innate immunological training, whereby exposure to pathogen-associated molecules activates a form of nonspecific innate memory that more effectively resists future &#8220;new&#8221; infections (<a title="valid: False, node: 176, tag: a, level: 15" node_number="176"><i title="valid: False, node: 177, tag: i, level: 16" node_number="177">1</i></a>). This heightened responsiveness is accomplished through metabolic reprogramming and epigenetic modifications that persists for months after the initial challenge. Trained immunity likely contributes to the increasing resistance to infectious disease, both previously encountered and new, which occurs over time in children as they are exposed to a range of microbes, and hence, vaccination hastens this process.</div><div class="valid" valid="valid" title="valid: True, node: 178, tag: div, level: 14" node_number="178">Diarrheagenic pathogens are the second leading cause of infection-related deaths in children under the age of 5 years according to the World Health Organization (<a title="valid: False, node: 179, tag: a, level: 15" node_number="179"><i title="valid: False, node: 180, tag: i, level: 16" node_number="180">2</i></a>, <a title="valid: False, node: 181, tag: a, level: 15" node_number="181"><i title="valid: False, node: 182, tag: i, level: 16" node_number="182">3</i></a>). <i title="valid: False, node: 183, tag: i, level: 15" node_number="183">Escherichia coli</i> is a major contributor to diarrheal-related deaths (<a title="valid: False, node: 184, tag: a, level: 15" node_number="184"><i title="valid: False, node: 185, tag: i, level: 16" node_number="185">4</i></a>, <a title="valid: False, node: 186, tag: a, level: 15" node_number="186"><i title="valid: False, node: 187, tag: i, level: 16" node_number="187">5</i></a>), with more than 300 million illnesses and 200,000 deaths globally each year (<a title="valid: False, node: 188, tag: a, level: 15" node_number="188"><i title="valid: False, node: 189, tag: i, level: 16" node_number="189">6</i></a>). <i title="valid: False, node: 190, tag: i, level: 15" node_number="190">Citrobacter rodentium</i> is widely studied as the murine equivalent to enteropathogenic <i title="valid: False, node: 191, tag: i, level: 15" node_number="191">E. coli</i> and enterohemorrhagic <i title="valid: False, node: 192, tag: i, level: 15" node_number="192">E. coli</i>, two pathotypes of diarrheagenic <i title="valid: False, node: 193, tag: i, level: 15" node_number="193">E. coli</i>, because they share a similar colonization strategy known as attaching and effacing lesion formation (<a title="valid: False, node: 194, tag: a, level: 15" node_number="194"><i title="valid: False, node: 195, tag: i, level: 16" node_number="195">7</i></a>, <a title="valid: False, node: 196, tag: a, level: 15" node_number="196"><i title="valid: False, node: 197, tag: i, level: 16" node_number="197">8</i></a>). Interleukin-17 (IL-17), interferon-&#947;, and IL-22 produced by T helper 17 (T<sub title="valid: False, node: 198, tag: sub, level: 15" node_number="198">H</sub>17) and innate lymphoid cells induce the production of antimicrobial peptides by intestinal epithelium and activate myeloid cells (<a title="valid: False, node: 199, tag: a, level: 15" node_number="199"><i title="valid: False, node: 200, tag: i, level: 16" node_number="200">9</i></a>&#8211;<a title="valid: False, node: 201, tag: a, level: 15" node_number="201"><i title="valid: False, node: 202, tag: i, level: 16" node_number="202">11</i></a>). Although effective in controlling the infection, the by-product of this proinflammatory response is transient colitis that lasts 2 to 4 weeks after infection. In contrast, antibody specific to <i title="valid: False, node: 203, tag: i, level: 15" node_number="203">C. rodentium</i> protects against reinfection without causing inflammation (<a title="valid: False, node: 204, tag: a, level: 15" node_number="204"><i title="valid: False, node: 205, tag: i, level: 16" node_number="205">12</i></a>, <a title="valid: False, node: 206, tag: a, level: 15" node_number="206"><i title="valid: False, node: 207, tag: i, level: 16" node_number="207">13</i></a>). This is the goal of vaccination programs, to bypass the early inflammation driven by innate and T cell immunity and invoke an antibody response that can provide protective immunity without affecting host health.</div><div class="valid" valid="valid" title="valid: True, node: 208, tag: div, level: 14" node_number="208">Secondary lymphoid organs provide critical support for both T and B cell activation and optimal antibody production through germinal center (GC) formation (<a title="valid: False, node: 209, tag: a, level: 15" node_number="209"><i title="valid: False, node: 210, tag: i, level: 16" node_number="210">14</i></a>, <a title="valid: False, node: 211, tag: a, level: 15" node_number="211"><i title="valid: False, node: 212, tag: i, level: 16" node_number="212">15</i></a>). Fibroblastic reticular cells (FRCs) are lymph node (LN) stromal cells that produce cytokines and chemokines to support survival and function of lymphocytes and organization of LN architecture (<a title="valid: False, node: 213, tag: a, level: 15" node_number="213"><i title="valid: False, node: 214, tag: i, level: 16" node_number="214">16</i></a>, <a title="valid: False, node: 215, tag: a, level: 15" node_number="215"><i title="valid: False, node: 216, tag: i, level: 16" node_number="216">17</i></a>). FRCs have been found to both promote and regulate adaptive immune responses and thus are considered active players in immune responses (<a title="valid: False, node: 217, tag: a, level: 15" node_number="217"><i title="valid: False, node: 218, tag: i, level: 16" node_number="218">18</i></a>). We recently showed that IL-17 signaling is critical for metabolic reprogramming of activated FRC during experimental autoimmune encephalomyelitis (EAE) and linked IL-17&#8211;dependent activation of FRC to enhanced autoantibody production (<a title="valid: False, node: 219, tag: a, level: 15" node_number="219"><i title="valid: False, node: 220, tag: i, level: 16" node_number="220">19</i></a>).</div><div class="valid" valid="valid" title="valid: True, node: 221, tag: div, level: 14" node_number="221">In this study, we queried the functional requirement for IL-17 receptor signaling in FRCs during development of protective antibody responses to gut infection. Because metabolic reprogramming is a hallmark of immunological training in myeloid cells (<a title="valid: False, node: 222, tag: a, level: 15" node_number="222"><i title="valid: False, node: 223, tag: i, level: 16" node_number="223">1</i></a>, <a title="valid: False, node: 224, tag: a, level: 15" node_number="224"><i title="valid: False, node: 225, tag: i, level: 16" node_number="225">20</i></a>), we further hypothesized that prior FRC activation through nonspecific gut inflammation could alter a subsequent immune response to gut infection with <i title="valid: False, node: 226, tag: i, level: 15" node_number="226">C. rodentium</i> by enhancing <i title="valid: False, node: 227, tag: i, level: 15" node_number="227">C. rodentium</i>&#8211;specific antibody. Here, we demonstrate that IL-17&#8211;dependent FRC activation promotes protective antibody responses both in adaptive memory and in nonspecific inflammatory training models. Furthermore, inflammatory training not only enhances antibody production but also reduces colon inflammation independent of <i title="valid: False, node: 228, tag: i, level: 15" node_number="228">C. rodentium</i> infection burden. Last, we show that inflammatory training relies on FRC-intrinsic IL-17 signaling and IL-10 production by B cells, revealing a previously unappreciated mechanism of FRC training that modulates adaptive immunity with increased host health during infection.</div></section><section class="valid" valid="valid" title="valid: True, node: 229, tag: section, level: 13" node_number="229"><h2 class="valid" valid="valid" title="valid: True, node: 230, tag: h2, level: 14" node_number="230">RESULTS</h2><section class="valid" valid="valid" title="valid: True, node: 231, tag: section, level: 14" node_number="231"><h3 title="valid: False, node: 232, tag: h3, level: 15" node_number="232">Loss of FRC-intrinsic IL-17 signaling delays <i title="valid: False, node: 233, tag: i, level: 16" node_number="233">C. rodentium</i> clearance</h3><div title="valid: False, node: 234, tag: div, level: 15" node_number="234">To determine whether IL-17 signaling in LN stromal cells plays a role in protection during infection of the gut, mice lacking the IL-17 receptor subunit IL-17RA specifically in FRCs were generated by crossing <i title="valid: False, node: 235, tag: i, level: 16" node_number="235">Ccl19</i><sup title="valid: False, node: 236, tag: sup, level: 16" node_number="236">cre</sup> mice with <i title="valid: False, node: 237, tag: i, level: 16" node_number="237">Il17ra</i><sup title="valid: False, node: 238, tag: sup, level: 16" node_number="238">fl/fl</sup> mice, hereafter termed FRC<sup title="valid: False, node: 239, tag: sup, level: 16" node_number="239">&#8710;</sup><i title="valid: False, node: 240, tag: i, level: 16" node_number="240"><sup title="valid: False, node: 241, tag: sup, level: 17" node_number="241">Il17ra</sup></i> mice. There is no difference in basal numbers of FRC in this mouse strain (<a title="valid: False, node: 242, tag: a, level: 16" node_number="242"><i title="valid: False, node: 243, tag: i, level: 17" node_number="243">19</i></a>). Control mice were <i title="valid: False, node: 244, tag: i, level: 16" node_number="244">Ccl19</i>cre<sup title="valid: False, node: 245, tag: sup, level: 16" node_number="245">&#8722;</sup><i title="valid: False, node: 246, tag: i, level: 16" node_number="246">Il17ra</i><sup title="valid: False, node: 247, tag: sup, level: 16" node_number="247">fl/fl</sup> wild-type (WT) littermates (FRC<sup title="valid: False, node: 248, tag: sup, level: 16" node_number="248">Ctrl</sup>). Upon infection with <i title="valid: False, node: 249, tag: i, level: 16" node_number="249">C. rodentium,</i> FRC numbers were reduced in the mesenteric LNs (MLNs) draining the gut of infected FRC<sup title="valid: False, node: 250, tag: sup, level: 16" node_number="250">&#8710;</sup><i title="valid: False, node: 251, tag: i, level: 16" node_number="251"><sup title="valid: False, node: 252, tag: sup, level: 17" node_number="252">Il17ra</sup></i> compared with FRC<sup title="valid: False, node: 253, tag: sup, level: 16" node_number="253">Ctrl</sup> mice (<a title="valid: False, node: 254, tag: a, level: 16" node_number="254">Fig. 1A</a> and fig. S1A). This was expected from our prior studies on FRC numbers in FRC<sup title="valid: False, node: 255, tag: sup, level: 16" node_number="255">&#8710;</sup><i title="valid: False, node: 256, tag: i, level: 16" node_number="256"><sup title="valid: False, node: 257, tag: sup, level: 17" node_number="257">Il17ra</sup></i> mice in EAE and dextran sulfate sodium (DSS) colitis (<a title="valid: False, node: 258, tag: a, level: 16" node_number="258"><i title="valid: False, node: 259, tag: i, level: 17" node_number="259">19</i></a>). Fecal burden of <i title="valid: False, node: 260, tag: i, level: 16" node_number="260">C. rodentium</i> was similar between FRC<sup title="valid: False, node: 261, tag: sup, level: 16" node_number="261">&#8710;</sup><i title="valid: False, node: 262, tag: i, level: 16" node_number="262"><sup title="valid: False, node: 263, tag: sup, level: 17" node_number="263">Il17ra</sup></i> and FRC<sup title="valid: False, node: 264, tag: sup, level: 16" node_number="264">Ctrl</sup> mice during the first week of infection, indicating that there was no difference in the ability of the innate response to control infection in the colon during this initial phase. However, during the second week of infection, corresponding to the adaptive immune response, FRC<sup title="valid: False, node: 265, tag: sup, level: 16" node_number="265">&#8710;</sup><i title="valid: False, node: 266, tag: i, level: 16" node_number="266"><sup title="valid: False, node: 267, tag: sup, level: 17" node_number="267">Il17ra</sup></i> mice showed an impaired ability to clear bacteria (<a title="valid: False, node: 268, tag: a, level: 16" node_number="268">Fig. 1B</a>).</div><div title="valid: False, node: 269, tag: div, level: 15" node_number="269">Although <i title="valid: False, node: 270, tag: i, level: 16" node_number="270">C. rodentium</i> infection and associated transient colitis do not typically induce severe weight loss in WT mice, infected FRC<sup title="valid: False, node: 271, tag: sup, level: 16" node_number="271">&#8710;</sup><i title="valid: False, node: 272, tag: i, level: 16" node_number="272"><sup title="valid: False, node: 273, tag: sup, level: 17" node_number="273">Il17ra</sup></i> mice had a slight but significant reduction in body mass compared to controls (<a title="valid: False, node: 274, tag: a, level: 16" node_number="274">Fig. 1C</a>). FRC<sup title="valid: False, node: 275, tag: sup, level: 16" node_number="275">&#8710;</sup><i title="valid: False, node: 276, tag: i, level: 16" node_number="276"><sup title="valid: False, node: 277, tag: sup, level: 17" node_number="277">Il17ra</sup></i> mice also had significantly shorter colons, indicating increased colitis (<a title="valid: False, node: 278, tag: a, level: 16" node_number="278">Fig. 1D</a>). Gene expression analysis of the FRC<sup title="valid: False, node: 279, tag: sup, level: 16" node_number="279">&#8710;</sup><i title="valid: False, node: 280, tag: i, level: 16" node_number="280"><sup title="valid: False, node: 281, tag: sup, level: 17" node_number="281">Il17ra</sup></i> colon further supported an enhanced local inflammatory response compared with controls, with increased expression of <i title="valid: False, node: 282, tag: i, level: 16" node_number="282">Il17a</i> and <i title="valid: False, node: 283, tag: i, level: 16" node_number="283">Ifng</i> (<a title="valid: False, node: 284, tag: a, level: 16" node_number="284">Fig. 1E</a>). Unexpectedly, the T<sub title="valid: False, node: 285, tag: sub, level: 16" node_number="285">H</sub>17-associated proinflammatory gene <i title="valid: False, node: 286, tag: i, level: 16" node_number="286">Csf2</i>, encoding granulocyte-macrophage colony-stimulating factor (GM-CSF), was reduced in FRC<sup title="valid: False, node: 287, tag: sup, level: 16" node_number="287">&#8710;</sup><i title="valid: False, node: 288, tag: i, level: 16" node_number="288"><sup title="valid: False, node: 289, tag: sup, level: 17" node_number="289">Il17ra</sup></i> mouse colon, suggesting a possible defect in myeloid cell activation. However, a major product of protective myeloid cell function in <i title="valid: False, node: 290, tag: i, level: 16" node_number="290">C. rodentium</i>, <i title="valid: False, node: 291, tag: i, level: 16" node_number="291">Il1b</i>, was increased in the absence of FRC signaling (<a title="valid: False, node: 292, tag: a, level: 16" node_number="292">Fig. 1E</a>) (<a title="valid: False, node: 293, tag: a, level: 16" node_number="293"><i title="valid: False, node: 294, tag: i, level: 17" node_number="294">21</i></a>, <a title="valid: False, node: 295, tag: a, level: 16" node_number="295"><i title="valid: False, node: 296, tag: i, level: 17" node_number="296">22</i></a>). IL-22 plays important roles in <i title="valid: False, node: 297, tag: i, level: 16" node_number="297">C. rodentium</i> clearance through induction of antimicrobial peptides including REGIII&#947; and increased IL-18 expression in infected epithelial cells (<a title="valid: False, node: 298, tag: a, level: 16" node_number="298"><i title="valid: False, node: 299, tag: i, level: 17" node_number="299">23</i></a>&#8211;<a title="valid: False, node: 300, tag: a, level: 16" node_number="300"><i title="valid: False, node: 301, tag: i, level: 17" node_number="301">26</i></a>). IL-22 expression was also notably reduced, but <i title="valid: False, node: 302, tag: i, level: 16" node_number="302">Il18</i> was unchanged, and <i title="valid: False, node: 303, tag: i, level: 16" node_number="303">RegIIIg</i> was increased (<a title="valid: False, node: 304, tag: a, level: 16" node_number="304">Fig. 1E</a>), suggesting possible compensation for example through enhanced IL-17 signaling.</div><div title="valid: False, node: 305, tag: div, level: 15" node_number="305">Overall, these data suggest that delayed clearance is associated with altered tissue cytokine responses and increased inflammation, but key effector molecules (such as antimicrobial peptides) continue to be induced and are perhaps increased. We therefore turned to investigate another key mediator of protective immunity in <i title="valid: False, node: 306, tag: i, level: 16" node_number="306">C. rodentium</i> infection, namely, B cell activation and antibody production. There was a significant decrease in the frequency of GC B cells when FRCs could not respond to IL-17 (<a title="valid: False, node: 307, tag: a, level: 16" node_number="307">Fig. 1F</a> and fig. S1B). Although immunoglobulin A (IgA) antibody responses are most strongly associated with mucosal immunity, <i title="valid: False, node: 308, tag: i, level: 16" node_number="308">C. rodentium</i>&#8211;specific IgG is essential for its clearance (<a title="valid: False, node: 309, tag: a, level: 16" node_number="309"><i title="valid: False, node: 310, tag: i, level: 17" node_number="310">27</i></a>, <a title="valid: False, node: 311, tag: a, level: 16" node_number="311"><i title="valid: False, node: 312, tag: i, level: 17" node_number="312">28</i></a>). Correspondingly, total IgG and <i title="valid: False, node: 313, tag: i, level: 16" node_number="313">C. rodentium</i>&#8211;specific IgG were significantly reduced in serum of FRC<sup title="valid: False, node: 314, tag: sup, level: 16" node_number="314">&#8710;</sup><i title="valid: False, node: 315, tag: i, level: 16" node_number="315"><sup title="valid: False, node: 316, tag: sup, level: 17" node_number="316">Il17ra</sup></i> mice on day 14 after infection (<a title="valid: False, node: 317, tag: a, level: 16" node_number="317">Fig. 1, G and H</a>). Fecal <i title="valid: False, node: 318, tag: i, level: 16" node_number="318">C. rodentium</i>&#8211;specific IgA was similarly reduced at multiple time points after infection (<a title="valid: False, node: 319, tag: a, level: 16" node_number="319">Fig. 1I</a>). Hence, delayed clearance of <i title="valid: False, node: 320, tag: i, level: 16" node_number="320">C. rodentium</i> in FRC<sup title="valid: False, node: 321, tag: sup, level: 16" node_number="321">&#8710;</sup><i title="valid: False, node: 322, tag: i, level: 16" node_number="322"><sup title="valid: False, node: 323, tag: sup, level: 17" node_number="323">Il17ra</sup></i> mice corresponds to impaired antibody responses accompanied by perturbation of the colon cytokine response and increased inflammation.</div></section><section class="valid" valid="valid" title="valid: True, node: 324, tag: section, level: 14" node_number="324"><h3 title="valid: False, node: 325, tag: h3, level: 15" node_number="325">Loss of protective immunity against <i title="valid: False, node: 326, tag: i, level: 16" node_number="326">C rodentium</i> without FRC-intrinsic IL-17 signaling</h3><div title="valid: False, node: 327, tag: div, level: 15" node_number="327">Because antibodies are the basis of protective immunity to <i title="valid: False, node: 328, tag: i, level: 16" node_number="328">C. rodentium</i>, we tested the susceptibility of FRC<sup title="valid: False, node: 329, tag: sup, level: 16" node_number="329">&#8710;</sup><i title="valid: False, node: 330, tag: i, level: 16" node_number="330"><sup title="valid: False, node: 331, tag: sup, level: 17" node_number="331">Il17ra</sup></i> mice to reinfection. Sixty days after primary infection, <i title="valid: False, node: 332, tag: i, level: 16" node_number="332">C. rodentium</i> DNA could not be detected in stool for either FRC<sup title="valid: False, node: 333, tag: sup, level: 16" node_number="333">Ctrl</sup> or FRC<sup title="valid: False, node: 334, tag: sup, level: 16" node_number="334">&#8710;</sup><i title="valid: False, node: 335, tag: i, level: 16" node_number="335"><sup title="valid: False, node: 336, tag: sup, level: 17" node_number="336">Il17ra</sup></i> mice (<a title="valid: False, node: 337, tag: a, level: 16" node_number="337">Fig. 2A</a>). This indicated that the increased cytokine-driven antimicrobial response in FRC<sup title="valid: False, node: 338, tag: sup, level: 16" node_number="338">&#8710;</sup><i title="valid: False, node: 339, tag: i, level: 16" node_number="339"><sup title="valid: False, node: 340, tag: sup, level: 17" node_number="340">Il17ra</sup></i> mice had sufficiently compensated for reduced antibody to clear the infection. Upon rechallenge with <i title="valid: False, node: 341, tag: i, level: 16" node_number="341">C. rodentium,</i> the bacteria were not detectable in most of the control mice and only in low amounts in those that developed infection, demonstrating the potency of immune memory (<a title="valid: False, node: 342, tag: a, level: 16" node_number="342">Fig. 2, A and B</a>). However, all of the FRC<sup title="valid: False, node: 343, tag: sup, level: 16" node_number="343">&#8710;</sup><i title="valid: False, node: 344, tag: i, level: 16" node_number="344"><sup title="valid: False, node: 345, tag: sup, level: 17" node_number="345">Il17ra</sup></i> mice developed detectable <i title="valid: False, node: 346, tag: i, level: 16" node_number="346">C. rodentium</i> infection by 10 days after reinfection (<a title="valid: False, node: 347, tag: a, level: 16" node_number="347">Fig. 2, A and B</a>). Reinfected FRC<sup title="valid: False, node: 348, tag: sup, level: 16" node_number="348">&#8710;</sup><i title="valid: False, node: 349, tag: i, level: 16" node_number="349"><sup title="valid: False, node: 350, tag: sup, level: 17" node_number="350">Il17ra</sup></i> mice experienced significant weight loss and colitis (colon shortening) compared with FRC<sup title="valid: False, node: 351, tag: sup, level: 16" node_number="351">Ctrl</sup> mice (<a title="valid: False, node: 352, tag: a, level: 16" node_number="352">Fig. 2, C and D</a>). Because memory T cell responses are expected to peak earlier upon reinfection, we analyzed the colon on day 10 for expression of inflammatory genes. These were mostly unchanged with a trend toward increased IL-17 and IL-1&#946; in FRC<sup title="valid: False, node: 353, tag: sup, level: 16" node_number="353">&#8710;</sup><i title="valid: False, node: 354, tag: i, level: 16" node_number="354"><sup title="valid: False, node: 355, tag: sup, level: 17" node_number="355">Il17ra</sup></i> mice compared with FRC<sup title="valid: False, node: 356, tag: sup, level: 16" node_number="356">Ctrl</sup> mice (<a title="valid: False, node: 357, tag: a, level: 16" node_number="357">Fig. 2E</a>). <i title="valid: False, node: 358, tag: i, level: 16" node_number="358">Csf2</i>, encoding GM-CSF, was the only marker to show decreased expression in FRC<sup title="valid: False, node: 359, tag: sup, level: 16" node_number="359">&#8710;</sup><i title="valid: False, node: 360, tag: i, level: 16" node_number="360"><sup title="valid: False, node: 361, tag: sup, level: 17" node_number="361">Il17ra</sup></i> mice on day 10 after reinfection (<a title="valid: False, node: 362, tag: a, level: 16" node_number="362">Fig. 2E</a>). However, both the percentage and absolute number of GC B cells in gut-draining LNs were reduced in FRC<sup title="valid: False, node: 363, tag: sup, level: 16" node_number="363">&#8710;</sup><i title="valid: False, node: 364, tag: i, level: 16" node_number="364"><sup title="valid: False, node: 365, tag: sup, level: 17" node_number="365">Il17ra</sup></i> mice (<a title="valid: False, node: 366, tag: a, level: 16" node_number="366">Fig. 2, F and G</a>). Correspondingly, the production of <i title="valid: False, node: 367, tag: i, level: 16" node_number="367">C. rodentium</i>&#8211;specific IgG was decreased in both FRC<sup title="valid: False, node: 368, tag: sup, level: 16" node_number="368">&#8710;</sup><i title="valid: False, node: 369, tag: i, level: 16" node_number="369"><sup title="valid: False, node: 370, tag: sup, level: 17" node_number="370">Il17ra</sup></i> mice serum and feces (<a title="valid: False, node: 371, tag: a, level: 16" node_number="371">Fig. 2, H and I</a>).</div></section><section class="valid" valid="valid" title="valid: True, node: 372, tag: section, level: 14" node_number="372"><h3 title="valid: False, node: 373, tag: h3, level: 15" node_number="373">Mild gut inflammation enhances FRC and antibody response to subsequent infection</h3><div title="valid: False, node: 374, tag: div, level: 15" node_number="374">DSS induces transient gut injury and inflammation and is a commonly used mouse model of colitis (<a title="valid: False, node: 375, tag: a, level: 16" node_number="375"><i title="valid: False, node: 376, tag: i, level: 17" node_number="376">29</i></a>). DSS colitis increases FRC numbers in MLNs (<a title="valid: False, node: 377, tag: a, level: 16" node_number="377"><i title="valid: False, node: 378, tag: i, level: 17" node_number="378">19</i></a>), lasting several weeks after DSS removal (fig. S2A). We therefore administered a low dose (1%) of DSS to induce mild gut injury as a nonspecific inflammatory immune training for a period of 7 days, followed by 1 week of rest to allow resolution of colon inflammation. Mice were then infected with <i title="valid: False, node: 379, tag: i, level: 16" node_number="379">C. rodentium</i>, and the outcome was compared 14 days after infection. Mild DSS training did not cause significant weight loss in most mice (fig. S2B). However, after <i title="valid: False, node: 380, tag: i, level: 16" node_number="380">C. rodentium</i> infection, MLN from trained mice had increased FRC numbers compared with MLNs from untrained mice (<a title="valid: False, node: 381, tag: a, level: 16" node_number="381">Fig. 3A</a>). Similarly, total numbers of MLN cells were increased in infected mice with prior inflammatory training (<a title="valid: False, node: 382, tag: a, level: 16" node_number="382">Fig. 3B</a>). The proportion of MLN CD4<sup title="valid: False, node: 383, tag: sup, level: 16" node_number="383">+</sup> T cells were not changed under any condition (fig. S2C). In contrast, the percentage and number of total B cells and GC B cells were significantly increased in mice that were infected by <i title="valid: False, node: 384, tag: i, level: 16" node_number="384">C. rodentium</i> after inflammatory training (<a title="valid: False, node: 385, tag: a, level: 16" node_number="385">Fig. 3, C and D</a>, and fig. S2, D and E). Corresponding to increased GC B cells, T follicular helper (T<sub title="valid: False, node: 386, tag: sub, level: 16" node_number="386">FH</sub>) cells were increased in MLN from trained mice after infection (<a title="valid: False, node: 387, tag: a, level: 16" node_number="387">Fig. 3, E and F</a>, and fig. S2F). DSS treatment alone did not induce any appreciable increase in total IgG or <i title="valid: False, node: 388, tag: i, level: 16" node_number="388">C. rodentium</i>&#8211;specific IgG (<a title="valid: False, node: 389, tag: a, level: 16" node_number="389">Fig. 3, G and H</a>). However, prior experience of gut inflammatory training significantly enhanced the IgG response to <i title="valid: False, node: 390, tag: i, level: 16" node_number="390">C. rodentium</i> (<a title="valid: False, node: 391, tag: a, level: 16" node_number="391">Fig. 3, G and H</a>). Despite the enhanced antibody response, there was no consistent change in kinetics of <i title="valid: False, node: 392, tag: i, level: 16" node_number="392">C. rodentium</i> infection or clearance in mice that had experienced mild DSS colitis before infection (<a title="valid: False, node: 393, tag: a, level: 16" node_number="393">Fig. 3I</a>).</div><div title="valid: False, node: 394, tag: div, level: 15" node_number="394"><i title="valid: False, node: 395, tag: i, level: 16" node_number="395">C. rodentium</i> induces transient colitis, and given that prior inflammatory training led to an increased adaptive immune response, we initially predicted that inflammatory gut training followed by infection would enhance colon inflammation and immunopathology. Instead, mice that had experienced mild DSS colitis were unexpectedly protected from <i title="valid: False, node: 396, tag: i, level: 16" node_number="396">C. rodentium</i>&#8211;induced colitis as measured by colon shortening (<a title="valid: False, node: 397, tag: a, level: 16" node_number="397">Fig. 3J</a>). This was further supported by reduced <i title="valid: False, node: 398, tag: i, level: 16" node_number="398">Il17a</i> expression in colon tissues on day 14 after infection, whereas other inflammatory cytokines and antimicrobial peptides were unchanged by training (<a title="valid: False, node: 399, tag: a, level: 16" node_number="399">Fig. 3, K to Q</a>). In accordance with the similar early infection load in trained and untrained mice, prior DSS treatment did not cause appreciable changes in inflammatory or antimicrobial immune responses in the distal colon on day 5 after infection (<a title="valid: False, node: 400, tag: a, level: 16" node_number="400">Fig. 3, K to Q</a>). Together, these data demonstrate that prior inflammation leads to an altered adaptive immune response to subsequent de novo infection, resulting in enhanced B cell immunity but reduced tissue inflammation.</div></section><section class="valid" valid="valid" title="valid: True, node: 401, tag: section, level: 14" node_number="401"><h3 title="valid: False, node: 402, tag: h3, level: 15" node_number="402">Evidence for trained immunity in MLN FRC after mild colitis</h3><div title="valid: False, node: 403, tag: div, level: 15" node_number="403">The enhanced protective response to a new infection after mild colitis was reminiscent of the protection provided by innate immune training. There are several hallmark features of trained immunity, particularly (i) enhanced response to de novo stimuli, (ii) longevity of the innate &#8220;memory,&#8221; (iii) epigenetic alterations that create memory, and (iv) enhanced metabolic status of trained cells. Our data, so far, support enhanced adaptive response to infection. To test for longevity, we administered DSS and rested mice for 6 weeks before infection with <i title="valid: False, node: 404, tag: i, level: 16" node_number="404">C. rodentium</i>. Mice that were trained 6 weeks before infection again showed significantly increased numbers of FRC (<a title="valid: False, node: 405, tag: a, level: 16" node_number="405">Fig. 4A</a>), accompanied by increased GC B cells in MLN (<a title="valid: False, node: 406, tag: a, level: 16" node_number="406">Fig. 4, B and C</a>), and enhanced antibody responses to <i title="valid: False, node: 407, tag: i, level: 16" node_number="407">C. rodentium</i> (<a title="valid: False, node: 408, tag: a, level: 16" node_number="408">Fig. 4, D and E</a>). As before, training resulted in protection of colon tissue as measured by colon length and expression of inflammatory cytokines (<a title="valid: False, node: 409, tag: a, level: 16" node_number="409">Fig. 4, F to M</a>). The reduction in inflammation was more clearly demarcated when mice were rested for 6 weeks, suggesting that residual inflammation from the mild DSS treatment was still present when rested for only 1 week. Hence, these data support the longevity of the trained response leading to enhanced humoral immunity and reduced inflammation.</div><div title="valid: False, node: 410, tag: div, level: 15" node_number="410">We next tested for epigenetic changes in the expanded FRC population after DSS training (<a title="valid: False, node: 411, tag: a, level: 16" node_number="411">Fig. 4N</a>). FRC from trained mice showed enhanced trimethylation at the fourth lysine residue of the DNA packaging protein histone H3 (H3K4me3), an epigenetic modification suggesting increased promoter activity (<a title="valid: False, node: 412, tag: a, level: 16" node_number="412">Fig. 4O</a> and fig. S3A).</div><div title="valid: False, node: 413, tag: div, level: 15" node_number="413">We have previously shown that inflammatory activation leads to enhanced glucose uptake by FRC in an IL-17&#8211;dependent manner, corresponding to enhanced function in metabolic assays (<a title="valid: False, node: 414, tag: a, level: 16" node_number="414"><i title="valid: False, node: 415, tag: i, level: 17" node_number="415">19</i></a>). On the basis of this, we asked whether prior activation of FRC by DSS colitis resulted in altered glucose uptake as a measure of metabolic capacity in response to subsequent infection. Glucose uptake by FRC at 5 days after infection was significantly enhanced in infected mice that had received DSS training compared with untrained infected controls (<a title="valid: False, node: 416, tag: a, level: 16" node_number="416">Fig. 4, P and Q</a>, and fig. S3B). Hence, FRC bear hallmark features of trained immunity after mild gut inflammation that corresponds to a sustained capacity to boost the immune response to a new infection.</div></section><section class="valid" valid="valid" title="valid: True, node: 417, tag: section, level: 14" node_number="417"><h3 title="valid: False, node: 418, tag: h3, level: 15" node_number="418">FRC-intrinsic IL-17 signaling is required for immune training during gut inflammation</h3><div title="valid: False, node: 419, tag: div, level: 15" node_number="419">The data so far suggest that FRC activation by prior gut inflammatory training results in increased antibody responses and reduced colon inflammation when a new pathogen (<i title="valid: False, node: 420, tag: i, level: 16" node_number="420">C. rodentium</i>) is encountered. However, other cell types in the colon or MLNs could also undergo immune training to contribute to the effect. We previously showed that FRC-intrinsic IL-17 signaling is required for metabolic reprogramming and proliferation of FRC (<a title="valid: False, node: 421, tag: a, level: 16" node_number="421"><i title="valid: False, node: 422, tag: i, level: 17" node_number="422">19</i></a>). We therefore tested the gut inflammation-trained response in FRC<sup title="valid: False, node: 423, tag: sup, level: 16" node_number="423">&#8710;</sup><i title="valid: False, node: 424, tag: i, level: 16" node_number="424"><sup title="valid: False, node: 425, tag: sup, level: 17" node_number="425">Il17ra</sup></i> mice. Inflammatory training did not prevent the weight loss experienced by FRC<sup title="valid: False, node: 426, tag: sup, level: 16" node_number="426">&#8710;</sup><i title="valid: False, node: 427, tag: i, level: 16" node_number="427"><sup title="valid: False, node: 428, tag: sup, level: 17" node_number="428">Il17ra</sup></i> mice upon infection (fig. S4). As predicted, FRC<sup title="valid: False, node: 429, tag: sup, level: 16" node_number="429">&#8710;</sup><i title="valid: False, node: 430, tag: i, level: 16" node_number="430"><sup title="valid: False, node: 431, tag: sup, level: 17" node_number="431">Il17ra</sup></i> mice had significantly fewer MLN FRC compared with trained FRC<sup title="valid: False, node: 432, tag: sup, level: 16" node_number="432">Ctrl</sup> mice after inflammatory training and infection (<a title="valid: False, node: 433, tag: a, level: 16" node_number="433">Fig. 5A</a>). Similar defects were seen in numbers of GC B cells and antibody response to <i title="valid: False, node: 434, tag: i, level: 16" node_number="434">C. rodentium</i> (<a title="valid: False, node: 435, tag: a, level: 16" node_number="435">Fig. 5, B to D</a>).</div><div title="valid: False, node: 436, tag: div, level: 15" node_number="436">FRC<sup title="valid: False, node: 437, tag: sup, level: 16" node_number="437">&#8710;</sup><i title="valid: False, node: 438, tag: i, level: 16" node_number="438"><sup title="valid: False, node: 439, tag: sup, level: 17" node_number="439">Il17ra</sup></i> mice have defects in <i title="valid: False, node: 440, tag: i, level: 16" node_number="440">C. rodentium</i> clearance and antibody response (<a title="valid: False, node: 441, tag: a, level: 16" node_number="441">Fig. 1</a>); therefore, we compared responses in untrained FRC<sup title="valid: False, node: 442, tag: sup, level: 16" node_number="442">&#8710;</sup><i title="valid: False, node: 443, tag: i, level: 16" node_number="443"><sup title="valid: False, node: 444, tag: sup, level: 17" node_number="444">Il17ra</sup></i> mice with trained FRC<sup title="valid: False, node: 445, tag: sup, level: 16" node_number="445">&#8710;</sup><i title="valid: False, node: 446, tag: i, level: 16" node_number="446"><sup title="valid: False, node: 447, tag: sup, level: 17" node_number="447">Il17ra</sup></i> mice. Inflammatory training was unable to boost the FRC or B cell response compared with untrained FRC<sup title="valid: False, node: 448, tag: sup, level: 16" node_number="448">&#8710;</sup><i title="valid: False, node: 449, tag: i, level: 16" node_number="449"><sup title="valid: False, node: 450, tag: sup, level: 17" node_number="450">Il17ra</sup></i> mice after infection (<a title="valid: False, node: 451, tag: a, level: 16" node_number="451">Fig. 5, A to D</a>). Similarly, FRC<sup title="valid: False, node: 452, tag: sup, level: 16" node_number="452">&#8710;</sup><i title="valid: False, node: 453, tag: i, level: 16" node_number="453"><sup title="valid: False, node: 454, tag: sup, level: 17" node_number="454">Il17ra</sup></i> mice retained a poor capacity to clear <i title="valid: False, node: 455, tag: i, level: 16" node_number="455">C. rodentium</i> infection after training (<a title="valid: False, node: 456, tag: a, level: 16" node_number="456">Fig. 5E</a>). Trained FRC<sup title="valid: False, node: 457, tag: sup, level: 16" node_number="457">&#8710;</sup><i title="valid: False, node: 458, tag: i, level: 16" node_number="458"><sup title="valid: False, node: 459, tag: sup, level: 17" node_number="459">Il17ra</sup></i> mice had no protection from gut inflammation as measured by colon length (<a title="valid: False, node: 460, tag: a, level: 16" node_number="460">Fig. 5F</a>). Inflammatory training of FRC<sup title="valid: False, node: 461, tag: sup, level: 16" node_number="461">&#8710;</sup><i title="valid: False, node: 462, tag: i, level: 16" node_number="462"><sup title="valid: False, node: 463, tag: sup, level: 17" node_number="463">Il17ra</sup></i> mice resulted in increased expression of inflammatory markers in colon tissue compared with untrained FRC<sup title="valid: False, node: 464, tag: sup, level: 16" node_number="464">&#8710;</sup><i title="valid: False, node: 465, tag: i, level: 16" node_number="465"><sup title="valid: False, node: 466, tag: sup, level: 17" node_number="466">Il17ra</sup></i> colon (<a title="valid: False, node: 467, tag: a, level: 16" node_number="467">Fig. 5G</a>). Hence, these data further implicate FRC in the trained gut immunity by showing that deletion of IL-17 receptor in FRC prevented the beneficial protective outcome of mild inflammatory training and instead promoted inflammation.</div><div title="valid: False, node: 468, tag: div, level: 15" node_number="468">Because FRC<sup title="valid: False, node: 469, tag: sup, level: 16" node_number="469">&#8710;</sup><i title="valid: False, node: 470, tag: i, level: 16" node_number="470"><sup title="valid: False, node: 471, tag: sup, level: 17" node_number="471">Il17ra</sup></i> mice have inherent defects in <i title="valid: False, node: 472, tag: i, level: 16" node_number="472">C. rodentium</i> antibody response, we took an additional approach to test the role of IL-17&#8211;dependent FRC expansion in this model of inflammatory training. IL-17A was transiently blocked during the training period by administering neutralizing antibody at the start of DSS challenge. IL-17A blockade during DSS treatment resulted in increased weight loss (fig. S5A), as expected from prior reports that IL-17 promotes epithelial repair after injury (<a title="valid: False, node: 473, tag: a, level: 16" node_number="473"><i title="valid: False, node: 474, tag: i, level: 17" node_number="474">30</i></a>, <a title="valid: False, node: 475, tag: a, level: 16" node_number="475"><i title="valid: False, node: 476, tag: i, level: 17" node_number="476">31</i></a>). To allow resolution of colon inflammation and for clearance of the administered anti&#8211;IL-17 antibody, we rested mice for 2 weeks after DSS before infecting with <i title="valid: False, node: 477, tag: i, level: 16" node_number="477">C. rodentium</i>. After infection, there were no significant changes in body weight between mice that received inflammatory training in the presence or absence of anti&#8211;IL-17, and weights were not altered compared with untrained controls (fig. S5A). Colon lengths were also similar at 2 weeks after DSS, confirming resolution of overt inflammation by this time point (fig. S5B). IL-17A blockade during training prevented the increased numbers of FRC (<a title="valid: False, node: 478, tag: a, level: 16" node_number="478">Fig. 6A</a>) and the enhanced B cell response to <i title="valid: False, node: 479, tag: i, level: 16" node_number="479">C. rodentium</i> infection in trained mice (<a title="valid: False, node: 480, tag: a, level: 16" node_number="480">Fig. 6, B to D</a>). IL-17A blockade also abrogated the tissue protective effect of training on colitis, as determined by increased colon shortening (<a title="valid: False, node: 481, tag: a, level: 16" node_number="481">Fig. 6E</a>) and increased expression of inflammatory cytokines compared with mice treated with isotype control during DSS training (<a title="valid: False, node: 482, tag: a, level: 16" node_number="482">Fig. 6F</a>). It was apparent that IL-17A neutralization did not completely abrogate the training effect, in contrast to IL-17RA deletion in FRCs (comparing <a title="valid: False, node: 483, tag: a, level: 16" node_number="483">Figs. 5</a> and <a title="valid: False, node: 484, tag: a, level: 16" node_number="484">6</a>). Because IL-17RA is a shared receptor with IL-17F, this suggests that there may be some additional IL-17F signaling that contributes to training of FRC, although the statistical significance of reductions observed suggest that this would be a minor contribution compared with IL-17A. Overall, these data demonstrate a critical role for IL-17 signaling, particularly in FRC, in promoting the enhanced B cell response to infection after DSS training.</div></section><section class="valid" valid="valid" title="valid: True, node: 485, tag: section, level: 14" node_number="485"><h3 title="valid: False, node: 486, tag: h3, level: 15" node_number="486">Colon protection from inflammatory training is mediated through B cell IL-10</h3><div title="valid: False, node: 487, tag: div, level: 15" node_number="487">The data so far indicate that inflammatory activation of FRC results in a trained response that enhances adaptive immunity through increased T<sub title="valid: False, node: 488, tag: sub, level: 16" node_number="488">FH</sub> and B cell activation but paradoxically decreased colon inflammation during <i title="valid: False, node: 489, tag: i, level: 16" node_number="489">C. rodentium</i> infection. IL-10 is a key regulatory cytokine for mucosal inflammation (<a title="valid: False, node: 490, tag: a, level: 16" node_number="490"><i title="valid: False, node: 491, tag: i, level: 17" node_number="491">32</i></a>). Training either 1 or 6 weeks before infection resulted in increased colon IL-10 expression on day 14 after infection (<a title="valid: False, node: 492, tag: a, level: 16" node_number="492">Fig. 7, A and B</a>), corresponding with the reduced inflammation. Colon IL-10 was reduced in trained mice when IL-17 was neutralized during training or FRC lacked IL-17RA (<a title="valid: False, node: 493, tag: a, level: 16" node_number="493">Fig. 7, C and D</a>). During primary infection without training, there was no difference in colon IL-10 expression between FRC<sup title="valid: False, node: 494, tag: sup, level: 16" node_number="494">&#8710;</sup><i title="valid: False, node: 495, tag: i, level: 16" node_number="495"><sup title="valid: False, node: 496, tag: sup, level: 17" node_number="496">Il17ra</sup></i> and FRC<sup title="valid: False, node: 497, tag: sup, level: 16" node_number="497">Ctrl</sup> mice (fig. S6A), suggesting that tissue IL-10 production is not inherently impaired in FRC<sup title="valid: False, node: 498, tag: sup, level: 16" node_number="498">&#8710;</sup><i title="valid: False, node: 499, tag: i, level: 16" node_number="499"><sup title="valid: False, node: 500, tag: sup, level: 17" node_number="500">Il17ra</sup></i> mice. However, there was reduced expression of IL-10 in the reinfected FRC<sup title="valid: False, node: 501, tag: sup, level: 16" node_number="501">&#916;</sup><i title="valid: False, node: 502, tag: i, level: 16" node_number="502"><sup title="valid: False, node: 503, tag: sup, level: 17" node_number="503">Il17ra</sup></i> mice (<a title="valid: False, node: 504, tag: a, level: 16" node_number="504">Fig. 7E</a>), again implicating an enhanced IL-10 response after an initial inflammatory event in an FRC-dependent manner. These findings thus support a role for training of FRC in an IL-17&#8211;dependent manner, leading to the increased expression of IL-10 and tissue protection in the colon.</div><div title="valid: False, node: 505, tag: div, level: 15" node_number="505">Although regulatory T cells are a common source of IL-10 in the gut, we saw no correlation between IL-10 and forkhead box P3 (Foxp3) expression in these experiments (fig. S6, B to E). B cells can also provide an important source of regulatory IL-10 (<a title="valid: False, node: 506, tag: a, level: 16" node_number="506"><i title="valid: False, node: 507, tag: i, level: 17" node_number="507">33</i></a>&#8211;<a title="valid: False, node: 508, tag: a, level: 16" node_number="508"><i title="valid: False, node: 509, tag: i, level: 17" node_number="509">36</i></a>). We therefore queried whether the increased activation of B cells contributes to tissue protection after training via IL-10 production. There was an increase of class-switched IgG<sup title="valid: False, node: 510, tag: sup, level: 16" node_number="510">+</sup> B cells in the colon lamina propria of trained mice after infection with <i title="valid: False, node: 511, tag: i, level: 16" node_number="511">C. rodentium</i> (<a title="valid: False, node: 512, tag: a, level: 16" node_number="512">Fig. 7F</a>), and IgG<sup title="valid: False, node: 513, tag: sup, level: 16" node_number="513">+</sup> B cells showed the greatest expression of IL-10 among colonic lamina propria B cells (<a title="valid: False, node: 514, tag: a, level: 16" node_number="514">Fig. 7G</a> and fig. S6F). We next tested the contribution of IL-10 produced by B cells by using <i title="valid: False, node: 515, tag: i, level: 16" node_number="515">Cd19</i><sup title="valid: False, node: 516, tag: sup, level: 16" node_number="516">Cre</sup> &#215; <i title="valid: False, node: 517, tag: i, level: 16" node_number="517">Il10</i><sup title="valid: False, node: 518, tag: sup, level: 16" node_number="518">fl/fl</sup> mice, which have a B cell&#8211;intrinsic deletion of IL-10 (B cell<sup title="valid: False, node: 519, tag: sup, level: 16" node_number="519">&#916;IL10</sup>). Control mice were <i title="valid: False, node: 520, tag: i, level: 16" node_number="520">Cd19</i><sup title="valid: False, node: 521, tag: sup, level: 16" node_number="521">cre</sup><i title="valid: False, node: 522, tag: i, level: 16" node_number="522">Il10</i><sup title="valid: False, node: 523, tag: sup, level: 16" node_number="523">+/+</sup> (B cell<sup title="valid: False, node: 524, tag: sup, level: 16" node_number="524">Ctrl</sup>). After <i title="valid: False, node: 525, tag: i, level: 16" node_number="525">C. rodentium</i> infection, IgG production was similar between B cell<sup title="valid: False, node: 526, tag: sup, level: 16" node_number="526">&#916;IL10</sup> and B cell<sup title="valid: False, node: 527, tag: sup, level: 16" node_number="527">Ctrl</sup> mice, and both B cell frequency and IgG were enhanced by training to an equal degree (<a title="valid: False, node: 528, tag: a, level: 16" node_number="528">Fig. 7H</a> and fig. S6G), demonstrating that B cell IL-10 is not required for the antibody response. However, deletion of B cell&#8211;derived IL-10 abrogated the colon protective outcome of training on infectious colitis (<a title="valid: False, node: 529, tag: a, level: 16" node_number="529">Fig. 7I</a>). Furthermore, after infection, trained B cell<sup title="valid: False, node: 530, tag: sup, level: 16" node_number="530">&#916;IL10</sup> mice had reduced colon IL-10 expression compared with trained controls and similar colon IL-10 expression to untrained mice (<a title="valid: False, node: 531, tag: a, level: 16" node_number="531">Fig. 7J</a>), confirming B cells as the critical source of colon IL-10 after training. The altered expression of inflammatory cytokines was similarly reversed in trained infected B cell<sup title="valid: False, node: 532, tag: sup, level: 16" node_number="532">&#916;IL10</sup> mice (<a title="valid: False, node: 533, tag: a, level: 16" node_number="533">Fig. 7, K to M</a>, and fig. S6, H to K). These data pinpoint the enhanced B cell IL-10 response as a major regulator of the tissue protective effects after inflammatory training in the gut.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 534, tag: section, level: 13" node_number="534"><h2 class="valid" valid="valid" title="valid: True, node: 535, tag: h2, level: 14" node_number="535">DISCUSSION</h2><div class="valid" valid="valid" title="valid: True, node: 536, tag: div, level: 14" node_number="536">Within a given population, the same infection can have vastly different outcomes for individuals, ranging from asymptomatic infection to severe inflammation and tissue injury. Some factors that contribute to determining these outcomes are known, including prior microbial experience through infection or vaccination leading to innate immune training. Our data have revealed a previously unknown pathway modulating adaptive immune responses through IL-17&#8211;dependent inflammatory FRC training. By enhancing B cell activation to a newly encountered infection, this form of inflammatory training through FRC boosts the protective antibody response along with B cell IL-10 production in the intestinal tissue. The result is improved host protection by clearing the infection with reduced inflammatory side effects.</div><div class="valid" valid="valid" title="valid: True, node: 537, tag: div, level: 14" node_number="537">IL-17 is required for B cell activation during autoimmune disease (<a title="valid: False, node: 538, tag: a, level: 15" node_number="538"><i title="valid: False, node: 539, tag: i, level: 16" node_number="539">37</i></a>, <a title="valid: False, node: 540, tag: a, level: 15" node_number="540"><i title="valid: False, node: 541, tag: i, level: 16" node_number="541">38</i></a>). Although early studies suggested a possible direct role for IL-17 acting on B cells, the consensus is that the mechanism is more likely to be indirect. We previously showed that IL-17 signaling in FRC was required for optimal autoimmune antibody in a model of multiple sclerosis (<a title="valid: False, node: 542, tag: a, level: 15" node_number="542"><i title="valid: False, node: 543, tag: i, level: 16" node_number="543">19</i></a>). Here, we confirmed a similar defect in antibody response to <i title="valid: False, node: 544, tag: i, level: 15" node_number="544">C. rodentium</i> when FRC could not respond to IL-17. On the other hand, increased expansion and activation of FRC by a mild inflammatory stimulus before infection increased both the numbers of T<sub title="valid: False, node: 545, tag: sub, level: 15" node_number="545">FH</sub> cells and GC B cells to enhance the antibody response. This finding is reminiscent of a study showing that T<sub title="valid: False, node: 546, tag: sub, level: 15" node_number="546">FH</sub> cells have reduced entry to GC light zones in the absence of IL-17 (<a title="valid: False, node: 547, tag: a, level: 15" node_number="547"><i title="valid: False, node: 548, tag: i, level: 16" node_number="548">39</i></a>) and further implicates an indirect role for IL-17 in promoting antibody responses through T<sub title="valid: False, node: 549, tag: sub, level: 15" node_number="549">FH</sub> cell activation via FRC. The molecular mechanisms by which FRC promote T<sub title="valid: False, node: 550, tag: sub, level: 15" node_number="550">FH</sub> have yet to be determined: One possibility is that IL-17&#8211;dependent proliferation of FRC is required to maintain the migratory routes of FRC to the GC because FRC are the &#8220;road&#8221; along which T cells move within lymphoid structures (<a title="valid: False, node: 551, tag: a, level: 15" node_number="551"><i title="valid: False, node: 552, tag: i, level: 16" node_number="552">40</i></a>). Another non-exclusive possibility is that IL-17&#8211;stimulated FRC provide cytokine cues, such as IL-6, to promote T<sub title="valid: False, node: 553, tag: sub, level: 15" node_number="553">FH</sub> cell activation and metabolic fitness, as has been shown for CD8 T cells (<a title="valid: False, node: 554, tag: a, level: 15" node_number="554"><i title="valid: False, node: 555, tag: i, level: 16" node_number="555">41</i></a>). Last, FRC are key providers of the B cell growth and survival factor B cell activating factor (BAFF), so increasing their numbers in an IL-17&#8211;dependent manner would also increase the availability of BAFF to support B cell activation, as suggested by the increased B cell frequency in trained MLN.</div><div class="valid" valid="valid" title="valid: True, node: 556, tag: div, level: 14" node_number="556">We had predicted that prior inflammation might exacerbate the transient colitis normally induced by <i title="valid: False, node: 557, tag: i, level: 15" node_number="557">C. rodentium</i> infection in the gut, so it was a surprise to instead find reduced inflammation in infected colons after inflammatory training. However, this finding corresponds well to the clinical conundrum presented by the presence of IL-17&#8211;producing cells in both health and disease states in the gut. Despite the clear association between increased IL-17 and inflammatory bowel disease (IBD), clinical trials targeting IL-17 in IBD failed because of lack of efficacy and exacerbated disease in some individuals (<a title="valid: False, node: 558, tag: a, level: 15" node_number="558"><i title="valid: False, node: 559, tag: i, level: 16" node_number="559">42</i></a>). It has been posited that IL-17 promotes restoration of the epithelial barrier after gut injury, in addition to regulating microbiota populations that are more numerous in the gut compared to skin (<a title="valid: False, node: 560, tag: a, level: 15" node_number="560"><i title="valid: False, node: 561, tag: i, level: 16" node_number="561">43</i></a>&#8211;<a title="valid: False, node: 562, tag: a, level: 15" node_number="562"><i title="valid: False, node: 563, tag: i, level: 16" node_number="563">45</i></a>). Our data further suggest that IL-17 signaling in gut-draining LN helps to tune the adaptive immune response, particularly B cells, with a net protective outcome to inflammatory microbes through increased production of IL-10. In this regard, IL-10<sup title="valid: False, node: 564, tag: sup, level: 15" node_number="564">+</sup> regulatory B cells exhibit potent anti-inflammatory effects in a number of autoimmune models including colitis and EAE (<a title="valid: False, node: 565, tag: a, level: 15" node_number="565"><i title="valid: False, node: 566, tag: i, level: 16" node_number="566">35</i></a>, <a title="valid: False, node: 567, tag: a, level: 15" node_number="567"><i title="valid: False, node: 568, tag: i, level: 16" node_number="568">46</i></a>, <a title="valid: False, node: 569, tag: a, level: 15" node_number="569"><i title="valid: False, node: 570, tag: i, level: 16" node_number="570">47</i></a>). Specifically, IL-10<sup title="valid: False, node: 571, tag: sup, level: 15" node_number="571">+</sup> B cells were shown to increase in the chronically inflamed colon to limit colitis progression in &#945; T cell receptor knockout mice lacking regulatory T cells (<a title="valid: False, node: 572, tag: a, level: 15" node_number="572"><i title="valid: False, node: 573, tag: i, level: 16" node_number="573">36</i></a>). Accordingly, we find that inflammation in the gut favors an enhanced regulatory B cell response to infection and implicate IL-17&#8211;dependent FRC activation in tuning gut immunoregulation.</div><div class="valid" valid="valid" title="valid: True, node: 574, tag: div, level: 14" node_number="574">Although we have not formally eliminated involvement of myeloid cells or innate lymphoid cells (ILC3) in our study, several lines of evidence lead us to think that these innate cells are not the primary driver of IL-17&#8211;dependent FRC effects on <i title="valid: False, node: 575, tag: i, level: 15" node_number="575">C. rodentium</i> clearance in primary infection or after training. In contrast to many innate immune training models, training through DSS did not significantly alter the infection load of <i title="valid: False, node: 576, tag: i, level: 15" node_number="576">C. rodentium</i>; this argues against a role for myeloid cells or innate lymphoid cells, which would be expected to more rapidly eliminate the infection. We did observe a reduction in <i title="valid: False, node: 577, tag: i, level: 15" node_number="577">Csf2</i>, encoding GM-CSF, not only in the colon of FRC<sup title="valid: False, node: 578, tag: sup, level: 15" node_number="578">&#916;IL17RA</sup> mice during primary infection but also in WT mice after training. ILC3 are a major producer of GM-CSF during colitis, along with IL-17 and IL-22, and GM-CSF recruits and activates inflammatory macrophages for which IL-1&#946; is a hallmark (<a title="valid: False, node: 579, tag: a, level: 15" node_number="579"><i title="valid: False, node: 580, tag: i, level: 16" node_number="580">21</i></a>, <a title="valid: False, node: 581, tag: a, level: 15" node_number="581"><i title="valid: False, node: 582, tag: i, level: 16" node_number="582">22</i></a>, <a title="valid: False, node: 583, tag: a, level: 15" node_number="583"><i title="valid: False, node: 584, tag: i, level: 16" node_number="584">48</i></a>). However, mice with defective IL-17 signaling in FRC experienced enhanced expression of inflammatory cytokines that are associated with myeloid or innate lymphoid cell activation and GM-CSF signaling during <i title="valid: False, node: 585, tag: i, level: 15" node_number="585">C. rodentium</i> control, including IL-1&#946;, REGIII&#947;, and IL-17 (<a title="valid: False, node: 586, tag: a, level: 15" node_number="586"><i title="valid: False, node: 587, tag: i, level: 16" node_number="587">21</i></a>, <a title="valid: False, node: 588, tag: a, level: 15" node_number="588"><i title="valid: False, node: 589, tag: i, level: 16" node_number="589">22</i></a>, <a title="valid: False, node: 590, tag: a, level: 15" node_number="590"><i title="valid: False, node: 591, tag: i, level: 16" node_number="591">48</i></a>); yet, these mice had delayed clearance during primary infection. Training further enhanced expression of IL-22 and IL-17 in the absence of FRC IL-17 signaling yet was still unable to improve <i title="valid: False, node: 592, tag: i, level: 15" node_number="592">C. rodentium</i> clearance. Furthermore, FRC<sup title="valid: False, node: 593, tag: sup, level: 15" node_number="593">&#916;IL17RA</sup> mice showed no benefit from training either in rate of infection clearance or colon inflammation, corresponding to reduced IL-10 and reduced B cell activation, supporting the importance of interactions between FRC and the adaptive immune system in this protective model.</div><div class="valid" valid="valid" title="valid: True, node: 594, tag: div, level: 14" node_number="594">Innate immunological training of myeloid lineage cells is typically mediated through IL-1&#946; or lipopolysaccharide (LPS) signaling leading to metabolic and epigenetic changes that outlast the acute inflammatory response (<a title="valid: False, node: 595, tag: a, level: 15" node_number="595"><i title="valid: False, node: 596, tag: i, level: 16" node_number="596">49</i></a>). It is worth noting some interesting commonalities between LPS, IL-1&#946;, and IL-17 signaling. All three stimuli drive nuclear factor &#954;B (NF-&#954;B) activation as a major signaling pathway and induce feed-forward transcriptional regulators including the NF-&#954;B coactivator NF-kappa-B inhibitor zeta (I&#954;b&#950;) and transcription factor CCAAT enhancer binding protein beta (C/EBP&#946;), which was recently shown to be critical for trained immunity in hematopoietic stem cells that generate myeloid cells (<a title="valid: False, node: 597, tag: a, level: 15" node_number="597"><i title="valid: False, node: 598, tag: i, level: 16" node_number="598">50</i></a>). LPS and IL-1&#946; are strong drivers of metabolic reprogramming in innate immune cells (<a title="valid: False, node: 599, tag: a, level: 15" node_number="599"><i title="valid: False, node: 600, tag: i, level: 16" node_number="600">51</i></a>); we recently showed that IL-17 is critical for metabolic reprogramming in FRC and identified I&#954;b&#950; as one of the regulators of IL-17&#8211;induced metabolic change (<a title="valid: False, node: 601, tag: a, level: 15" node_number="601"><i title="valid: False, node: 602, tag: i, level: 16" node_number="602">19</i></a>). Metabolic reprogramming and epigenetic modifications are intricately intertwined, and metabolites such as acetyl coenzyme A, succinate, and mevalonate influence chromatin accessibility. Rewiring of metabolic circuits thus poises innate immune cells to respond more rapidly after immune training (<a title="valid: False, node: 603, tag: a, level: 15" node_number="603"><i title="valid: False, node: 604, tag: i, level: 16" node_number="604">20</i></a>, <a title="valid: False, node: 605, tag: a, level: 15" node_number="605"><i title="valid: False, node: 606, tag: i, level: 16" node_number="606">52</i></a>). IL-17 typically targets nonhematopoietic cells including fibroblast-type stromal cells and epithelia, whereas LPS and IL-1&#946; primarily activate immune cells. Nevertheless, these shared signaling outputs may provide the common outcomes of trained immunity through metabolic and epigenetic rewiring of target cells.</div><div class="valid" valid="valid" title="valid: True, node: 607, tag: div, level: 14" node_number="607">There is very limited understanding of contributions of immune or inflammatory training in non-immune cells to date. However, Naik <i title="valid: False, node: 608, tag: i, level: 15" node_number="608">et al.</i> (<a title="valid: False, node: 609, tag: a, level: 15" node_number="609"><i title="valid: False, node: 610, tag: i, level: 16" node_number="610">53</i></a>) demonstrated that skin inflammation could speed up subsequent wound healing through &#8220;inflammatory memory&#8221; epigenetically programmed into epithelial stem cells. This form of inflammatory training required both IL-1&#946; production and presence of RAR-related orphan receptor gamma (ROR&#947;t<sup title="valid: False, node: 611, tag: sup, level: 15" node_number="611">+</sup>) and IL-17&#8211;producing T cells (<a title="valid: False, node: 612, tag: a, level: 15" node_number="612"><i title="valid: False, node: 613, tag: i, level: 16" node_number="613">53</i></a>), again suggesting interplay between immune and non-immune systems for the enhanced outcome. Here, we showed that inflammatory training through DSS-induced IL-17 results in metabolic and epigenetic changes in FRC to promote enhanced function.</div><div class="valid" valid="valid" title="valid: True, node: 614, tag: div, level: 14" node_number="614">In summary, this study shows that IL-17 helps to simultaneously maintain intestinal defense and promote immunoregulation by enhancing the capacity of gut-draining LNs to support antibody and IL-10 production through improved B cell activation. We therefore propose that IL-17 induced by microbiota or infections during early life could tune the balance of antibody-mediated versus proinflammatory cytokine-mediated immune responses to reduce severity of infectious disease in mucosal tissues. The ability to induce IL-17 for FRC training should thus be considered as a factor that could enhance the efficacy of vaccines or the ability of individuals to respond to a known pathogenic threat for which there is not yet a vaccine, without boosting side effects of inflammation and tissue damage.</div></section><section class="valid" valid="valid" title="valid: True, node: 615, tag: section, level: 13" node_number="615"><h2 class="valid" valid="valid" title="valid: True, node: 616, tag: h2, level: 14" node_number="616">MATERIALS AND METHODS</h2><section class="valid" valid="valid" title="valid: True, node: 617, tag: section, level: 14" node_number="617"><h3 title="valid: False, node: 618, tag: h3, level: 15" node_number="618">Study design</h3><div title="valid: False, node: 619, tag: div, level: 15" node_number="619">The overall objective of this study was to determine the role of IL-17 signaling in FRC either before or during responses to infection with <i title="valid: False, node: 620, tag: i, level: 16" node_number="620">C. rodentium</i> and to elucidate mechanisms that result in tissue protection after inflammatory training. This was achieved by using global IL-17&#8211; and IL-17RA&#8211;deficient mice, FRC-intrinsic deletion of IL-17RA, and antibody-mediated neutralization of IL-17 in DSS-mediated colitis and <i title="valid: False, node: 621, tag: i, level: 16" node_number="621">C. rodentium</i> infection models of gut inflammation. Outcomes were changes in specific cell population numbers, phenotype, and function [measured by flow cytometry, enzyme-linked immunosorbent assay (ELISA), gene expression, and body weight]. All data points generated were included in the analysis. Group sizes were based on power analysis of previous publications and pilot studies for the included experiments. Groups for antibody neutralization and DSS treatment were randomly assigned. Groups with transgenic mice were assigned controls on the basis of existing age-matched littermates. The study was unblinded. All experiments were repeated more than once, and numbers of experimental repeats are indicated in figure legends.</div></section><section class="valid" valid="valid" title="valid: True, node: 622, tag: section, level: 14" node_number="622"><h3 title="valid: False, node: 623, tag: h3, level: 15" node_number="623">Mice</h3><div title="valid: False, node: 624, tag: div, level: 15" node_number="624">C57BL/6 was obtained from the Jackson Laboratory. FRC<sup title="valid: False, node: 625, tag: sup, level: 16" node_number="625">&#916;</sup><i title="valid: False, node: 626, tag: i, level: 16" node_number="626"><sup title="valid: False, node: 627, tag: sup, level: 17" node_number="627">Il17ra</sup></i> mice generated by crossing <i title="valid: False, node: 628, tag: i, level: 16" node_number="628">Il17ra</i><sup title="valid: False, node: 629, tag: sup, level: 16" node_number="629">fl/fl</sup> [a gift from J. Kolls (<a title="valid: False, node: 630, tag: a, level: 16" node_number="630"><i title="valid: False, node: 631, tag: i, level: 17" node_number="631">45</i></a>)] with Ccl19<sup title="valid: False, node: 632, tag: sup, level: 16" node_number="632">Cre</sup> [obtained from B. Ludewig via Eur0pean Mouse Mutant Archive (EMMA) repository, Infrafrontier (<a title="valid: False, node: 633, tag: a, level: 16" node_number="633"><i title="valid: False, node: 634, tag: i, level: 17" node_number="634">54</i></a>)]. B cell<sup title="valid: False, node: 635, tag: sup, level: 16" node_number="635">&#916;</sup><i title="valid: False, node: 636, tag: i, level: 16" node_number="636"><sup title="valid: False, node: 637, tag: sup, level: 17" node_number="637">Il10</sup></i> mice were generated by crossing IL-10<sup title="valid: False, node: 638, tag: sup, level: 16" node_number="638">fl/fl</sup> [provided by D. Rothstein with permission of W. Muller (<a title="valid: False, node: 639, tag: a, level: 16" node_number="639"><i title="valid: False, node: 640, tag: i, level: 17" node_number="640">55</i></a>)] with CD19<sup title="valid: False, node: 641, tag: sup, level: 16" node_number="641">cre</sup> (the Jackson Laboratory). All experiments included age- and sex-matched littermate controls that were cohoused before experiments, and both males and females aged between 7 and 10 weeks were used. Mice were housed under specific pathogen&#8211;free conditions in an American Association of Laboratory Animal Care (AAALAC)-approved facility at the University of Pittsburgh. Protocols were approved by the University of Pittsburgh Institutional Animal Care and Use Committee and adhered to guidelines in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.</div></section><section class="valid" valid="valid" title="valid: True, node: 642, tag: section, level: 14" node_number="642"><h3 title="valid: False, node: 643, tag: h3, level: 15" node_number="643"><i title="valid: False, node: 644, tag: i, level: 16" node_number="644">C. rodentium</i> infection and fecal bacteria detection</h3><div title="valid: False, node: 645, tag: div, level: 15" node_number="645">Mice were orally gavaged with fresh cultured 10<sup title="valid: False, node: 646, tag: sup, level: 16" node_number="646">9</sup> colony-forming units (CFUs) of <i title="valid: False, node: 647, tag: i, level: 16" node_number="647">C. rodentium</i> strain DBS100 (American Type Culture Collection 51459). For reinfection experiments, two doses of <i title="valid: False, node: 648, tag: i, level: 16" node_number="648">C. rodentium</i> were given 60 days apart. Body weight was monitored every 3 days. For fecal culture, fresh feces were collected, weighed, and homogenized in 300 &#956;l of phosphate-buffered saline (PBS). Serial dilutions of feces homogenates were plated onto MacConkey agar (Oxoid) and incubated for 18 hours at 37&#176;C. <i title="valid: False, node: 649, tag: i, level: 16" node_number="649">C. rodentium</i> colonies were identified by their characteristic pink center surrounded by a white rim. For fecal <i title="valid: False, node: 650, tag: i, level: 16" node_number="650">C. rodentium</i> polymerase chain reaction (PCR), DNA in feces was isolated with the QIAamp Fast DNA Stool Mini Kit (QIAGEN), <i title="valid: False, node: 651, tag: i, level: 16" node_number="651">Espb</i> gene expression was quantified by quantitative PCR (qPCR) (SYBR Green; espB-F: 5&#8242;-ATGCCGCAGATGAGACAGTTG-3&#8242;, espB-R: 5&#8242;-CGTCAGCAGCCTTTTCAGCTA-3&#8242;) and normalized relative to total bacterial 16<i title="valid: False, node: 652, tag: i, level: 16" node_number="652">S rRNA</i> (5&#8242;-ATTACCGCGGCTGCTGGC-3&#8242;, 5&#8242;-ACTCCTACGGGAGGCAGCAGT-3&#8242;).</div></section><section class="valid" valid="valid" title="valid: True, node: 653, tag: section, level: 14" node_number="653"><h3 title="valid: False, node: 654, tag: h3, level: 15" node_number="654">DSS-induced colitis</h3><div title="valid: False, node: 655, tag: div, level: 15" node_number="655">Mice received 1% DSS (36,000 to 50,000 molecular weight; MP Biomedicals) in their drinking water for 7 days, followed by 7 or 14 days of distilled water without DSS. Control animals received distilled water for the entire period. Mice were monitored every 3 days for body weight and infected with <i title="valid: False, node: 656, tag: i, level: 16" node_number="656">C. rodentium</i> after rest. For in vivo neutralization of IL-17, 100 &#956;g of anti&#8211;IL-17 monoclonal antibody (clone 17F3; Bio X Cell) and an equal amount of isotype control IgG (IgG1, clone MOPC-21; Bio X Cell) were administered intraperitoneally on day 0 starting DSS.</div></section><section class="valid" valid="valid" title="valid: True, node: 657, tag: section, level: 14" node_number="657"><h3 title="valid: False, node: 658, tag: h3, level: 15" node_number="658">Quantitative PCR</h3><div title="valid: False, node: 659, tag: div, level: 15" node_number="659">RNA was isolated with the RNeasy Mini Kit (QIAGEN), and cDNA was generated with Superscript III First Strand kits (Invitrogen), followed by real-time PCR (RT-PCR) using SYBR Green Master mix with ROX (Invitrogen) and the following RT2 qPCR primers from QIAGEN: <i title="valid: False, node: 660, tag: i, level: 16" node_number="660">Foxp3</i> (<i title="valid: False, node: 661, tag: i, level: 16" node_number="661">catalog number</i> PPM05497F), <i title="valid: False, node: 662, tag: i, level: 16" node_number="662">Il1b</i> (PPM03109F), <i title="valid: False, node: 663, tag: i, level: 16" node_number="663">Il10</i> (PPM03017C), <i title="valid: False, node: 664, tag: i, level: 16" node_number="664">Il17a</i> (PPM03023A), <i title="valid: False, node: 665, tag: i, level: 16" node_number="665">Il18</i> (PPM03112B), <i title="valid: False, node: 666, tag: i, level: 16" node_number="666">Il22</i> (PPM05481A), <i title="valid: False, node: 667, tag: i, level: 16" node_number="667">Ifng</i> (PPM03121A), <i title="valid: False, node: 668, tag: i, level: 16" node_number="668">Csf2</i> (PPM02990F), and <i title="valid: False, node: 669, tag: i, level: 16" node_number="669">Reg3g</i> (PPM35204A) on a 7300 Real-Time instrument (Applied Biosystems). Gene expression was normalized to <i title="valid: False, node: 670, tag: i, level: 16" node_number="670">Gapdh</i> (PPM02946E).</div></section><section class="valid" valid="valid" title="valid: True, node: 671, tag: section, level: 14" node_number="671"><h3 title="valid: False, node: 672, tag: h3, level: 15" node_number="672">FRC preparation for flow cytometry</h3><div title="valid: False, node: 673, tag: div, level: 15" node_number="673">MLNs were incubated at 37&#176;C in digestion medium (RPMI), deoxyribonuclease I (DNase I; 0.1 mg/ml; Invitrogen), and Liberase (0.1 mg/ml; Roche). Collected single-cell suspensions were filtered. For flow cytometry, cells were stained with Ghostdye510 viability dye (Tonbo Biosciences) in PBS, followed by labeling with CD45 (clone 30-F11, Invitrogen), CD45.2 (104, BD Biosciences), podoplanin (PDPN) (8.1.1, BioLegend), CD31 (MEC 13.3, BD Biosciences), H3K4me3 (C42D8, Cell Signaling Technology), and CountBright Absolute Counting Beads (Molecular Probes). For glucose uptake assays, 500 nM 2-(<i title="valid: False, node: 674, tag: i, level: 16" node_number="674">N</i>-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2NBDG; Cayman Chemicals) was injected via tail vein 30 min before sacrifice.</div></section><section class="valid" valid="valid" title="valid: True, node: 675, tag: section, level: 14" node_number="675"><h3 title="valid: False, node: 676, tag: h3, level: 15" node_number="676">CD4 and B cell analysis in MLN by flow cytometry</h3><div title="valid: False, node: 677, tag: div, level: 15" node_number="677">Single-cell suspensions were obtained from LNs by mechanical isolation and filtered before staining with Ghostdye510 (Tonbo Biosciences) viability dye in PBS and then surface staining in fluorescence-activated cell sorting (FACS) buffer. For T<sub title="valid: False, node: 678, tag: sub, level: 16" node_number="678">FH</sub> staining, cells were fixed, permeabilized with eBioscience Foxp3/Transcription Factor Staining Buffer Set, and incubated with antibodies to CXCR5 in Permeabilization Buffer with 3.3% normal rat serum overnight at 4&#176;C. FACS antibodies and staining reagents were purchased from the following companies: CD4 (no. GK1.5, Invitrogen), B220 (no. RA3-6B2, BD Biosciences), CD19 (6D5, BioLegend), GL-7 (no. GL-7, BD Pharmingen), CD44 (IM7, eBioscience), PD1 (RMP1-30, BioLegend), CXCR5 (2G8, BD Biosciences), IL-10 (JES5-16E3, BioLegend), and IgG (Poly4053, BioLegend). Flow cytometry data were acquired on a FACS LSRFortessa (BD Biosciences) and analyzed with FlowJo software.</div></section><section class="valid" valid="valid" title="valid: True, node: 679, tag: section, level: 14" node_number="679"><h3 title="valid: False, node: 680, tag: h3, level: 15" node_number="680">Lamina propria preparation and B cell IL-10 analysis</h3><div title="valid: False, node: 681, tag: div, level: 15" node_number="681">Colons were excised, splayed open, and rinsed with cold RPMI 1640 containing 3% fetal calf serum (FCS), penicillin-streptomycin (100 &#956;g/ml), 25 mM Hepes, and 50 mM &#946;-mercaptoethanol (&#946;-ME). Tissue was minced and digested with RPMI 1640 containing 3% FCS, penicillin-streptomycin (100 &#956;g/ml), 25 mM Hepes, 50 mM &#946;-ME, 5 mM EDTA, and 1,4-dithiothreitol (145 &#956;g/ml) for 20 min with continuous stirring in an incubator at 37&#176;C/5% CO<sub title="valid: False, node: 682, tag: sub, level: 16" node_number="682">2</sub>. Tissue was strained and further digested by briefly agitating tissue with RPMI 1640 containing penicillin-streptomycin (100 &#956;g/ml), 25 mM Hepes, 50 mM &#946;-ME, and 2 mM EDTA. Tissue was strained, minced, and further digested with serum-free RPMI 1640 containing penicillin-streptomycin (100 &#956;g/ml), 25 mM Hepes, 50 mM &#946;-ME, 2 mM l-glutamine, 1 mM sodium pyruvate, 1&#215; minimum essential medium (MEM) non-essential amino acids, DNase I (500 &#956;g/ml; Sigma-Aldrich), and Liberase TL (100 &#956;g/ml; Roche) for 25 min with continuous stirring in an incubator at 37&#176;C/5% CO<sub title="valid: False, node: 683, tag: sub, level: 16" node_number="683">2</sub>. Cell suspensions were serially filtered through 70- and 40-&#956;m cell strainers, spun down, and resuspended in complete RPMI 1640 medium containing 10% fetal bovine serum, penicillin-streptomycin (100 &#956;g/ml), 25 mM Hepes, 50 mM &#946;-ME, 2 mM l-glutamine, 1 mM sodium pyruvate, and 1&#215; MEM nonessential amino acids before use. For IL-10 analysis, colon lamina propria lymphocytes were stimulated with LPS from <i title="valid: False, node: 684, tag: i, level: 16" node_number="684">E. coli</i> O111:B4 (Sigma-Aldrich; 10 &#956;g/ml), phorbol 12-myristate 13-acetate (50 ng/ml), and ionomycin (1 &#956;g/ml) for 5 hours at 37&#176;C; GolgiStop (BD) and GolgiPlug (BD) were added to cultures after 1 hour. Cells were incubated with viability dye in PBS, washed, incubated with Fc block, and then stained for surface markers as previously described. Intracellular staining for IL-10 was performed using BD Cytofix/Cytoperm reagents as per the manufacturer&#8217;s protocol, using antibody clones listed above.</div></section><section class="valid" valid="valid" title="valid: True, node: 685, tag: section, level: 14" node_number="685"><h3 title="valid: False, node: 686, tag: h3, level: 15" node_number="686">Antibody ELISA</h3><div title="valid: False, node: 687, tag: div, level: 15" node_number="687">Total IgG concentrations in serum were detected using a mouse IgG ELISA kit (Invitrogen). For detection of <i title="valid: False, node: 688, tag: i, level: 16" node_number="688">C. rodentium</i>&#8211;specific antibody in serum, 96-well plates were coated overnight with <i title="valid: False, node: 689, tag: i, level: 16" node_number="689">C. rodentium</i> (10<sup title="valid: False, node: 690, tag: sup, level: 16" node_number="690">8</sup> CFU per well) at 37&#176;C incubator, blocked for 2 hours, and then incubated with sera (serial dilutions starting at 1:100) for 3 hours. After washing, antibodies bound to <i title="valid: False, node: 691, tag: i, level: 16" node_number="691">C. rodentium</i> were detected by horseradish peroxidase&#8211;labeled anti-IgG (RD Systems). Optical density (OD) value for 1:1000 dilution was used for each experiment because standards for anti&#8211;<i title="valid: False, node: 692, tag: i, level: 16" node_number="692">C. rodentium</i> IgG are not commercially available. For fecal antibody, fecal pellets were collected from the indicated groups at specific time points. Fecal supernatant was prepared [10% (w/v)] with PBS, and fecal IgG was detected by the same protocol as <i title="valid: False, node: 693, tag: i, level: 16" node_number="693">C. rodentium</i>&#8211;specific antibody in serum. Horseradish peroxidase&#8211;labeled anti-IgA (Thermo Fisher Scientific) was used for detecting <i title="valid: False, node: 694, tag: i, level: 16" node_number="694">C. rodentium&#8211;</i>specific IgA in feces with a similar protocol.</div></section><section class="valid" valid="valid" title="valid: True, node: 695, tag: section, level: 14" node_number="695"><h3 title="valid: False, node: 696, tag: h3, level: 15" node_number="696">Statistics</h3><div title="valid: False, node: 697, tag: div, level: 15" node_number="697">Experimental results were analyzed for significance using one-way analysis of variance (ANOVA) with Tukey&#8217;s multiple comparisons test (for multiple groups) or unpaired Student&#8217;s <i title="valid: False, node: 698, tag: i, level: 16" node_number="698">t</i> test. Statistical analyses were performed using GraphPad Prism. <i title="valid: False, node: 699, tag: i, level: 16" node_number="699">P</i> values are shown as *<i title="valid: False, node: 700, tag: i, level: 16" node_number="700">P</i> &lt; 0.05, **<i title="valid: False, node: 701, tag: i, level: 16" node_number="701">P</i> &lt; 0.01, ***<i title="valid: False, node: 702, tag: i, level: 16" node_number="702">P</i> &lt; 0.001, and ****<i title="valid: False, node: 703, tag: i, level: 16" node_number="703">P</i> &lt; 0.0001 where statistical significance was found, and all data are represented as means &#177; SEM. Individual points in graphs represent biological replicates (i.e., individual mice) pooled from multiple experiments.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 704, tag: section, level: 13" node_number="704"><h2 class="valid" valid="valid" title="valid: True, node: 705, tag: h2, level: 14" node_number="705">Acknowledgments</h2><div class="valid" valid="valid" title="valid: True, node: 706, tag: div, level: 14" node_number="706">We thank P. Biswas, S. Gaffen, R. Elsner, and T. Hand for thoughtful discussion and reading of manuscript; staff of the Division of Laboratory Animal Research for animal husbandry; and the Unified Flow Core for flow cytometry services.</div><div class="valid" valid="valid" title="valid: True, node: 707, tag: div, level: 14" node_number="707"><b title="valid: False, node: 708, tag: b, level: 15" node_number="708">Funding:</b> Funding for the project was from NIH AI148356 to M.J.M. D.W. was sponsored by the Third Xiangya Hospital, Central South University and acknowledges the encouragement of F. Wang. S.M. was a recipient of the AAI 2019-2020 trainee fellowship, CLP funded by T32 trainee award AI089443, and D.R. acknowledges funding from NIH AI114587.</div><div class="valid" valid="valid" title="valid: True, node: 709, tag: div, level: 14" node_number="709"><b title="valid: False, node: 710, tag: b, level: 15" node_number="710">Author contributions:</b> D.W. designed and performed experiments and data analysis. C.H.P., S.K.R., Q.L., and S.M. performed experiments and data analysis. R.E., S.M., K.M., and D.M.R. provided technical expertise. D.M.R. also provided mice. M.J.M. designed and directed the study, obtained funding, and wrote the manuscript with assistance from D.W., C.H.P., and D.M.R.</div><div class="valid" valid="valid" title="valid: True, node: 711, tag: div, level: 14" node_number="711"><b title="valid: False, node: 712, tag: b, level: 15" node_number="712">Competing interests</b>: The authors declare that they have no competing interests.</div><div class="valid" valid="valid" title="valid: True, node: 713, tag: div, level: 14" node_number="713"><b title="valid: False, node: 714, tag: b, level: 15" node_number="714">Data and materials availability</b>: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials.</div></section> </div></section><section class="valid" valid="valid" title="valid: True, node: 715, tag: section, level: 11" node_number="715"><div class="valid" valid="valid" title="valid: True, node: 716, tag: div, level: 12" node_number="716"><section class="valid" valid="valid" title="valid: True, node: 717, tag: section, level: 13" node_number="717"><h2 class="valid" valid="valid" title="valid: True, node: 718, tag: h2, level: 14" node_number="718">Supplementary Materials</h2><section class="valid" valid="valid" title="valid: True, node: 719, tag: section, level: 14" node_number="719"><h3 title="valid: False, node: 720, tag: h3, level: 15" node_number="720">This PDF file includes:</h3><div title="valid: False, node: 721, tag: div, level: 15" node_number="721"><div title="valid: False, node: 722, tag: div, level: 16" node_number="722"><div title="valid: False, node: 723, tag: div, level: 17" node_number="723">Figs. S1 to S6</div></div><div title="valid: False, node: 724, tag: div, level: 16" node_number="724">Download (1.50 MB)</div></div></section><section class="valid" valid="valid" title="valid: True, node: 725, tag: section, level: 14" node_number="725"><h3 title="valid: False, node: 726, tag: h3, level: 15" node_number="726">Other Supplementary Material for this manuscript includes the following:</h3><div title="valid: False, node: 727, tag: div, level: 15" node_number="727"><div title="valid: False, node: 728, tag: div, level: 16" node_number="728"><div title="valid: False, node: 729, tag: div, level: 17" node_number="729">Table S1</div></div><div title="valid: False, node: 730, tag: div, level: 16" node_number="730"><a title="valid: False, node: 731, tag: a, level: 17" node_number="731">Download (137.45 KB)</a></div></div></section></section><div class="valid" valid="valid" title="valid: True, node: 732, tag: div, level: 13" node_number="732"><a class="valid" valid="valid" title="valid: True, node: 733, tag: a, level: 14" node_number="733">View/request a protocol for this paper from <i title="valid: False, node: 734, tag: i, level: 15" node_number="734">Bio-protocol</i>.</a></div><section class="valid" valid="valid" title="valid: True, node: 735, tag: section, level: 13" node_number="735"><h2 class="valid" valid="valid" title="valid: True, node: 736, tag: h2, level: 14" node_number="736">REFERENCES AND NOTES</h2><div class="valid" valid="valid" title="valid: True, node: 737, tag: div, level: 14" node_number="737"><div title="valid: False, node: 738, tag: div, level: 15" node_number="738">1</div><div title="valid: False, node: 739, tag: div, level: 15" node_number="739"><div title="valid: False, node: 740, tag: div, level: 16" node_number="740"><div title="valid: False, node: 741, tag: div, level: 17" node_number="741">M. G. Netea, J. Dom&#237;nguez-Andr&#233;s, L. B. Barreiro, T. Chavakis, M. Divangahi, E. Fuchs, L. A. B. Joosten, J. W. M. van der Meer, M. M. Mhlanga, W. J. M. Mulder, N. P. Riksen, A. Schlitzer, J. L. Schultze, C. Stabell Benn, J. C. Sun, R. J. Xavier, E. Latz, Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. <b title="valid: False, node: 742, tag: b, level: 18" node_number="742">20</b>, 375&#8211;388 (2020).</div><div title="valid: False, node: 743, tag: div, level: 17" node_number="743"><div title="valid: False, node: 744, tag: div, level: 18" node_number="744"><a title="valid: False, node: 745, tag: a, level: 19" node_number="745">Crossref</a></div><div title="valid: False, node: 746, tag: div, level: 18" node_number="746"><a title="valid: False, node: 747, tag: a, level: 19" node_number="747">PubMed</a></div><div title="valid: False, node: 748, tag: div, level: 18" node_number="748"><a title="valid: False, node: 749, tag: a, level: 19" node_number="749">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 750, tag: div, level: 14" node_number="750"><div title="valid: False, node: 751, tag: div, level: 15" node_number="751">2</div><div title="valid: False, node: 752, tag: div, level: 15" node_number="752"><div title="valid: False, node: 753, tag: div, level: 16" node_number="753"><div title="valid: False, node: 754, tag: div, level: 17" node_number="754">L. Liu, H. L. Johnson, S. Cousens, J. Perin, S. Scott, J. E. Lawn, I. Rudan, H. Campbell, R. Cibulskis, M. Li, C. Mathers, R. E. Black; Child Health Epidemiology Reference Group of WHO and UNICEF, Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet <b title="valid: False, node: 755, tag: b, level: 18" node_number="755">379</b>, 2151&#8211;2161 (2012).</div><div title="valid: False, node: 756, tag: div, level: 17" node_number="756"><div title="valid: False, node: 757, tag: div, level: 18" node_number="757"><a title="valid: False, node: 758, tag: a, level: 19" node_number="758">Crossref</a></div><div title="valid: False, node: 759, tag: div, level: 18" node_number="759"><a title="valid: False, node: 760, tag: a, level: 19" node_number="760">PubMed</a></div><div title="valid: False, node: 761, tag: div, level: 18" node_number="761"><a title="valid: False, node: 762, tag: a, level: 19" node_number="762">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 763, tag: div, level: 14" node_number="763"><div title="valid: False, node: 764, tag: div, level: 15" node_number="764">3</div><div title="valid: False, node: 765, tag: div, level: 15" node_number="765"><div title="valid: False, node: 766, tag: div, level: 16" node_number="766"><div title="valid: False, node: 767, tag: div, level: 17" node_number="767">K. L. Kotloff, J. P. Nataro, W. C. Blackwelder, D. Nasrin, T. H. Farag, S. Panchalingam, Y. Wu, S. O. Sow, D. Sur, R. F. Breiman, A. S. Faruque, A. K. Zaidi, D. Saha, P. L. Alonso, B. Tamboura, D. Sanogo, U. Onwuchekwa, B. Manna, T. Ramamurthy, S. Kanungo, J. B. Ochieng, R. Omore, J. O. Oundo, A. Hossain, S. K. Das, S. Ahmed, S. Qureshi, F. Quadri, R. A. Adegbola, M. Antonio, M. J. Hossain, A. Akinsola, I. Mandomando, T. Nhampossa, S. Ac&#225;cio, K. Biswas, C. E. O&#8217;Reilly, E. D. Mintz, L. Y. Berkeley, K. Muhsen, H. Sommerfelt, R. M. Robins-Browne, M. M. Levine, Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet <b title="valid: False, node: 768, tag: b, level: 18" node_number="768">382</b>, 209&#8211;222 (2013).</div><div title="valid: False, node: 769, tag: div, level: 17" node_number="769"><div title="valid: False, node: 770, tag: div, level: 18" node_number="770"><a title="valid: False, node: 771, tag: a, level: 19" node_number="771">Crossref</a></div><div title="valid: False, node: 772, tag: div, level: 18" node_number="772"><a title="valid: False, node: 773, tag: a, level: 19" node_number="773">PubMed</a></div><div title="valid: False, node: 774, tag: div, level: 18" node_number="774"><a title="valid: False, node: 775, tag: a, level: 19" node_number="775">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 776, tag: div, level: 14" node_number="776"><div title="valid: False, node: 777, tag: div, level: 15" node_number="777">4</div><div title="valid: False, node: 778, tag: div, level: 15" node_number="778"><div title="valid: False, node: 779, tag: div, level: 16" node_number="779"><div title="valid: False, node: 780, tag: div, level: 17" node_number="780">M. A. Croxen, R. J. Law, R. Scholz, K. M. Keeney, M. Wlodarska, B. B. Finlay, Recent advances in understanding enteric pathogenic <i title="valid: False, node: 781, tag: i, level: 18" node_number="781">Escherichia coli</i>. Clin. Microbiol. Rev. <b title="valid: False, node: 782, tag: b, level: 18" node_number="782">26</b>, 822&#8211;880 (2013).</div><div title="valid: False, node: 783, tag: div, level: 17" node_number="783"><div title="valid: False, node: 784, tag: div, level: 18" node_number="784"><a title="valid: False, node: 785, tag: a, level: 19" node_number="785">Crossref</a></div><div title="valid: False, node: 786, tag: div, level: 18" node_number="786"><a title="valid: False, node: 787, tag: a, level: 19" node_number="787">PubMed</a></div><div title="valid: False, node: 788, tag: div, level: 18" node_number="788"><a title="valid: False, node: 789, tag: a, level: 19" node_number="789">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 790, tag: div, level: 14" node_number="790"><div title="valid: False, node: 791, tag: div, level: 15" node_number="791">5</div><div title="valid: False, node: 792, tag: div, level: 15" node_number="792"><div title="valid: False, node: 793, tag: div, level: 16" node_number="793"><div title="valid: False, node: 794, tag: div, level: 17" node_number="794">J. P. Nataro, J. B. Kaper, Diarrheagenic <i title="valid: False, node: 795, tag: i, level: 18" node_number="795">Escherichia coli</i>. Clin. Microbiol. Rev. <b title="valid: False, node: 796, tag: b, level: 18" node_number="796">11</b>, 142&#8211;201 (1998).</div><div title="valid: False, node: 797, tag: div, level: 17" node_number="797"><div title="valid: False, node: 798, tag: div, level: 18" node_number="798"><a title="valid: False, node: 799, tag: a, level: 19" node_number="799">Crossref</a></div><div title="valid: False, node: 800, tag: div, level: 18" node_number="800"><a title="valid: False, node: 801, tag: a, level: 19" node_number="801">PubMed</a></div><div title="valid: False, node: 802, tag: div, level: 18" node_number="802"><a title="valid: False, node: 803, tag: a, level: 19" node_number="803">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 804, tag: div, level: 14" node_number="804"><div title="valid: False, node: 805, tag: div, level: 15" node_number="805">6</div><div title="valid: False, node: 806, tag: div, level: 15" node_number="806"><div title="valid: False, node: 807, tag: div, level: 16" node_number="807"><div title="valid: False, node: 808, tag: div, level: 17" node_number="808">A. H. Havelaar, M. D. Kirk, P. R. Torgerson, H. J. Gibb, T. Hald, R. J. Lake, N. Praet, D. C. Bellinger, N. R. de Silva, N. Gargouri, N. Speybroeck, A. Cawthorne, C. Mathers, C. Stein, F. J. Angulo, B. Devleesschauwer; World Health Organization Foodborne Disease Burden Epidemiology Reference Group, World health organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. <b title="valid: False, node: 809, tag: b, level: 18" node_number="809">12</b>, e1001923 (2015).</div><div title="valid: False, node: 810, tag: div, level: 17" node_number="810"><div title="valid: False, node: 811, tag: div, level: 18" node_number="811"><a title="valid: False, node: 812, tag: a, level: 19" node_number="812">Crossref</a></div><div title="valid: False, node: 813, tag: div, level: 18" node_number="813"><a title="valid: False, node: 814, tag: a, level: 19" node_number="814">PubMed</a></div><div title="valid: False, node: 815, tag: div, level: 18" node_number="815"><a title="valid: False, node: 816, tag: a, level: 19" node_number="816">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 817, tag: div, level: 14" node_number="817"><div title="valid: False, node: 818, tag: div, level: 15" node_number="818">7</div><div title="valid: False, node: 819, tag: div, level: 15" node_number="819"><div title="valid: False, node: 820, tag: div, level: 16" node_number="820"><div title="valid: False, node: 821, tag: div, level: 17" node_number="821">S. W. Barthold, G. L. Coleman, P. N. Bhatt, G. W. Osbaldiston, A. M. Jonas, The etiology of transmissible murine colonic hyperplasia. Lab. Anim. Sci. <b title="valid: False, node: 822, tag: b, level: 18" node_number="822">26</b>, 889&#8211;894 (1976).</div><div title="valid: False, node: 823, tag: div, level: 17" node_number="823"><div title="valid: False, node: 824, tag: div, level: 18" node_number="824"><a title="valid: False, node: 825, tag: a, level: 19" node_number="825">PubMed</a></div><div title="valid: False, node: 826, tag: div, level: 18" node_number="826"><a title="valid: False, node: 827, tag: a, level: 19" node_number="827">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 828, tag: div, level: 14" node_number="828"><div title="valid: False, node: 829, tag: div, level: 15" node_number="829">8</div><div title="valid: False, node: 830, tag: div, level: 15" node_number="830"><div title="valid: False, node: 831, tag: div, level: 16" node_number="831"><div title="valid: False, node: 832, tag: div, level: 17" node_number="832">C. Mullineaux-Sanders, J. Suez, E. Elinav, G. Frankel, Sieving through gut models of colonization resistance. Nat. Microbiol. <b title="valid: False, node: 833, tag: b, level: 18" node_number="833">3</b>, 132&#8211;140 (2018).</div><div title="valid: False, node: 834, tag: div, level: 17" node_number="834"><div title="valid: False, node: 835, tag: div, level: 18" node_number="835"><a title="valid: False, node: 836, tag: a, level: 19" node_number="836">Crossref</a></div><div title="valid: False, node: 837, tag: div, level: 18" node_number="837"><a title="valid: False, node: 838, tag: a, level: 19" node_number="838">PubMed</a></div><div title="valid: False, node: 839, tag: div, level: 18" node_number="839"><a title="valid: False, node: 840, tag: a, level: 19" node_number="840">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 841, tag: div, level: 14" node_number="841"><div title="valid: False, node: 842, tag: div, level: 15" node_number="842">9</div><div title="valid: False, node: 843, tag: div, level: 15" node_number="843"><div title="valid: False, node: 844, tag: div, level: 16" node_number="844"><div title="valid: False, node: 845, tag: div, level: 17" node_number="845">J. M. Chan, G. Bhinder, H. P. Sham, N. Ryz, T. Huang, K. S. Bergstrom, B. A. Vallance, CD4<sup title="valid: False, node: 846, tag: sup, level: 18" node_number="846">+</sup> T cells drive goblet cell depletion during <i title="valid: False, node: 847, tag: i, level: 18" node_number="847">Citrobacter rodentium</i> infection. Infect. Immun. <b title="valid: False, node: 848, tag: b, level: 18" node_number="848">81</b>, 4649&#8211;4658 (2013).</div><div title="valid: False, node: 849, tag: div, level: 17" node_number="849"><div title="valid: False, node: 850, tag: div, level: 18" node_number="850"><a title="valid: False, node: 851, tag: a, level: 19" node_number="851">Crossref</a></div><div title="valid: False, node: 852, tag: div, level: 18" node_number="852"><a title="valid: False, node: 853, tag: a, level: 19" node_number="853">PubMed</a></div><div title="valid: False, node: 854, tag: div, level: 18" node_number="854"><a title="valid: False, node: 855, tag: a, level: 19" node_number="855">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 856, tag: div, level: 14" node_number="856"><div title="valid: False, node: 857, tag: div, level: 15" node_number="857">10</div><div title="valid: False, node: 858, tag: div, level: 15" node_number="858"><div title="valid: False, node: 859, tag: div, level: 16" node_number="859"><div title="valid: False, node: 860, tag: div, level: 17" node_number="860">H. Ahlfors, P. J. Morrison, J. H. Duarte, Y. Li, J. Biro, M. Tolaini, P. Di Meglio, A. J. Potocnik, B. Stockinger, IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. <b title="valid: False, node: 861, tag: b, level: 18" node_number="861">193</b>, 4602&#8211;4613 (2014).</div><div title="valid: False, node: 862, tag: div, level: 17" node_number="862"><div title="valid: False, node: 863, tag: div, level: 18" node_number="863"><a title="valid: False, node: 864, tag: a, level: 19" node_number="864">Crossref</a></div><div title="valid: False, node: 865, tag: div, level: 18" node_number="865"><a title="valid: False, node: 866, tag: a, level: 19" node_number="866">PubMed</a></div><div title="valid: False, node: 867, tag: div, level: 18" node_number="867"><a title="valid: False, node: 868, tag: a, level: 19" node_number="868">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 869, tag: div, level: 14" node_number="869"><div title="valid: False, node: 870, tag: div, level: 15" node_number="870">11</div><div title="valid: False, node: 871, tag: div, level: 15" node_number="871"><div title="valid: False, node: 872, tag: div, level: 16" node_number="872"><div title="valid: False, node: 873, tag: div, level: 17" node_number="873">K. Atarashi, T. Tanoue, M. Ando, N. Kamada, Y. Nagano, S. Narushima, W. Suda, A. Imaoka, H. Setoyama, T. Nagamori, E. Ishikawa, T. Shima, T. Hara, S. Kado, T. Jinnohara, H. Ohno, T. Kondo, K. Toyooka, E. Watanabe, S.-I. Yokoyama, S. Tokoro, H. Mori, Y. Noguchi, H. Morita, I. I. Ivanov, T. Sugiyama, G. Nu&#241;ez, J. G. Camp, M. Hattori, Y. Umesaki, K. Honda, Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell <b title="valid: False, node: 874, tag: b, level: 18" node_number="874">163</b>, 367&#8211;380 (2015).</div><div title="valid: False, node: 875, tag: div, level: 17" node_number="875"><div title="valid: False, node: 876, tag: div, level: 18" node_number="876"><a title="valid: False, node: 877, tag: a, level: 19" node_number="877">Crossref</a></div><div title="valid: False, node: 878, tag: div, level: 18" node_number="878"><a title="valid: False, node: 879, tag: a, level: 19" node_number="879">PubMed</a></div><div title="valid: False, node: 880, tag: div, level: 18" node_number="880"><a title="valid: False, node: 881, tag: a, level: 19" node_number="881">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 882, tag: div, level: 14" node_number="882"><div title="valid: False, node: 883, tag: div, level: 15" node_number="883">12</div><div title="valid: False, node: 884, tag: div, level: 15" node_number="884"><div title="valid: False, node: 885, tag: div, level: 16" node_number="885"><div title="valid: False, node: 886, tag: div, level: 17" node_number="886">N. Kamada, K. Sakamoto, S.-U. Seo, M. Y. Zeng, Y.-G. Kim, M. Cascalho, B. A. Vallance, J. L. Puente, G. N&#250;&#241;ez, Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe <b title="valid: False, node: 887, tag: b, level: 18" node_number="887">17</b>, 617&#8211;627 (2015).</div><div title="valid: False, node: 888, tag: div, level: 17" node_number="888"><div title="valid: False, node: 889, tag: div, level: 18" node_number="889"><a title="valid: False, node: 890, tag: a, level: 19" node_number="890">Crossref</a></div><div title="valid: False, node: 891, tag: div, level: 18" node_number="891"><a title="valid: False, node: 892, tag: a, level: 19" node_number="892">PubMed</a></div><div title="valid: False, node: 893, tag: div, level: 18" node_number="893"><a title="valid: False, node: 894, tag: a, level: 19" node_number="894">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 895, tag: div, level: 14" node_number="895"><div title="valid: False, node: 896, tag: div, level: 15" node_number="896">13</div><div title="valid: False, node: 897, tag: div, level: 15" node_number="897"><div title="valid: False, node: 898, tag: div, level: 16" node_number="898"><div title="valid: False, node: 899, tag: div, level: 17" node_number="899">X. Bai, X. Chi, Q. Qiao, S. Xie, S. Wan, L. Ni, P. Wang, W. Jin, C. Dong, T. Follicular, T follicular helper cells regulate humoral response for host protection against intestinal <i title="valid: False, node: 900, tag: i, level: 18" node_number="900">Citrobacter rodentium</i> infection. J. Immunol. <b title="valid: False, node: 901, tag: b, level: 18" node_number="901">204</b>, 2754&#8211;2761 (2020).</div><div title="valid: False, node: 902, tag: div, level: 17" node_number="902"><div title="valid: False, node: 903, tag: div, level: 18" node_number="903"><a title="valid: False, node: 904, tag: a, level: 19" node_number="904">Crossref</a></div><div title="valid: False, node: 905, tag: div, level: 18" node_number="905"><a title="valid: False, node: 906, tag: a, level: 19" node_number="906">PubMed</a></div><div title="valid: False, node: 907, tag: div, level: 18" node_number="907"><a title="valid: False, node: 908, tag: a, level: 19" node_number="908">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 909, tag: div, level: 14" node_number="909"><div title="valid: False, node: 910, tag: div, level: 15" node_number="910">14</div><div title="valid: False, node: 911, tag: div, level: 15" node_number="911"><div title="valid: False, node: 912, tag: div, level: 16" node_number="912"><div title="valid: False, node: 913, tag: div, level: 17" node_number="913">N. H. Ruddle, E. M. Akirav, Secondary lymphoid organs: Responding to genetic and environmental cues in ontogeny and the immune response. J. Immunol. <b title="valid: False, node: 914, tag: b, level: 18" node_number="914">183</b>, 2205&#8211;2212 (2009).</div><div title="valid: False, node: 915, tag: div, level: 17" node_number="915"><div title="valid: False, node: 916, tag: div, level: 18" node_number="916"><a title="valid: False, node: 917, tag: a, level: 19" node_number="917">Crossref</a></div><div title="valid: False, node: 918, tag: div, level: 18" node_number="918"><a title="valid: False, node: 919, tag: a, level: 19" node_number="919">PubMed</a></div><div title="valid: False, node: 920, tag: div, level: 18" node_number="920"><a title="valid: False, node: 921, tag: a, level: 19" node_number="921">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 922, tag: div, level: 14" node_number="922"><div title="valid: False, node: 923, tag: div, level: 15" node_number="923">15</div><div title="valid: False, node: 924, tag: div, level: 15" node_number="924"><div title="valid: False, node: 925, tag: div, level: 16" node_number="925"><div title="valid: False, node: 926, tag: div, level: 17" node_number="926">S. Fagarasan, S. Kawamoto, O. Kanagawa, K. Suzuki, Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. <b title="valid: False, node: 927, tag: b, level: 18" node_number="927">28</b>, 243&#8211;273 (2010).</div><div title="valid: False, node: 928, tag: div, level: 17" node_number="928"><div title="valid: False, node: 929, tag: div, level: 18" node_number="929"><a title="valid: False, node: 930, tag: a, level: 19" node_number="930">Crossref</a></div><div title="valid: False, node: 931, tag: div, level: 18" node_number="931"><a title="valid: False, node: 932, tag: a, level: 19" node_number="932">PubMed</a></div><div title="valid: False, node: 933, tag: div, level: 18" node_number="933"><a title="valid: False, node: 934, tag: a, level: 19" node_number="934">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 935, tag: div, level: 14" node_number="935"><div title="valid: False, node: 936, tag: div, level: 15" node_number="936">16</div><div title="valid: False, node: 937, tag: div, level: 15" node_number="937"><div title="valid: False, node: 938, tag: div, level: 16" node_number="938"><div title="valid: False, node: 939, tag: div, level: 17" node_number="939">A. Link, T. K. Vogt, S. Favre, M. R. Britschgi, H. Acha-Orbea, B. Hinz, J. G. Cyster, S. A. Luther, Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. <b title="valid: False, node: 940, tag: b, level: 18" node_number="940">8</b>, 1255&#8211;1265 (2007).</div><div title="valid: False, node: 941, tag: div, level: 17" node_number="941"><div title="valid: False, node: 942, tag: div, level: 18" node_number="942"><a title="valid: False, node: 943, tag: a, level: 19" node_number="943">Crossref</a></div><div title="valid: False, node: 944, tag: div, level: 18" node_number="944"><a title="valid: False, node: 945, tag: a, level: 19" node_number="945">PubMed</a></div><div title="valid: False, node: 946, tag: div, level: 18" node_number="946"><a title="valid: False, node: 947, tag: a, level: 19" node_number="947">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 948, tag: div, level: 14" node_number="948"><div title="valid: False, node: 949, tag: div, level: 15" node_number="949">17</div><div title="valid: False, node: 950, tag: div, level: 15" node_number="950"><div title="valid: False, node: 951, tag: div, level: 16" node_number="951"><div title="valid: False, node: 952, tag: div, level: 17" node_number="952">F. D. Brown, S. J. Turley, Fibroblastic reticular cells: Organization and regulation of the T lymphocyte life cycle. J. Immunol. <b title="valid: False, node: 953, tag: b, level: 18" node_number="953">194</b>, 1389&#8211;1394 (2015).</div><div title="valid: False, node: 954, tag: div, level: 17" node_number="954"><div title="valid: False, node: 955, tag: div, level: 18" node_number="955"><a title="valid: False, node: 956, tag: a, level: 19" node_number="956">Crossref</a></div><div title="valid: False, node: 957, tag: div, level: 18" node_number="957"><a title="valid: False, node: 958, tag: a, level: 19" node_number="958">PubMed</a></div><div title="valid: False, node: 959, tag: div, level: 18" node_number="959"><a title="valid: False, node: 960, tag: a, level: 19" node_number="960">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 961, tag: div, level: 14" node_number="961"><div title="valid: False, node: 962, tag: div, level: 15" node_number="962">18</div><div title="valid: False, node: 963, tag: div, level: 15" node_number="963"><div title="valid: False, node: 964, tag: div, level: 16" node_number="964"><div title="valid: False, node: 965, tag: div, level: 17" node_number="965">A. T. Krishnamurty, S. J. Turley, Lymph node stromal cells: Cartographers of the immune system. Nat. Immunol. <b title="valid: False, node: 966, tag: b, level: 18" node_number="966">21</b>, 369&#8211;380 (2020).</div><div title="valid: False, node: 967, tag: div, level: 17" node_number="967"><div title="valid: False, node: 968, tag: div, level: 18" node_number="968"><a title="valid: False, node: 969, tag: a, level: 19" node_number="969">Crossref</a></div><div title="valid: False, node: 970, tag: div, level: 18" node_number="970"><a title="valid: False, node: 971, tag: a, level: 19" node_number="971">PubMed</a></div><div title="valid: False, node: 972, tag: div, level: 18" node_number="972"><a title="valid: False, node: 973, tag: a, level: 19" node_number="973">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 974, tag: div, level: 14" node_number="974"><div title="valid: False, node: 975, tag: div, level: 15" node_number="975">19</div><div title="valid: False, node: 976, tag: div, level: 15" node_number="976"><div title="valid: False, node: 977, tag: div, level: 16" node_number="977"><div title="valid: False, node: 978, tag: div, level: 17" node_number="978">S. Majumder, N. Amatya, S. Revu, C. V. Jawale, D. Wu, N. Rittenhouse, A. Menk, S. Kupul, F. Du, I. Raphael, A. Bhattacharjee, U. Siebenlist, T. W. Hand, G. M. Delgoffe, A. C. Poholek, S. L. Gaffen, P. S. Biswas, M. J. McGeachy, IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nat. Immunol. <b title="valid: False, node: 979, tag: b, level: 18" node_number="979">20</b>, 534&#8211;545 (2019).</div><div title="valid: False, node: 980, tag: div, level: 17" node_number="980"><div title="valid: False, node: 981, tag: div, level: 18" node_number="981"><a title="valid: False, node: 982, tag: a, level: 19" node_number="982">Crossref</a></div><div title="valid: False, node: 983, tag: div, level: 18" node_number="983"><a title="valid: False, node: 984, tag: a, level: 19" node_number="984">PubMed</a></div><div title="valid: False, node: 985, tag: div, level: 18" node_number="985"><a title="valid: False, node: 986, tag: a, level: 19" node_number="986">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 987, tag: div, level: 14" node_number="987"><div title="valid: False, node: 988, tag: div, level: 15" node_number="988">20</div><div title="valid: False, node: 989, tag: div, level: 15" node_number="989"><div title="valid: False, node: 990, tag: div, level: 16" node_number="990"><div title="valid: False, node: 991, tag: div, level: 17" node_number="991">S.-C. Cheng, J. Quintin, R. A. Cramer, K. M. Shepardson, S. Saeed, V. Kumar, E. J. Giamarellos-Bourboulis, J. H. A. Martens, N. A. Rao, A. Aghajanirefah, G. R. Manjeri, Y. Li, D. C. Ifrim, R. J. W. Arts, B. M. J. W. van der Veer, P. M. T. Deen, C. Logie, L. A. O&#8217;Neill, P. Willems, F. L. van de Veerdonk, J. W. M. van der Meer, A. Ng, L. A. B. Joosten, C. Wijmenga, H. G. Stunnenberg, R. J. Xavier, M. G. Netea, mTOR- and HIF-1&#945;-mediated aerobic glycolysis as metabolic basis for trained immunity. Science <b title="valid: False, node: 992, tag: b, level: 18" node_number="992">345</b>, 1250684 (2014).</div><div title="valid: False, node: 993, tag: div, level: 17" node_number="993"><div title="valid: False, node: 994, tag: div, level: 18" node_number="994"><a title="valid: False, node: 995, tag: a, level: 19" node_number="995">Crossref</a></div><div title="valid: False, node: 996, tag: div, level: 18" node_number="996"><a title="valid: False, node: 997, tag: a, level: 19" node_number="997">PubMed</a></div><div title="valid: False, node: 998, tag: div, level: 18" node_number="998"><a title="valid: False, node: 999, tag: a, level: 19" node_number="999">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1000, tag: div, level: 14" node_number="1000"><div title="valid: False, node: 1001, tag: div, level: 15" node_number="1001">21</div><div title="valid: False, node: 1002, tag: div, level: 15" node_number="1002"><div title="valid: False, node: 1003, tag: div, level: 16" node_number="1003"><div title="valid: False, node: 1004, tag: div, level: 17" node_number="1004">S.-U. Seo, P. Kuffa, S. Kitamoto, H. Nagao-Kitamoto, J. Rousseau, Y.-G. Kim, G. N&#250;&#241;ez, N. Kamada, Intestinal macrophages arising from CCR2<sup title="valid: False, node: 1005, tag: sup, level: 18" node_number="1005">+</sup> monocytes control pathogen infection by activating innate lymphoid cells. Nat. Commun. <b title="valid: False, node: 1006, tag: b, level: 18" node_number="1006">6</b>, 8010 (2015).</div><div title="valid: False, node: 1007, tag: div, level: 17" node_number="1007"><div title="valid: False, node: 1008, tag: div, level: 18" node_number="1008"><a title="valid: False, node: 1009, tag: a, level: 19" node_number="1009">Crossref</a></div><div title="valid: False, node: 1010, tag: div, level: 18" node_number="1010"><a title="valid: False, node: 1011, tag: a, level: 19" node_number="1011">PubMed</a></div><div title="valid: False, node: 1012, tag: div, level: 18" node_number="1012"><a title="valid: False, node: 1013, tag: a, level: 19" node_number="1013">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 14" node_number="1014"><div title="valid: False, node: 1015, tag: div, level: 15" node_number="1015">22</div><div title="valid: False, node: 1016, tag: div, level: 15" node_number="1016"><div title="valid: False, node: 1017, tag: div, level: 16" node_number="1017"><div title="valid: False, node: 1018, tag: div, level: 17" node_number="1018">R. S. Longman, G. E. Diehl, D. A. Victorio, J. R. Huh, C. Galan, E. R. Miraldi, A. Swaminath, R. Bonneau, E. J. Scherl, D. R. Littman, CX<sub title="valid: False, node: 1019, tag: sub, level: 18" node_number="1019">3</sub>CR1<sup title="valid: False, node: 1020, tag: sup, level: 18" node_number="1020">+</sup> mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. <b title="valid: False, node: 1021, tag: b, level: 18" node_number="1021">211</b>, 1571&#8211;1583 (2014).</div><div title="valid: False, node: 1022, tag: div, level: 17" node_number="1022"><div title="valid: False, node: 1023, tag: div, level: 18" node_number="1023"><a title="valid: False, node: 1024, tag: a, level: 19" node_number="1024">Crossref</a></div><div title="valid: False, node: 1025, tag: div, level: 18" node_number="1025"><a title="valid: False, node: 1026, tag: a, level: 19" node_number="1026">PubMed</a></div><div title="valid: False, node: 1027, tag: div, level: 18" node_number="1027"><a title="valid: False, node: 1028, tag: a, level: 19" node_number="1028">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1029, tag: div, level: 14" node_number="1029"><div title="valid: False, node: 1030, tag: div, level: 15" node_number="1030">23</div><div title="valid: False, node: 1031, tag: div, level: 15" node_number="1031"><div title="valid: False, node: 1032, tag: div, level: 16" node_number="1032"><div title="valid: False, node: 1033, tag: div, level: 17" node_number="1033">S. C. Liang, X.-Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, L. A. Fouser, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. <b title="valid: False, node: 1034, tag: b, level: 18" node_number="1034">203</b>, 2271&#8211;2279 (2006).</div><div title="valid: False, node: 1035, tag: div, level: 17" node_number="1035"><div title="valid: False, node: 1036, tag: div, level: 18" node_number="1036"><a title="valid: False, node: 1037, tag: a, level: 19" node_number="1037">Crossref</a></div><div title="valid: False, node: 1038, tag: div, level: 18" node_number="1038"><a title="valid: False, node: 1039, tag: a, level: 19" node_number="1039">PubMed</a></div><div title="valid: False, node: 1040, tag: div, level: 18" node_number="1040"><a title="valid: False, node: 1041, tag: a, level: 19" node_number="1041">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1042, tag: div, level: 14" node_number="1042"><div title="valid: False, node: 1043, tag: div, level: 15" node_number="1043">24</div><div title="valid: False, node: 1044, tag: div, level: 15" node_number="1044"><div title="valid: False, node: 1045, tag: div, level: 16" node_number="1045"><div title="valid: False, node: 1046, tag: div, level: 17" node_number="1046">M. Mu&#241;oz, C. Eidenschenk, N. Ota, K. Wong, U. Lohmann, A. A. K&#252;hl, X. Wang, P. Manzanillo, Y. Li, S. Rutz, Y. Zheng, L. Diehl, N. Kayagaki, M. van Lookeren-Campagne, O. Liesenfeld, M. Heimesaat, W. Ouyang, Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity <b title="valid: False, node: 1047, tag: b, level: 18" node_number="1047">42</b>, 321&#8211;331 (2015).</div><div title="valid: False, node: 1048, tag: div, level: 17" node_number="1048"><div title="valid: False, node: 1049, tag: div, level: 18" node_number="1049"><a title="valid: False, node: 1050, tag: a, level: 19" node_number="1050">Crossref</a></div><div title="valid: False, node: 1051, tag: div, level: 18" node_number="1051"><a title="valid: False, node: 1052, tag: a, level: 19" node_number="1052">PubMed</a></div><div title="valid: False, node: 1053, tag: div, level: 18" node_number="1053"><a title="valid: False, node: 1054, tag: a, level: 19" node_number="1054">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1055, tag: div, level: 14" node_number="1055"><div title="valid: False, node: 1056, tag: div, level: 15" node_number="1056">25</div><div title="valid: False, node: 1057, tag: div, level: 15" node_number="1057"><div title="valid: False, node: 1058, tag: div, level: 16" node_number="1058"><div title="valid: False, node: 1059, tag: div, level: 17" node_number="1059">I. Backert, S. B. Koralov, S. Wirtz, V. Kitowski, U. Billmeier, E. Martini, K. Hofmann, K. Hildner, N. Wittkopf, K. Brecht, M. Waldner, K. Rajewsky, M. F. Neurath, C. Becker, C. Neufert, STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis. J. Immunol. <b title="valid: False, node: 1060, tag: b, level: 18" node_number="1060">193</b>, 3779&#8211;3791 (2014).</div><div title="valid: False, node: 1061, tag: div, level: 17" node_number="1061"><div title="valid: False, node: 1062, tag: div, level: 18" node_number="1062"><a title="valid: False, node: 1063, tag: a, level: 19" node_number="1063">Crossref</a></div><div title="valid: False, node: 1064, tag: div, level: 18" node_number="1064"><a title="valid: False, node: 1065, tag: a, level: 19" node_number="1065">PubMed</a></div><div title="valid: False, node: 1066, tag: div, level: 18" node_number="1066"><a title="valid: False, node: 1067, tag: a, level: 19" node_number="1067">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1068, tag: div, level: 14" node_number="1068"><div title="valid: False, node: 1069, tag: div, level: 15" node_number="1069">26</div><div title="valid: False, node: 1070, tag: div, level: 15" node_number="1070"><div title="valid: False, node: 1071, tag: div, level: 16" node_number="1071"><div title="valid: False, node: 1072, tag: div, level: 17" node_number="1072">C. Manta, E. Heupel, K. Radulovic, V. Rossini, N. Garbi, C. U. Riedel, J. H. Niess, CX<sub title="valid: False, node: 1073, tag: sub, level: 18" node_number="1073">3</sub>CR1<sup title="valid: False, node: 1074, tag: sup, level: 18" node_number="1074">+</sup> macrophages support IL-22 production by innate lymphoid cells during infection with <i title="valid: False, node: 1075, tag: i, level: 18" node_number="1075">Citrobacter rodentium</i>. Mucosal Immunol. <b title="valid: False, node: 1076, tag: b, level: 18" node_number="1076">6</b>, 177&#8211;188 (2013).</div><div title="valid: False, node: 1077, tag: div, level: 17" node_number="1077"><div title="valid: False, node: 1078, tag: div, level: 18" node_number="1078"><a title="valid: False, node: 1079, tag: a, level: 19" node_number="1079">Crossref</a></div><div title="valid: False, node: 1080, tag: div, level: 18" node_number="1080"><a title="valid: False, node: 1081, tag: a, level: 19" node_number="1081">PubMed</a></div><div title="valid: False, node: 1082, tag: div, level: 18" node_number="1082"><a title="valid: False, node: 1083, tag: a, level: 19" node_number="1083">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 14" node_number="1084"><div title="valid: False, node: 1085, tag: div, level: 15" node_number="1085">27</div><div title="valid: False, node: 1086, tag: div, level: 15" node_number="1086"><div title="valid: False, node: 1087, tag: div, level: 16" node_number="1087"><div title="valid: False, node: 1088, tag: div, level: 17" node_number="1088">G. Caballero-Flores, K. Sakamoto, M. Y. Zeng, Y. Wang, J. Hakim, V. Matus-Acu&#241;a, N. Inohara, G. N&#250;&#241;ez, Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk. Cell Host Microbe <b title="valid: False, node: 1089, tag: b, level: 18" node_number="1089">25</b>, 313&#8211;323.e4 (2019).</div><div title="valid: False, node: 1090, tag: div, level: 17" node_number="1090"><div title="valid: False, node: 1091, tag: div, level: 18" node_number="1091"><a title="valid: False, node: 1092, tag: a, level: 19" node_number="1092">Crossref</a></div><div title="valid: False, node: 1093, tag: div, level: 18" node_number="1093"><a title="valid: False, node: 1094, tag: a, level: 19" node_number="1094">PubMed</a></div><div title="valid: False, node: 1095, tag: div, level: 18" node_number="1095"><a title="valid: False, node: 1096, tag: a, level: 19" node_number="1096">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 14" node_number="1097"><div title="valid: False, node: 1098, tag: div, level: 15" node_number="1098">28</div><div title="valid: False, node: 1099, tag: div, level: 15" node_number="1099"><div title="valid: False, node: 1100, tag: div, level: 16" node_number="1100"><div title="valid: False, node: 1101, tag: div, level: 17" node_number="1101">J. R. Singer, E. G. Blosser, C. L. Zindl, D. J. Silberger, S. Conlan, V. A. Laufer, D. DiToro, C. Deming, R. Kumar, C. D. Morrow, J. A. Segre, M. J. Gray, D. A. Randolph, C. T. Weaver, Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis. Nat. Med. <b title="valid: False, node: 1102, tag: b, level: 18" node_number="1102">25</b>, 1772&#8211;1782 (2019).</div><div title="valid: False, node: 1103, tag: div, level: 17" node_number="1103"><div title="valid: False, node: 1104, tag: div, level: 18" node_number="1104"><a title="valid: False, node: 1105, tag: a, level: 19" node_number="1105">Crossref</a></div><div title="valid: False, node: 1106, tag: div, level: 18" node_number="1106"><a title="valid: False, node: 1107, tag: a, level: 19" node_number="1107">PubMed</a></div><div title="valid: False, node: 1108, tag: div, level: 18" node_number="1108"><a title="valid: False, node: 1109, tag: a, level: 19" node_number="1109">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 14" node_number="1110"><div title="valid: False, node: 1111, tag: div, level: 15" node_number="1111">29</div><div title="valid: False, node: 1112, tag: div, level: 15" node_number="1112"><div title="valid: False, node: 1113, tag: div, level: 16" node_number="1113"><div title="valid: False, node: 1114, tag: div, level: 17" node_number="1114">S. Wirtz, C. Neufert, B. Weigmann, M. F. Neurath, Chemically induced mouse models of intestinal inflammation. Nat. Protoc. <b title="valid: False, node: 1115, tag: b, level: 18" node_number="1115">2</b>, 541&#8211;546 (2007).</div><div title="valid: False, node: 1116, tag: div, level: 17" node_number="1116"><div title="valid: False, node: 1117, tag: div, level: 18" node_number="1117"><a title="valid: False, node: 1118, tag: a, level: 19" node_number="1118">Crossref</a></div><div title="valid: False, node: 1119, tag: div, level: 18" node_number="1119"><a title="valid: False, node: 1120, tag: a, level: 19" node_number="1120">PubMed</a></div><div title="valid: False, node: 1121, tag: div, level: 18" node_number="1121"><a title="valid: False, node: 1122, tag: a, level: 19" node_number="1122">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1123, tag: div, level: 14" node_number="1123"><div title="valid: False, node: 1124, tag: div, level: 15" node_number="1124">30</div><div title="valid: False, node: 1125, tag: div, level: 15" node_number="1125"><div title="valid: False, node: 1126, tag: div, level: 16" node_number="1126"><div title="valid: False, node: 1127, tag: div, level: 17" node_number="1127">M. Veldhoen, Interleukin 17 is a chief orchestrator of immunity. Nat. Immunol. <b title="valid: False, node: 1128, tag: b, level: 18" node_number="1128">18</b>, 612&#8211;621 (2017).</div><div title="valid: False, node: 1129, tag: div, level: 17" node_number="1129"><div title="valid: False, node: 1130, tag: div, level: 18" node_number="1130"><a title="valid: False, node: 1131, tag: a, level: 19" node_number="1131">Crossref</a></div><div title="valid: False, node: 1132, tag: div, level: 18" node_number="1132"><a title="valid: False, node: 1133, tag: a, level: 19" node_number="1133">PubMed</a></div><div title="valid: False, node: 1134, tag: div, level: 18" node_number="1134"><a title="valid: False, node: 1135, tag: a, level: 19" node_number="1135">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1136, tag: div, level: 14" node_number="1136"><div title="valid: False, node: 1137, tag: div, level: 15" node_number="1137">31</div><div title="valid: False, node: 1138, tag: div, level: 15" node_number="1138"><div title="valid: False, node: 1139, tag: div, level: 16" node_number="1139"><div title="valid: False, node: 1140, tag: div, level: 17" node_number="1140">J. A. Zepp, J. Zhao, C. Liu, K. Bulek, L. Wu, X. Chen, Y. Hao, Z. Wang, X. Wang, W. Ouyang, M. F. Kalady, J. Carman, W.-P. Yang, J. Zhu, C. Blackburn, Y. H. Huang, T. A. Hamilton, B. Su, X. Li, IL-17A-induced PLET1 expression contributes to tissue repair and colon tumorigenesis. J. Immunol. <b title="valid: False, node: 1141, tag: b, level: 18" node_number="1141">199</b>, 3849&#8211;3857 (2017).</div><div title="valid: False, node: 1142, tag: div, level: 17" node_number="1142"><div title="valid: False, node: 1143, tag: div, level: 18" node_number="1143"><a title="valid: False, node: 1144, tag: a, level: 19" node_number="1144">Crossref</a></div><div title="valid: False, node: 1145, tag: div, level: 18" node_number="1145"><a title="valid: False, node: 1146, tag: a, level: 19" node_number="1146">PubMed</a></div><div title="valid: False, node: 1147, tag: div, level: 18" node_number="1147"><a title="valid: False, node: 1148, tag: a, level: 19" node_number="1148">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1149, tag: div, level: 14" node_number="1149"><div title="valid: False, node: 1150, tag: div, level: 15" node_number="1150">32</div><div title="valid: False, node: 1151, tag: div, level: 15" node_number="1151"><div title="valid: False, node: 1152, tag: div, level: 16" node_number="1152"><div title="valid: False, node: 1153, tag: div, level: 17" node_number="1153">O. Annacker, C. Asseman, S. Read, F. Powrie, Interleukin-10 in the regulation of T cell-induced colitis. J. Autoimmun. <b title="valid: False, node: 1154, tag: b, level: 18" node_number="1154">20</b>, 277&#8211;279 (2003).</div><div title="valid: False, node: 1155, tag: div, level: 17" node_number="1155"><div title="valid: False, node: 1156, tag: div, level: 18" node_number="1156"><a title="valid: False, node: 1157, tag: a, level: 19" node_number="1157">Crossref</a></div><div title="valid: False, node: 1158, tag: div, level: 18" node_number="1158"><a title="valid: False, node: 1159, tag: a, level: 19" node_number="1159">PubMed</a></div><div title="valid: False, node: 1160, tag: div, level: 18" node_number="1160"><a title="valid: False, node: 1161, tag: a, level: 19" node_number="1161">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1162, tag: div, level: 14" node_number="1162"><div title="valid: False, node: 1163, tag: div, level: 15" node_number="1163">33</div><div title="valid: False, node: 1164, tag: div, level: 15" node_number="1164"><div title="valid: False, node: 1165, tag: div, level: 16" node_number="1165"><div title="valid: False, node: 1166, tag: div, level: 17" node_number="1166">E. C. Rosser, C. Mauri, Regulatory B cells: Origin, phenotype, and function. Immunity <b title="valid: False, node: 1167, tag: b, level: 18" node_number="1167">42</b>, 607&#8211;612 (2015).</div><div title="valid: False, node: 1168, tag: div, level: 17" node_number="1168"><div title="valid: False, node: 1169, tag: div, level: 18" node_number="1169"><a title="valid: False, node: 1170, tag: a, level: 19" node_number="1170">Crossref</a></div><div title="valid: False, node: 1171, tag: div, level: 18" node_number="1171"><a title="valid: False, node: 1172, tag: a, level: 19" node_number="1172">PubMed</a></div><div title="valid: False, node: 1173, tag: div, level: 18" node_number="1173"><a title="valid: False, node: 1174, tag: a, level: 19" node_number="1174">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1175, tag: div, level: 14" node_number="1175"><div title="valid: False, node: 1176, tag: div, level: 15" node_number="1176">34</div><div title="valid: False, node: 1177, tag: div, level: 15" node_number="1177"><div title="valid: False, node: 1178, tag: div, level: 16" node_number="1178"><div title="valid: False, node: 1179, tag: div, level: 17" node_number="1179">S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray, S. M. Anderton, B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. <b title="valid: False, node: 1180, tag: b, level: 18" node_number="1180">3</b>, 944&#8211;950 (2002).</div><div title="valid: False, node: 1181, tag: div, level: 17" node_number="1181"><div title="valid: False, node: 1182, tag: div, level: 18" node_number="1182"><a title="valid: False, node: 1183, tag: a, level: 19" node_number="1183">Crossref</a></div><div title="valid: False, node: 1184, tag: div, level: 18" node_number="1184"><a title="valid: False, node: 1185, tag: a, level: 19" node_number="1185">PubMed</a></div><div title="valid: False, node: 1186, tag: div, level: 18" node_number="1186"><a title="valid: False, node: 1187, tag: a, level: 19" node_number="1187">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1188, tag: div, level: 14" node_number="1188"><div title="valid: False, node: 1189, tag: div, level: 15" node_number="1189">35</div><div title="valid: False, node: 1190, tag: div, level: 15" node_number="1190"><div title="valid: False, node: 1191, tag: div, level: 16" node_number="1191"><div title="valid: False, node: 1192, tag: div, level: 17" node_number="1192">O. L. Rojas, A.-K. Pr&#246;bstel, E. A. Porfilio, A. A. Wang, M. Charabati, T. Sun, D. S. W. Lee, G. Galicia, V. Ramaglia, L. A. Ward, L. Y. T. Leung, G. Najafi, K. Khaleghi, B. Garcill&#225;n, A. Li, R. Besla, I. Naouar, E. Y. Cao, P. Chiaranunt, K. Burrows, H. G. Robinson, J. R. Allanach, J. Yam, H. Luck, D. J. Campbell, D. Allman, D. G. Brooks, M. Tomura, R. Baumann, S. S. Zamvil, A. Bar-Or, M. S. Horwitz, D. A. Winer, A. Mortha, F. Mackay, A. Prat, L. C. Osborne, C. Robbins, S. E. Baranzini, J. L. Gommerman, Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell <b title="valid: False, node: 1193, tag: b, level: 18" node_number="1193">176</b>, 610&#8211;624.e18 (2019).</div><div title="valid: False, node: 1194, tag: div, level: 17" node_number="1194"><div title="valid: False, node: 1195, tag: div, level: 18" node_number="1195"><a title="valid: False, node: 1196, tag: a, level: 19" node_number="1196">Crossref</a></div><div title="valid: False, node: 1197, tag: div, level: 18" node_number="1197"><a title="valid: False, node: 1198, tag: a, level: 19" node_number="1198">PubMed</a></div><div title="valid: False, node: 1199, tag: div, level: 18" node_number="1199"><a title="valid: False, node: 1200, tag: a, level: 19" node_number="1200">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1201, tag: div, level: 14" node_number="1201"><div title="valid: False, node: 1202, tag: div, level: 15" node_number="1202">36</div><div title="valid: False, node: 1203, tag: div, level: 15" node_number="1203"><div title="valid: False, node: 1204, tag: div, level: 16" node_number="1204"><div title="valid: False, node: 1205, tag: div, level: 17" node_number="1205">A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, A. K. Bhan, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity <b title="valid: False, node: 1206, tag: b, level: 18" node_number="1206">16</b>, 219&#8211;230 (2002).</div><div title="valid: False, node: 1207, tag: div, level: 17" node_number="1207"><div title="valid: False, node: 1208, tag: div, level: 18" node_number="1208"><a title="valid: False, node: 1209, tag: a, level: 19" node_number="1209">Crossref</a></div><div title="valid: False, node: 1210, tag: div, level: 18" node_number="1210"><a title="valid: False, node: 1211, tag: a, level: 19" node_number="1211">PubMed</a></div><div title="valid: False, node: 1212, tag: div, level: 18" node_number="1212"><a title="valid: False, node: 1213, tag: a, level: 19" node_number="1213">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1214, tag: div, level: 14" node_number="1214"><div title="valid: False, node: 1215, tag: div, level: 15" node_number="1215">37</div><div title="valid: False, node: 1216, tag: div, level: 15" node_number="1216"><div title="valid: False, node: 1217, tag: div, level: 16" node_number="1217"><div title="valid: False, node: 1218, tag: div, level: 17" node_number="1218">M. Mitsdoerffer, Y. Lee, A. J&#228;ger, H.-J. Kim, T. Korn, J. K. Kolls, H. Cantor, E. Bettelli, V. K. Kuchroo, Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. U.S.A. <b title="valid: False, node: 1219, tag: b, level: 18" node_number="1219">107</b>, 14292&#8211;14297 (2010).</div><div title="valid: False, node: 1220, tag: div, level: 17" node_number="1220"><div title="valid: False, node: 1221, tag: div, level: 18" node_number="1221"><a title="valid: False, node: 1222, tag: a, level: 19" node_number="1222">Crossref</a></div><div title="valid: False, node: 1223, tag: div, level: 18" node_number="1223"><a title="valid: False, node: 1224, tag: a, level: 19" node_number="1224">PubMed</a></div><div title="valid: False, node: 1225, tag: div, level: 18" node_number="1225"><a title="valid: False, node: 1226, tag: a, level: 19" node_number="1226">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1227, tag: div, level: 14" node_number="1227"><div title="valid: False, node: 1228, tag: div, level: 15" node_number="1228">38</div><div title="valid: False, node: 1229, tag: div, level: 15" node_number="1229"><div title="valid: False, node: 1230, tag: div, level: 16" node_number="1230"><div title="valid: False, node: 1231, tag: div, level: 17" node_number="1231">H.-C. Hsu, P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, T. L. Le, R. G. Lorenz, H. Xu, J. K. Kolls, R. H. Carter, D. D. Chaplin, R. W. Williams, J. D. Mountz, Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. <b title="valid: False, node: 1232, tag: b, level: 18" node_number="1232">9</b>, 166&#8211;175 (2008).</div><div title="valid: False, node: 1233, tag: div, level: 17" node_number="1233"><div title="valid: False, node: 1234, tag: div, level: 18" node_number="1234"><a title="valid: False, node: 1235, tag: a, level: 19" node_number="1235">Crossref</a></div><div title="valid: False, node: 1236, tag: div, level: 18" node_number="1236"><a title="valid: False, node: 1237, tag: a, level: 19" node_number="1237">PubMed</a></div><div title="valid: False, node: 1238, tag: div, level: 18" node_number="1238"><a title="valid: False, node: 1239, tag: a, level: 19" node_number="1239">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1240, tag: div, level: 14" node_number="1240"><div title="valid: False, node: 1241, tag: div, level: 15" node_number="1241">39</div><div title="valid: False, node: 1242, tag: div, level: 15" node_number="1242"><div title="valid: False, node: 1243, tag: div, level: 16" node_number="1243"><div title="valid: False, node: 1244, tag: div, level: 17" node_number="1244">Y. Ding, J. Li, Q. Wu, P. Yang, B. Luo, S. Xie, K. M. Druey, A. J. Zajac, H.-C. Hsu, J. D. Mountz, IL-17RA is essential for optimal localization of follicular Th cells in the germinal center light zone to promote autoantibody-producing B cells. J. Immunol. <b title="valid: False, node: 1245, tag: b, level: 18" node_number="1245">191</b>, 1614&#8211;1624 (2013).</div><div title="valid: False, node: 1246, tag: div, level: 17" node_number="1246"><div title="valid: False, node: 1247, tag: div, level: 18" node_number="1247"><a title="valid: False, node: 1248, tag: a, level: 19" node_number="1248">Crossref</a></div><div title="valid: False, node: 1249, tag: div, level: 18" node_number="1249"><a title="valid: False, node: 1250, tag: a, level: 19" node_number="1250">PubMed</a></div><div title="valid: False, node: 1251, tag: div, level: 18" node_number="1251"><a title="valid: False, node: 1252, tag: a, level: 19" node_number="1252">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1253, tag: div, level: 14" node_number="1253"><div title="valid: False, node: 1254, tag: div, level: 15" node_number="1254">40</div><div title="valid: False, node: 1255, tag: div, level: 15" node_number="1255"><div title="valid: False, node: 1256, tag: div, level: 16" node_number="1256"><div title="valid: False, node: 1257, tag: div, level: 17" node_number="1257">M. Baj&#233;noff, J. G. Egen, L. Y. Koo, J. P. Laugier, F. Brau, N. Glaichenhaus, R. N. Germain, Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity <b title="valid: False, node: 1258, tag: b, level: 18" node_number="1258">25</b>, 989&#8211;1001 (2006).</div><div title="valid: False, node: 1259, tag: div, level: 17" node_number="1259"><div title="valid: False, node: 1260, tag: div, level: 18" node_number="1260"><a title="valid: False, node: 1261, tag: a, level: 19" node_number="1261">Crossref</a></div><div title="valid: False, node: 1262, tag: div, level: 18" node_number="1262"><a title="valid: False, node: 1263, tag: a, level: 19" node_number="1263">PubMed</a></div><div title="valid: False, node: 1264, tag: div, level: 18" node_number="1264"><a title="valid: False, node: 1265, tag: a, level: 19" node_number="1265">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1266, tag: div, level: 14" node_number="1266"><div title="valid: False, node: 1267, tag: div, level: 15" node_number="1267">41</div><div title="valid: False, node: 1268, tag: div, level: 15" node_number="1268"><div title="valid: False, node: 1269, tag: div, level: 16" node_number="1269"><div title="valid: False, node: 1270, tag: div, level: 17" node_number="1270">F. D. Brown, D. R. Sen, M. W. LaFleur, J. Godec, V. Lukacs-Kornek, F. A. Schildberg, H.-J. Kim, K. B. Yates, S. J. H. Ricoult, K. Bi, J. D. Trombley, V. N. Kapoor, I. A. Stanley, V. Cremasco, N. N. Danial, B. D. Manning, A. H. Sharpe, W. N. Haining, S. J. Turley, Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nat. Immunol. <b title="valid: False, node: 1271, tag: b, level: 18" node_number="1271">20</b>, 1668&#8211;1680 (2019).</div><div title="valid: False, node: 1272, tag: div, level: 17" node_number="1272"><div title="valid: False, node: 1273, tag: div, level: 18" node_number="1273"><a title="valid: False, node: 1274, tag: a, level: 19" node_number="1274">Crossref</a></div><div title="valid: False, node: 1275, tag: div, level: 18" node_number="1275"><a title="valid: False, node: 1276, tag: a, level: 19" node_number="1276">PubMed</a></div><div title="valid: False, node: 1277, tag: div, level: 18" node_number="1277"><a title="valid: False, node: 1278, tag: a, level: 19" node_number="1278">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1279, tag: div, level: 14" node_number="1279"><div title="valid: False, node: 1280, tag: div, level: 15" node_number="1280">42</div><div title="valid: False, node: 1281, tag: div, level: 15" node_number="1281"><div title="valid: False, node: 1282, tag: div, level: 16" node_number="1282"><div title="valid: False, node: 1283, tag: div, level: 17" node_number="1283">A. Yamada, J. Wang, Y. Komaki, F. Komaki, D. Micic, A. Sakuraba, Systematic review with meta-analysis: Risk of new onset IBD with the use of anti-interleukin-17 agents. Aliment. Pharmacol. Ther. <b title="valid: False, node: 1284, tag: b, level: 18" node_number="1284">50</b>, 373&#8211;385 (2019).</div><div title="valid: False, node: 1285, tag: div, level: 17" node_number="1285"><div title="valid: False, node: 1286, tag: div, level: 18" node_number="1286"><a title="valid: False, node: 1287, tag: a, level: 19" node_number="1287">Crossref</a></div><div title="valid: False, node: 1288, tag: div, level: 18" node_number="1288"><a title="valid: False, node: 1289, tag: a, level: 19" node_number="1289">PubMed</a></div><div title="valid: False, node: 1290, tag: div, level: 18" node_number="1290"><a title="valid: False, node: 1291, tag: a, level: 19" node_number="1291">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1292, tag: div, level: 14" node_number="1292"><div title="valid: False, node: 1293, tag: div, level: 15" node_number="1293">43</div><div title="valid: False, node: 1294, tag: div, level: 15" node_number="1294"><div title="valid: False, node: 1295, tag: div, level: 16" node_number="1295"><div title="valid: False, node: 1296, tag: div, level: 17" node_number="1296">J. S. Lee, C. M. Tato, B. Joyce-Shaikh, M. F. Gulen, C. Cayatte, Y. Chen, W. M. Blumenschein, M. Judo, G. Ayanoglu, T. K. McClanahan, X. Li, D. J. Cua, Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity <b title="valid: False, node: 1297, tag: b, level: 18" node_number="1297">43</b>, 727&#8211;738 (2015).</div><div title="valid: False, node: 1298, tag: div, level: 17" node_number="1298"><div title="valid: False, node: 1299, tag: div, level: 18" node_number="1299"><a title="valid: False, node: 1300, tag: a, level: 19" node_number="1300">Crossref</a></div><div title="valid: False, node: 1301, tag: div, level: 18" node_number="1301"><a title="valid: False, node: 1302, tag: a, level: 19" node_number="1302">PubMed</a></div><div title="valid: False, node: 1303, tag: div, level: 18" node_number="1303"><a title="valid: False, node: 1304, tag: a, level: 19" node_number="1304">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1305, tag: div, level: 14" node_number="1305"><div title="valid: False, node: 1306, tag: div, level: 15" node_number="1306">44</div><div title="valid: False, node: 1307, tag: div, level: 15" node_number="1307"><div title="valid: False, node: 1308, tag: div, level: 16" node_number="1308"><div title="valid: False, node: 1309, tag: div, level: 17" node_number="1309">Y. Belkaid, T. W. Hand, Role of the microbiota in immunity and inflammation. Cell <b title="valid: False, node: 1310, tag: b, level: 18" node_number="1310">157</b>, 121&#8211;141 (2014).</div><div title="valid: False, node: 1311, tag: div, level: 17" node_number="1311"><div title="valid: False, node: 1312, tag: div, level: 18" node_number="1312"><a title="valid: False, node: 1313, tag: a, level: 19" node_number="1313">Crossref</a></div><div title="valid: False, node: 1314, tag: div, level: 18" node_number="1314"><a title="valid: False, node: 1315, tag: a, level: 19" node_number="1315">PubMed</a></div><div title="valid: False, node: 1316, tag: div, level: 18" node_number="1316"><a title="valid: False, node: 1317, tag: a, level: 19" node_number="1317">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1318, tag: div, level: 14" node_number="1318"><div title="valid: False, node: 1319, tag: div, level: 15" node_number="1319">45</div><div title="valid: False, node: 1320, tag: div, level: 15" node_number="1320"><div title="valid: False, node: 1321, tag: div, level: 16" node_number="1321"><div title="valid: False, node: 1322, tag: div, level: 17" node_number="1322">P. Kumar, L. Monin, P. Castillo, W. Elsegeiny, W. Horne, T. Eddens, A. Vikram, M. Good, A. A. Schoenborn, K. Bibby, R. C. Montelaro, D. W. Metzger, A. S. Gulati, J. K. Kolls, Intestinal interleukin-17 receptor signaling mediates reciprocal control of the Gut microbiota and autoimmune inflammation. Immunity <b title="valid: False, node: 1323, tag: b, level: 18" node_number="1323">44</b>, 659&#8211;671 (2016).</div><div title="valid: False, node: 1324, tag: div, level: 17" node_number="1324"><div title="valid: False, node: 1325, tag: div, level: 18" node_number="1325"><a title="valid: False, node: 1326, tag: a, level: 19" node_number="1326">Crossref</a></div><div title="valid: False, node: 1327, tag: div, level: 18" node_number="1327"><a title="valid: False, node: 1328, tag: a, level: 19" node_number="1328">PubMed</a></div><div title="valid: False, node: 1329, tag: div, level: 18" node_number="1329"><a title="valid: False, node: 1330, tag: a, level: 19" node_number="1330">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1331, tag: div, level: 14" node_number="1331"><div title="valid: False, node: 1332, tag: div, level: 15" node_number="1332">46</div><div title="valid: False, node: 1333, tag: div, level: 15" node_number="1333"><div title="valid: False, node: 1334, tag: div, level: 16" node_number="1334"><div title="valid: False, node: 1335, tag: div, level: 17" node_number="1335">A. Cherukuri, K. Mohib, D. M. Rothstein, Regulatory B cells: TIM-1, transplant tolerance, and rejection. Immunol. Rev. <b title="valid: False, node: 1336, tag: b, level: 18" node_number="1336">299</b>, 31&#8211;44 (2021).</div><div title="valid: False, node: 1337, tag: div, level: 17" node_number="1337"><div title="valid: False, node: 1338, tag: div, level: 18" node_number="1338"><a title="valid: False, node: 1339, tag: a, level: 19" node_number="1339">Crossref</a></div><div title="valid: False, node: 1340, tag: div, level: 18" node_number="1340"><a title="valid: False, node: 1341, tag: a, level: 19" node_number="1341">PubMed</a></div><div title="valid: False, node: 1342, tag: div, level: 18" node_number="1342"><a title="valid: False, node: 1343, tag: a, level: 19" node_number="1343">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1344, tag: div, level: 14" node_number="1344"><div title="valid: False, node: 1345, tag: div, level: 15" node_number="1345">47</div><div title="valid: False, node: 1346, tag: div, level: 15" node_number="1346"><div title="valid: False, node: 1347, tag: div, level: 16" node_number="1347"><div title="valid: False, node: 1348, tag: div, level: 17" node_number="1348">A. C. Lino, T. D&#246;rner, A. Bar-Or, S. Fillatreau, Cytokine-producing B cells: A translational view on their roles in human and mouse autoimmune diseases. Immunol. Rev. <b title="valid: False, node: 1349, tag: b, level: 18" node_number="1349">269</b>, 130&#8211;144 (2016).</div><div title="valid: False, node: 1350, tag: div, level: 17" node_number="1350"><div title="valid: False, node: 1351, tag: div, level: 18" node_number="1351"><a title="valid: False, node: 1352, tag: a, level: 19" node_number="1352">Crossref</a></div><div title="valid: False, node: 1353, tag: div, level: 18" node_number="1353"><a title="valid: False, node: 1354, tag: a, level: 19" node_number="1354">PubMed</a></div><div title="valid: False, node: 1355, tag: div, level: 18" node_number="1355"><a title="valid: False, node: 1356, tag: a, level: 19" node_number="1356">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1357, tag: div, level: 14" node_number="1357"><div title="valid: False, node: 1358, tag: div, level: 15" node_number="1358">48</div><div title="valid: False, node: 1359, tag: div, level: 15" node_number="1359"><div title="valid: False, node: 1360, tag: div, level: 16" node_number="1360"><div title="valid: False, node: 1361, tag: div, level: 17" node_number="1361">T. Castro-Dopico, A. Fleming, T. W. Dennison, J. R. Ferdinand, K. Harcourt, B. J. Stewart, Z. Cader, Z. K. Tuong, C. Jing, L. S. C. Lok, R. J. Mathews, A. Portet, A. Kaser, S. Clare, M. R. Clatworthy, GM-CSF calibrates macrophage defense and wound healing programs during intestinal infection and inflammation. Cell Rep. <b title="valid: False, node: 1362, tag: b, level: 18" node_number="1362">32</b>, 107857 (2020).</div><div title="valid: False, node: 1363, tag: div, level: 17" node_number="1363"><div title="valid: False, node: 1364, tag: div, level: 18" node_number="1364"><a title="valid: False, node: 1365, tag: a, level: 19" node_number="1365">Crossref</a></div><div title="valid: False, node: 1366, tag: div, level: 18" node_number="1366"><a title="valid: False, node: 1367, tag: a, level: 19" node_number="1367">PubMed</a></div><div title="valid: False, node: 1368, tag: div, level: 18" node_number="1368"><a title="valid: False, node: 1369, tag: a, level: 19" node_number="1369">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1370, tag: div, level: 14" node_number="1370"><div title="valid: False, node: 1371, tag: div, level: 15" node_number="1371">49</div><div title="valid: False, node: 1372, tag: div, level: 15" node_number="1372"><div title="valid: False, node: 1373, tag: div, level: 16" node_number="1373"><div title="valid: False, node: 1374, tag: div, level: 17" node_number="1374">S. J. C. F. M. Moorlag, R. J. R&#246;ring, L. A. B. Joosten, M. G. Netea, The role of the interleukin-1 family in trained immunity. Immunol. Rev. <b title="valid: False, node: 1375, tag: b, level: 18" node_number="1375">281</b>, 28&#8211;39 (2018).</div><div title="valid: False, node: 1376, tag: div, level: 17" node_number="1376"><div title="valid: False, node: 1377, tag: div, level: 18" node_number="1377"><a title="valid: False, node: 1378, tag: a, level: 19" node_number="1378">Crossref</a></div><div title="valid: False, node: 1379, tag: div, level: 18" node_number="1379"><a title="valid: False, node: 1380, tag: a, level: 19" node_number="1380">PubMed</a></div><div title="valid: False, node: 1381, tag: div, level: 18" node_number="1381"><a title="valid: False, node: 1382, tag: a, level: 19" node_number="1382">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1383, tag: div, level: 14" node_number="1383"><div title="valid: False, node: 1384, tag: div, level: 15" node_number="1384">50</div><div title="valid: False, node: 1385, tag: div, level: 15" node_number="1385"><div title="valid: False, node: 1386, tag: div, level: 16" node_number="1386"><div title="valid: False, node: 1387, tag: div, level: 17" node_number="1387">B. de Laval, J. Maurizio, P. K. Kandalla, G. Brisou, L. Simonnet, C. Huber, G. Gimenez, O. Matcovitch-Natan, S. Reinhardt, E. David, A. Mildner, A. Leutz, B. Nadel, C. Bordi, I. Amit, S. Sarrazin, M. H. Sieweke, C/EBP&#946;-dependent epigenetic memory induces trained immunity in hematopoietic stem cells. Cell Stem Cell <b title="valid: False, node: 1388, tag: b, level: 18" node_number="1388">26</b>, 657&#8211;674.e8 (2020).</div><div title="valid: False, node: 1389, tag: div, level: 17" node_number="1389"><div title="valid: False, node: 1390, tag: div, level: 18" node_number="1390"><a title="valid: False, node: 1391, tag: a, level: 19" node_number="1391">Crossref</a></div><div title="valid: False, node: 1392, tag: div, level: 18" node_number="1392"><a title="valid: False, node: 1393, tag: a, level: 19" node_number="1393">PubMed</a></div><div title="valid: False, node: 1394, tag: div, level: 18" node_number="1394"><a title="valid: False, node: 1395, tag: a, level: 19" node_number="1395">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1396, tag: div, level: 14" node_number="1396"><div title="valid: False, node: 1397, tag: div, level: 15" node_number="1397">51</div><div title="valid: False, node: 1398, tag: div, level: 15" node_number="1398"><div title="valid: False, node: 1399, tag: div, level: 16" node_number="1399"><div title="valid: False, node: 1400, tag: div, level: 17" node_number="1400">B. Kelly, L. A. J. O&#8217;Neill, Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. <b title="valid: False, node: 1401, tag: b, level: 18" node_number="1401">25</b>, 771&#8211;784 (2015).</div><div title="valid: False, node: 1402, tag: div, level: 17" node_number="1402"><div title="valid: False, node: 1403, tag: div, level: 18" node_number="1403"><a title="valid: False, node: 1404, tag: a, level: 19" node_number="1404">Crossref</a></div><div title="valid: False, node: 1405, tag: div, level: 18" node_number="1405"><a title="valid: False, node: 1406, tag: a, level: 19" node_number="1406">PubMed</a></div><div title="valid: False, node: 1407, tag: div, level: 18" node_number="1407"><a title="valid: False, node: 1408, tag: a, level: 19" node_number="1408">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1409, tag: div, level: 14" node_number="1409"><div title="valid: False, node: 1410, tag: div, level: 15" node_number="1410">52</div><div title="valid: False, node: 1411, tag: div, level: 15" node_number="1411"><div title="valid: False, node: 1412, tag: div, level: 16" node_number="1412"><div title="valid: False, node: 1413, tag: div, level: 17" node_number="1413">S. Bekkering, R. J. W. Arts, B. Novakovic, I. Kourtzelis, C. D. C. C. van der Heijden, Y. Li, C. D. Popa, R. Ter Horst, J. van Tuijl, R. T. Netea-Maier, F. L. van de Veerdonk, T. Chavakis, L. A. B. Joosten, J. W. M. van der Meer, H. Stunnenberg, N. P. Riksen, M. G. Netea, Metabolic induction of trained immunity through the mevalonate pathway. Cell <b title="valid: False, node: 1414, tag: b, level: 18" node_number="1414">172</b>, 135&#8211;146.e9 (2018).</div><div title="valid: False, node: 1415, tag: div, level: 17" node_number="1415"><div title="valid: False, node: 1416, tag: div, level: 18" node_number="1416"><a title="valid: False, node: 1417, tag: a, level: 19" node_number="1417">Crossref</a></div><div title="valid: False, node: 1418, tag: div, level: 18" node_number="1418"><a title="valid: False, node: 1419, tag: a, level: 19" node_number="1419">PubMed</a></div><div title="valid: False, node: 1420, tag: div, level: 18" node_number="1420"><a title="valid: False, node: 1421, tag: a, level: 19" node_number="1421">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1422, tag: div, level: 14" node_number="1422"><div title="valid: False, node: 1423, tag: div, level: 15" node_number="1423">53</div><div title="valid: False, node: 1424, tag: div, level: 15" node_number="1424"><div title="valid: False, node: 1425, tag: div, level: 16" node_number="1425"><div title="valid: False, node: 1426, tag: div, level: 17" node_number="1426">S. Naik, S. B. Larsen, N. C. Gomez, K. Alaverdyan, A. Sendoel, S. Yuan, L. Polak, A. Kulukian, S. Chai, E. Fuchs, Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature <b title="valid: False, node: 1427, tag: b, level: 18" node_number="1427">550</b>, 475&#8211;480 (2017).</div><div title="valid: False, node: 1428, tag: div, level: 17" node_number="1428"><div title="valid: False, node: 1429, tag: div, level: 18" node_number="1429"><a title="valid: False, node: 1430, tag: a, level: 19" node_number="1430">Crossref</a></div><div title="valid: False, node: 1431, tag: div, level: 18" node_number="1431"><a title="valid: False, node: 1432, tag: a, level: 19" node_number="1432">PubMed</a></div><div title="valid: False, node: 1433, tag: div, level: 18" node_number="1433"><a title="valid: False, node: 1434, tag: a, level: 19" node_number="1434">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1435, tag: div, level: 14" node_number="1435"><div title="valid: False, node: 1436, tag: div, level: 15" node_number="1436">54</div><div title="valid: False, node: 1437, tag: div, level: 15" node_number="1437"><div title="valid: False, node: 1438, tag: div, level: 16" node_number="1438"><div title="valid: False, node: 1439, tag: div, level: 17" node_number="1439">Q. Chai, L. Onder, E. Scandella, C. Gil-Cruz, C. Perez-Shibayama, J. Cupovic, R. Danuser, T. Sparwasser, S. A. Luther, V. Thiel, T. R&#252;licke, J. V. Stein, T. Hehlgans, B. Ludewig, Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity <b title="valid: False, node: 1440, tag: b, level: 18" node_number="1440">38</b>, 1013&#8211;1024 (2013).</div><div title="valid: False, node: 1441, tag: div, level: 17" node_number="1441"><div title="valid: False, node: 1442, tag: div, level: 18" node_number="1442"><a title="valid: False, node: 1443, tag: a, level: 19" node_number="1443">Crossref</a></div><div title="valid: False, node: 1444, tag: div, level: 18" node_number="1444"><a title="valid: False, node: 1445, tag: a, level: 19" node_number="1445">PubMed</a></div><div title="valid: False, node: 1446, tag: div, level: 18" node_number="1446"><a title="valid: False, node: 1447, tag: a, level: 19" node_number="1447">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1448, tag: div, level: 14" node_number="1448"><div title="valid: False, node: 1449, tag: div, level: 15" node_number="1449">55</div><div title="valid: False, node: 1450, tag: div, level: 15" node_number="1450"><div title="valid: False, node: 1451, tag: div, level: 16" node_number="1451"><div title="valid: False, node: 1452, tag: div, level: 17" node_number="1452">A. Roers, L. Siewe, E. Strittmatter, M. Deckert, D. Schl&#252;ter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, W. M&#252;ller, T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. <b title="valid: False, node: 1453, tag: b, level: 18" node_number="1453">200</b>, 1289&#8211;1297 (2004).</div><div title="valid: False, node: 1454, tag: div, level: 17" node_number="1454"><div title="valid: False, node: 1455, tag: div, level: 18" node_number="1455"><a title="valid: False, node: 1456, tag: a, level: 19" node_number="1456">Crossref</a></div><div title="valid: False, node: 1457, tag: div, level: 18" node_number="1457"><a title="valid: False, node: 1458, tag: a, level: 19" node_number="1458">PubMed</a></div><div title="valid: False, node: 1459, tag: div, level: 18" node_number="1459"><a title="valid: False, node: 1460, tag: a, level: 19" node_number="1460">Google Scholar</a></div></div></div></div></div></section></div></section><div class="valid" valid="valid" title="valid: True, node: 1461, tag: div, level: 11" node_number="1461"><div class="valid" valid="valid" title="valid: True, node: 1462, tag: div, level: 12" node_number="1462"><header class="valid" valid="valid" title="valid: True, node: 1463, tag: header, level: 13" node_number="1463"><h2 class="valid" valid="valid" title="valid: True, node: 1464, tag: h2, level: 14" node_number="1464">Information Authors</h2></header><section class="valid" valid="valid" title="valid: True, node: 1465, tag: section, level: 13" node_number="1465"><h3 class="valid" valid="valid" title="valid: True, node: 1466, tag: h3, level: 14" node_number="1466">Information</h3><section class="valid" valid="valid" title="valid: True, node: 1467, tag: section, level: 14" node_number="1467"><h4 title="valid: False, node: 1468, tag: h4, level: 15" node_number="1468">Published In</h4><div title="valid: False, node: 1469, tag: div, level: 15" node_number="1469"> <div title="valid: False, node: 1470, tag: div, level: 16" node_number="1470"><div title="valid: False, node: 1471, tag: div, level: 17" node_number="1471">Science Immunology</div><div title="valid: False, node: 1472, tag: div, level: 17" node_number="1472">Volume 6 | Issue 66December 2021</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1473, tag: section, level: 14" node_number="1473"><h4 title="valid: False, node: 1474, tag: h4, level: 15" node_number="1474">Copyright</h4><div title="valid: False, node: 1475, tag: div, level: 15" node_number="1475">Copyright &#169; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</div><div title="valid: False, node: 1476, tag: div, level: 15" node_number="1476">https://www.sciencemag.org/about/science-licenses-journal-article-reuse</div><div title="valid: False, node: 1477, tag: div, level: 15" node_number="1477">This is an article distributed under the terms of the Science Journals Default License.</div></section><section class="valid" valid="valid" title="valid: True, node: 1478, tag: section, level: 14" node_number="1478"><h4 title="valid: False, node: 1479, tag: h4, level: 15" node_number="1479">Submission history</h4><div title="valid: False, node: 1480, tag: div, level: 15" node_number="1480"><b title="valid: False, node: 1481, tag: b, level: 16" node_number="1481">Received</b>: 28 August 2020</div><div title="valid: False, node: 1482, tag: div, level: 15" node_number="1482"><b title="valid: False, node: 1483, tag: b, level: 16" node_number="1483">Accepted</b>: 12 November 2021</div></section><section class="valid" valid="valid" title="valid: True, node: 1484, tag: section, level: 14" node_number="1484"><h4 title="valid: False, node: 1485, tag: h4, level: 15" node_number="1485">Permissions</h4><div title="valid: False, node: 1486, tag: div, level: 15" node_number="1486">Request permissions for this article.</div><div title="valid: False, node: 1487, tag: div, level: 15" node_number="1487"><a title="valid: False, node: 1488, tag: a, level: 16" node_number="1488">Request Permissions</a></div></section><section class="valid" valid="valid" title="valid: True, node: 1489, tag: section, level: 14" node_number="1489"><h4 title="valid: False, node: 1490, tag: h4, level: 15" node_number="1490">Acknowledgments</h4><div title="valid: False, node: 1491, tag: div, level: 15" node_number="1491">We thank P. Biswas, S. Gaffen, R. Elsner, and T. Hand for thoughtful discussion and reading of manuscript; staff of the Division of Laboratory Animal Research for animal husbandry; and the Unified Flow Core for flow cytometry services.</div><div title="valid: False, node: 1492, tag: div, level: 15" node_number="1492"><b title="valid: False, node: 1493, tag: b, level: 16" node_number="1493">Funding:</b> Funding for the project was from NIH AI148356 to M.J.M. D.W. was sponsored by the Third Xiangya Hospital, Central South University and acknowledges the encouragement of F. Wang. S.M. was a recipient of the AAI 2019-2020 trainee fellowship, CLP funded by T32 trainee award AI089443, and D.R. acknowledges funding from NIH AI114587.</div><div title="valid: False, node: 1494, tag: div, level: 15" node_number="1494"><b title="valid: False, node: 1495, tag: b, level: 16" node_number="1495">Author contributions:</b> D.W. designed and performed experiments and data analysis. C.H.P., S.K.R., Q.L., and S.M. performed experiments and data analysis. R.E., S.M., K.M., and D.M.R. provided technical expertise. D.M.R. also provided mice. M.J.M. designed and directed the study, obtained funding, and wrote the manuscript with assistance from D.W., C.H.P., and D.M.R.</div><div title="valid: False, node: 1496, tag: div, level: 15" node_number="1496"><b title="valid: False, node: 1497, tag: b, level: 16" node_number="1497">Competing interests</b>: The authors declare that they have no competing interests.</div><div title="valid: False, node: 1498, tag: div, level: 15" node_number="1498"><b title="valid: False, node: 1499, tag: b, level: 16" node_number="1499">Data and materials availability</b>: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 1500, tag: section, level: 13" node_number="1500"><h3 class="valid" valid="valid" title="valid: True, node: 1501, tag: h3, level: 14" node_number="1501">Authors</h3><section class="valid" valid="valid" title="valid: True, node: 1502, tag: section, level: 14" node_number="1502"><h4 title="valid: False, node: 1503, tag: h4, level: 15" node_number="1503">Affiliations</h4><div title="valid: False, node: 1504, tag: div, level: 15" node_number="1504"><div title="valid: False, node: 1505, tag: div, level: 16" node_number="1505">Dongwen Wu https://orcid.org/0000-0001-7909-5708</div><div title="valid: False, node: 1506, tag: div, level: 16" node_number="1506"><div title="valid: False, node: 1507, tag: div, level: 17" node_number="1507"><div title="valid: False, node: 1508, tag: div, level: 18" node_number="1508">Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</div><div title="valid: False, node: 1509, tag: div, level: 18" node_number="1509">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1510, tag: div, level: 17" node_number="1510">View all articles by this author</div></div></div><div title="valid: False, node: 1511, tag: div, level: 15" node_number="1511"><div title="valid: False, node: 1512, tag: div, level: 16" node_number="1512">Catherine H. Poholek https://orcid.org/0000-0002-9381-9618</div><div title="valid: False, node: 1513, tag: div, level: 16" node_number="1513"><div title="valid: False, node: 1514, tag: div, level: 17" node_number="1514"><div title="valid: False, node: 1515, tag: div, level: 18" node_number="1515">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div><div title="valid: False, node: 1516, tag: div, level: 18" node_number="1516">Division of Pediatric Rheumatology, Department of Pediatrics, UPMC Children&#8217;s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1517, tag: div, level: 17" node_number="1517">View all articles by this author</div></div></div><div title="valid: False, node: 1518, tag: div, level: 15" node_number="1518"><div title="valid: False, node: 1519, tag: div, level: 16" node_number="1519">Saikat Majumder https://orcid.org/0000-0002-6591-9515</div><div title="valid: False, node: 1520, tag: div, level: 16" node_number="1520"><div title="valid: False, node: 1521, tag: div, level: 17" node_number="1521"><div title="valid: False, node: 1522, tag: div, level: 18" node_number="1522">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1523, tag: div, level: 17" node_number="1523">View all articles by this author</div></div></div><div title="valid: False, node: 1524, tag: div, level: 15" node_number="1524"><div title="valid: False, node: 1525, tag: div, level: 16" node_number="1525">Qixing Liu https://orcid.org/0000-0002-9076-6274</div><div title="valid: False, node: 1526, tag: div, level: 16" node_number="1526"><div title="valid: False, node: 1527, tag: div, level: 17" node_number="1527"><div title="valid: False, node: 1528, tag: div, level: 18" node_number="1528">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div><div title="valid: False, node: 1529, tag: div, level: 18" node_number="1529">School of Medicine, Tsinghua University Beijing, China.</div></div><div title="valid: False, node: 1530, tag: div, level: 17" node_number="1530">View all articles by this author</div></div></div><div title="valid: False, node: 1531, tag: div, level: 15" node_number="1531"><div title="valid: False, node: 1532, tag: div, level: 16" node_number="1532">Shankar K. Revu</div><div title="valid: False, node: 1533, tag: div, level: 16" node_number="1533"><div title="valid: False, node: 1534, tag: div, level: 17" node_number="1534"><div title="valid: False, node: 1535, tag: div, level: 18" node_number="1535">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1536, tag: div, level: 17" node_number="1536">View all articles by this author</div></div></div><div title="valid: False, node: 1537, tag: div, level: 15" node_number="1537"><div title="valid: False, node: 1538, tag: div, level: 16" node_number="1538">Kanishka Mohib https://orcid.org/0000-0002-7332-5530</div><div title="valid: False, node: 1539, tag: div, level: 16" node_number="1539"><div title="valid: False, node: 1540, tag: div, level: 17" node_number="1540"><div title="valid: False, node: 1541, tag: div, level: 18" node_number="1541">Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1542, tag: div, level: 17" node_number="1542">View all articles by this author</div></div></div><div title="valid: False, node: 1543, tag: div, level: 15" node_number="1543"><div title="valid: False, node: 1544, tag: div, level: 16" node_number="1544">David M. Rothstein https://orcid.org/0000-0002-9455-7971</div><div title="valid: False, node: 1545, tag: div, level: 16" node_number="1545"><div title="valid: False, node: 1546, tag: div, level: 17" node_number="1546"><div title="valid: False, node: 1547, tag: div, level: 18" node_number="1547">Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1548, tag: div, level: 17" node_number="1548">View all articles by this author</div></div></div><div title="valid: False, node: 1549, tag: div, level: 15" node_number="1549"><div title="valid: False, node: 1550, tag: div, level: 16" node_number="1550">Mandy J. McGeachy<sup title="valid: False, node: 1551, tag: sup, level: 17" node_number="1551">*</sup> https://orcid.org/0000-0001-5029-1668 [email&#160;protected]</div><div title="valid: False, node: 1552, tag: div, level: 16" node_number="1552"><div title="valid: False, node: 1553, tag: div, level: 17" node_number="1553"><div title="valid: False, node: 1554, tag: div, level: 18" node_number="1554">Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh PA, USA.</div></div><div title="valid: False, node: 1555, tag: div, level: 17" node_number="1555">View all articles by this author</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1556, tag: section, level: 14" node_number="1556"><h4 title="valid: False, node: 1557, tag: h4, level: 15" node_number="1557">Funding Information</h4><div title="valid: False, node: 1558, tag: div, level: 15" node_number="1558">American Association of Immunologists: AAI 2019-2020</div><div title="valid: False, node: 1559, tag: div, level: 15" node_number="1559">NIH: AI148356</div><div title="valid: False, node: 1560, tag: div, level: 15" node_number="1560">NIH: AI089443</div><div title="valid: False, node: 1561, tag: div, level: 15" node_number="1561">NIH: AI114587</div></section><section class="valid" valid="valid" title="valid: True, node: 1562, tag: section, level: 14" node_number="1562"><h4 title="valid: False, node: 1563, tag: h4, level: 15" node_number="1563">Notes</h4><div title="valid: False, node: 1564, tag: div, level: 15" node_number="1564">*Corresponding author. Email: <a title="valid: False, node: 1565, tag: a, level: 16" node_number="1565">[email&#160;protected]</a></div></section></section></div><div class="valid" valid="valid" title="valid: True, node: 1566, tag: div, level: 12" node_number="1566"><header class="valid" valid="valid" title="valid: True, node: 1567, tag: header, level: 13" node_number="1567"><h2 class="valid" valid="valid" title="valid: True, node: 1568, tag: h2, level: 14" node_number="1568">Metrics Citations</h2></header><section class="valid" valid="valid" title="valid: True, node: 1569, tag: section, level: 13" node_number="1569"><h3 class="valid" valid="valid" title="valid: True, node: 1570, tag: h3, level: 14" node_number="1570">Metrics</h3><section class="valid" valid="valid" title="valid: True, node: 1571, tag: section, level: 14" node_number="1571"> <h5 title="valid: False, node: 1572, tag: h5, level: 15" node_number="1572"> Article Usage </h5> </section><section class="valid" valid="valid" title="valid: True, node: 1573, tag: section, level: 14" node_number="1573"> <h5 title="valid: False, node: 1574, tag: h5, level: 15" node_number="1574"> Altmetrics </h5> </section></section><section class="valid" valid="valid" title="valid: True, node: 1575, tag: section, level: 13" node_number="1575"><h3 class="valid" valid="valid" title="valid: True, node: 1576, tag: h3, level: 14" node_number="1576">Citations</h3><section class="valid" valid="valid" title="valid: True, node: 1577, tag: section, level: 14" node_number="1577"> <div title="valid: False, node: 1578, tag: div, level: 15" node_number="1578"> <h5 title="valid: False, node: 1579, tag: h5, level: 16" node_number="1579">Export citation</h5> <p title="valid: False, node: 1580, tag: p, level: 16" node_number="1580">Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div class="valid" valid="valid" title="valid: True, node: 1581, tag: div, level: 12" node_number="1581"><header class="valid" valid="valid" title="valid: True, node: 1582, tag: header, level: 13" node_number="1582"><h2 class="valid" valid="valid" title="valid: True, node: 1583, tag: h2, level: 14" node_number="1583">View Options</h2></header><div class="valid" valid="valid" title="valid: True, node: 1584, tag: div, level: 13" node_number="1584"><h3 class="valid" valid="valid" title="valid: True, node: 1585, tag: h3, level: 14" node_number="1585">View options</h3><section class="valid" valid="valid" title="valid: True, node: 1586, tag: section, level: 14" node_number="1586"><h4 title="valid: False, node: 1587, tag: h4, level: 15" node_number="1587">PDF format</h4><p title="valid: False, node: 1588, tag: p, level: 15" node_number="1588">Download this article as a PDF file</p><a title="valid: False, node: 1589, tag: a, level: 15" node_number="1589">Download PDF</a></section></div><div class="valid" valid="valid" title="valid: True, node: 1590, tag: div, level: 13" node_number="1590"><h3 class="valid" valid="valid" title="valid: True, node: 1591, tag: h3, level: 14" node_number="1591">Get Access</h3><section class="valid" valid="valid" title="valid: True, node: 1592, tag: section, level: 14" node_number="1592"> <div title="valid: False, node: 1593, tag: div, level: 15" node_number="1593"><h5 title="valid: False, node: 1594, tag: h5, level: 16" node_number="1594">Log in to view the full text</h5> <p title="valid: False, node: 1595, tag: p, level: 16" node_number="1595"><a title="valid: False, node: 1596, tag: a, level: 17" node_number="1596">AAAS Log in</a></p> <p title="valid: False, node: 1597, tag: p, level: 16" node_number="1597">AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul title="valid: False, node: 1598, tag: ul, level: 16" node_number="1598"> <li title="valid: False, node: 1599, tag: li, level: 17" node_number="1599">Become a AAAS Member</li> <li title="valid: False, node: 1600, tag: li, level: 17" node_number="1600"><a title="valid: False, node: 1601, tag: a, level: 18" node_number="1601">Activate your Account</a></li> <li title="valid: False, node: 1602, tag: li, level: 17" node_number="1602"><a title="valid: False, node: 1603, tag: a, level: 18" node_number="1603">Purchase Access to Other Journals in the Science Family</a></li> <li title="valid: False, node: 1604, tag: li, level: 17" node_number="1604"><a title="valid: False, node: 1605, tag: a, level: 18" node_number="1605">Account Help</a></li> </ul> <div title="valid: False, node: 1606, tag: div, level: 16" node_number="1606"> <div title="valid: False, node: 1607, tag: div, level: 17" node_number="1607">Log in via OpenAthens. <div title="valid: False, node: 1608, tag: div, level: 18" node_number="1608"><a title="valid: False, node: 1609, tag: a, level: 19" node_number="1609">via OpenAthens</a></div> </div> <div title="valid: False, node: 1610, tag: div, level: 17" node_number="1610">Log in via Shibboleth. <div title="valid: False, node: 1611, tag: div, level: 18" node_number="1611"><a title="valid: False, node: 1612, tag: a, level: 19" node_number="1612">via Shibboleth</a></div> </div> </div> </div> <div title="valid: False, node: 1613, tag: div, level: 15" node_number="1613"><h4 title="valid: False, node: 1614, tag: h4, level: 16" node_number="1614">More options</h4><p title="valid: False, node: 1615, tag: p, level: 16" node_number="1615"><a title="valid: False, node: 1616, tag: a, level: 17" node_number="1616">Purchase digital access to this article</a></p><p title="valid: False, node: 1617, tag: p, level: 16" node_number="1617">Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div></div><div class="valid" valid="valid" title="valid: True, node: 1618, tag: div, level: 12" node_number="1618"><header class="valid" valid="valid" title="valid: True, node: 1619, tag: header, level: 13" node_number="1619"><h2 class="valid" valid="valid" title="valid: True, node: 1620, tag: h2, level: 14" node_number="1620">Media</h2></header><section class="valid" valid="valid" title="valid: True, node: 1621, tag: section, level: 13" node_number="1621"><h3 class="valid" valid="valid" title="valid: True, node: 1622, tag: h3, level: 14" node_number="1622">Figures</h3></section><section class="valid" valid="valid" title="valid: True, node: 1623, tag: section, level: 13" node_number="1623"><h3 class="valid" valid="valid" title="valid: True, node: 1624, tag: h3, level: 14" node_number="1624">Multimedia</h3></section></div><div class="valid" valid="valid" title="valid: True, node: 1625, tag: div, level: 12" node_number="1625"><header class="valid" valid="valid" title="valid: True, node: 1626, tag: header, level: 13" node_number="1626"><h2 class="valid" valid="valid" title="valid: True, node: 1627, tag: h2, level: 14" node_number="1627">Tables</h2></header></div><div class="valid" valid="valid" title="valid: True, node: 1628, tag: div, level: 12" node_number="1628"><header class="valid" valid="valid" title="valid: True, node: 1629, tag: header, level: 13" node_number="1629"><h2 class="valid" valid="valid" title="valid: True, node: 1630, tag: h2, level: 14" node_number="1630">Share</h2></header><h3 class="valid" valid="valid" title="valid: True, node: 1631, tag: h3, level: 13" node_number="1631">Share</h3><div class="valid" valid="valid" title="valid: True, node: 1632, tag: div, level: 13" node_number="1632"><section class="valid" valid="valid" title="valid: True, node: 1633, tag: section, level: 14" node_number="1633"><h4 title="valid: False, node: 1634, tag: h4, level: 15" node_number="1634">Share article link</h4><div title="valid: False, node: 1635, tag: div, level: 15" node_number="1635"><a title="valid: False, node: 1636, tag: a, level: 16" node_number="1636">Copy Link</a><div title="valid: False, node: 1637, tag: div, level: 16" node_number="1637"><p title="valid: False, node: 1638, tag: p, level: 17" node_number="1638">Copied!</p><p title="valid: False, node: 1639, tag: p, level: 17" node_number="1639">Copying failed.</p></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1640, tag: section, level: 14" node_number="1640"><h4 title="valid: False, node: 1641, tag: h4, level: 15" node_number="1641">Share on social media</h4><div title="valid: False, node: 1642, tag: div, level: 15" node_number="1642"><a title="valid: False, node: 1643, tag: a, level: 16" node_number="1643">facebook</a><a title="valid: False, node: 1644, tag: a, level: 16" node_number="1644">twitter</a><a title="valid: False, node: 1645, tag: a, level: 16" node_number="1645">linkedin</a><a title="valid: False, node: 1646, tag: a, level: 16" node_number="1646">email</a></div></section></div></div></div></article><section class="valid" valid="valid" title="valid: True, node: 1647, tag: section, level: 10" node_number="1647"><div class="valid" valid="valid" title="valid: True, node: 1648, tag: div, level: 11" node_number="1648"><div class="valid" valid="valid" title="valid: True, node: 1649, tag: div, level: 12" node_number="1649"><div class="valid" valid="valid" title="valid: True, node: 1650, tag: div, level: 13" node_number="1650"><div class="valid" valid="valid" title="valid: True, node: 1651, tag: div, level: 14" node_number="1651"><h3 title="valid: False, node: 1652, tag: h3, level: 15" node_number="1652">Submit a Response to This Article</h3></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 1653, tag: div, level: 11" node_number="1653"> <div class="valid" valid="valid" title="valid: True, node: 1654, tag: div, level: 12" node_number="1654"> <h2 class="valid" valid="valid" title="valid: True, node: 1655, tag: h2, level: 13" node_number="1655">(0)eLetters</h2> </div> <p class="valid" valid="valid" title="valid: True, node: 1656, tag: p, level: 12" node_number="1656">eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p class="valid" valid="valid" title="valid: True, node: 1657, tag: p, level: 12" node_number="1657">No eLetters have been published for this article yet.</p> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1658, tag: div, level: 10" node_number="1658"><a class="valid" valid="valid" title="valid: True, node: 1659, tag: a, level: 11" node_number="1659">View Full Text</a><a class="valid" valid="valid" title="valid: True, node: 1660, tag: a, level: 11" node_number="1660">Download PDF</a></div> </div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1661, tag: div, level: 6" node_number="1661"><div class="valid" valid="valid" title="valid: True, node: 1662, tag: div, level: 7" node_number="1662"><div class="valid" valid="valid" title="valid: True, node: 1663, tag: div, level: 8" node_number="1663"><div class="valid" valid="valid" title="valid: True, node: 1664, tag: div, level: 9" node_number="1664"><section class="valid" valid="valid" title="valid: True, node: 1665, tag: section, level: 10" node_number="1665"><div class="valid" valid="valid" title="valid: True, node: 1666, tag: div, level: 11" node_number="1666"><h4 class="valid" valid="valid" title="valid: True, node: 1667, tag: h4, level: 12" node_number="1667"> Current Issue </h4><div class="valid" valid="valid" title="valid: True, node: 1668, tag: div, level: 12" node_number="1668"><div class="valid" valid="valid" title="valid: True, node: 1669, tag: div, level: 13" node_number="1669"> <div class="valid" valid="valid" title="valid: True, node: 1670, tag: div, level: 14" node_number="1670"><div title="valid: False, node: 1671, tag: div, level: 15" node_number="1671"><article title="valid: False, node: 1672, tag: article, level: 16" node_number="1672"><div title="valid: False, node: 1673, tag: div, level: 17" node_number="1673"><div title="valid: False, node: 1674, tag: div, level: 18" node_number="1674"><h3 title="valid: False, node: 1675, tag: h3, level: 19" node_number="1675"><a title="valid: False, node: 1676, tag: a, level: 20" node_number="1676">Mitochondrial C5aR1 activity in macrophages controls IL-1&#946; production underlying sterile inflammation</a></h3><ul title="valid: False, node: 1677, tag: ul, level: 19" node_number="1677"><li title="valid: False, node: 1678, tag: li, level: 20" node_number="1678">By<ul title="valid: False, node: 1679, tag: ul, level: 21" node_number="1679"> <li title="valid: False, node: 1680, tag: li, level: 22" node_number="1680">Nathalie Niyonzima</li> <li title="valid: False, node: 1681, tag: li, level: 22" node_number="1681">Jubayer Rahman</li> <li title="valid: False, node: 1682, tag: li, level: 22" node_number="1682">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1683, tag: article, level: 16" node_number="1683"><div title="valid: False, node: 1684, tag: div, level: 17" node_number="1684"><div title="valid: False, node: 1685, tag: div, level: 18" node_number="1685"><h3 title="valid: False, node: 1686, tag: h3, level: 19" node_number="1686">Tuft cell&#8211;produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation</h3><ul title="valid: False, node: 1687, tag: ul, level: 19" node_number="1687"><li title="valid: False, node: 1688, tag: li, level: 20" node_number="1688">By<ul title="valid: False, node: 1689, tag: ul, level: 21" node_number="1689"> <li title="valid: False, node: 1690, tag: li, level: 22" node_number="1690">Saltanat Ualiyeva</li> <li title="valid: False, node: 1691, tag: li, level: 22" node_number="1691">Evan Lemire</li> <li title="valid: False, node: 1692, tag: li, level: 22" node_number="1692">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1693, tag: article, level: 16" node_number="1693"><div title="valid: False, node: 1694, tag: div, level: 17" node_number="1694"><div title="valid: False, node: 1695, tag: div, level: 18" node_number="1695"><h3 title="valid: False, node: 1696, tag: h3, level: 19" node_number="1696">BNT162b2 vaccination induces durable SARS-CoV-2&#8211;specific T cells with a stem cell memory phenotype</h3><ul title="valid: False, node: 1697, tag: ul, level: 19" node_number="1697"><li title="valid: False, node: 1698, tag: li, level: 20" node_number="1698">By<ul title="valid: False, node: 1699, tag: ul, level: 21" node_number="1699"> <li title="valid: False, node: 1700, tag: li, level: 22" node_number="1700">Gisella Guerrera</li> <li title="valid: False, node: 1701, tag: li, level: 22" node_number="1701">Mario Picozza</li> <li title="valid: False, node: 1702, tag: li, level: 22" node_number="1702">et al.</li> </ul> </li></ul></div></div></article></div><div title="valid: False, node: 1703, tag: div, level: 15" node_number="1703">Table of Contents</div></div> </div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1704, tag: section, level: 10" node_number="1704"> <h4 class="valid" valid="valid" title="valid: True, node: 1705, tag: h4, level: 11" node_number="1705">LATEST NEWS</h4> <div class="valid" valid="valid" title="valid: True, node: 1706, tag: div, level: 11" node_number="1706"> <div class="valid" valid="valid" title="valid: True, node: 1707, tag: div, level: 12" node_number="1707"><div class="valid" valid="valid" title="valid: True, node: 1708, tag: div, level: 13" node_number="1708"> <article class="valid" valid="valid" title="valid: True, node: 1709, tag: article, level: 14" node_number="1709"> <div title="valid: False, node: 1710, tag: div, level: 15" node_number="1710"> <div title="valid: False, node: 1711, tag: div, level: 16" node_number="1711"> News<time title="valid: False, node: 1712, tag: time, level: 17" node_number="1712">30 Dec 2021</time> </div> <div title="valid: False, node: 1713, tag: div, level: 16" node_number="1713"> Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1714, tag: article, level: 14" node_number="1714"> <div title="valid: False, node: 1715, tag: div, level: 15" node_number="1715"> <div title="valid: False, node: 1716, tag: div, level: 16" node_number="1716"> ScienceInsider<time title="valid: False, node: 1717, tag: time, level: 17" node_number="1717">29 Dec 2021</time> </div> <div title="valid: False, node: 1718, tag: div, level: 16" node_number="1718"> <a title="valid: False, node: 1719, tag: a, level: 17" node_number="1719"> Once a &#8216;crazy idea,&#8217; patent-pooling nonprofit will help bring COVID-19 pills to world&#8217;s poor </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1720, tag: article, level: 14" node_number="1720"> <div title="valid: False, node: 1721, tag: div, level: 15" node_number="1721"> <div title="valid: False, node: 1722, tag: div, level: 16" node_number="1722"> ScienceInsider<time title="valid: False, node: 1723, tag: time, level: 17" node_number="1723">28 Dec 2021</time> </div> <div title="valid: False, node: 1724, tag: div, level: 16" node_number="1724"> The natural world loses two of its biggest advocates </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1725, tag: article, level: 14" node_number="1725"> <div title="valid: False, node: 1726, tag: div, level: 15" node_number="1726"> <div title="valid: False, node: 1727, tag: div, level: 16" node_number="1727"> ScienceInsider<time title="valid: False, node: 1728, tag: time, level: 17" node_number="1728">28 Dec 2021</time> </div> <div title="valid: False, node: 1729, tag: div, level: 16" node_number="1729"> <a title="valid: False, node: 1730, tag: a, level: 17" node_number="1730"> What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1731, tag: article, level: 14" node_number="1731"> <div title="valid: False, node: 1732, tag: div, level: 15" node_number="1732"> <div title="valid: False, node: 1733, tag: div, level: 16" node_number="1733"> ScienceInsider<time title="valid: False, node: 1734, tag: time, level: 17" node_number="1734">25 Dec 2021</time> </div> <div title="valid: False, node: 1735, tag: div, level: 16" node_number="1735"> NASA&#8217;s Webb telescope takes flight&#8212;a Christmas gift to astronomers everywhere </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1736, tag: article, level: 14" node_number="1736"> <div title="valid: False, node: 1737, tag: div, level: 15" node_number="1737"> <div title="valid: False, node: 1738, tag: div, level: 16" node_number="1738"> News<time title="valid: False, node: 1739, tag: time, level: 17" node_number="1739">23 Dec 2021</time> </div> <div title="valid: False, node: 1740, tag: div, level: 16" node_number="1740"> <a title="valid: False, node: 1741, tag: a, level: 17" node_number="1741"> More than a virus: Science&#8217;s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>